Second Report on Human Biomonitoring of Environmental Chemicals in Canada - Tables 13.1.1 to 15.12.6

Table 13.1.1: Perfluorobutanoic acid (PFBA) -- Geometric means and selected percentiles of plasma concentrations ( μg/L) for the Canadian population aged 12-79 years by age group, Canadian Health Measures Survey cycle 2 (2009-2011).
Cycle	N	%<LOD^{Table c1 footnote a}	GM (95% CI)	10^th (95% CI)	50^th (95% CI)	75^th (95% CI)	95^th (95% CI)
Table c1 footnotes Table c1 footnote 1 If >40% of samples were below the LOD, the percentile distribution is reported but means were not calculated. Return to table c1 footnote a referrer
Total, 12-79 years
2	1524	99.67	--	<LOD	<LOD	<LOD	<LOD
12-19 years
2	507	99.41	--	<LOD	<LOD	<LOD	<LOD
20-39 years
2	362	100	--	<LOD	<LOD	<LOD	<LOD
40-59 years
2	334	100	--	<LOD	<LOD	<LOD	<LOD
60-79 years
2	321	99.38	--	<LOD	<LOD	<LOD	<LOD

Table 13.1.2: Perfluorobutanoic acid (PFBA) -- Geometric means and selected percentiles of plasma concentrations ( μg/L) for the Canadian population aged 12-79 years by sex and age group, Canadian Health Measures Survey cycle 2 (2009-2011).
Cycle	N	%<LOD^{Table c2 footnote a}	GM (95% CI)	10^th (95% CI)	50^th (95% CI)	75^th (95% CI)	95^th (95% CI)
Table c2 footnotes Table c2 footnote 1 If >40% of samples were below the LOD, the percentile distribution is reported but means were not calculated. Return to table c2 footnote a referrer
Males, Total 12-79 years
2	765	100	--	<LOD	<LOD	<LOD	<LOD
Males, 12-19 years
2	254	100	--	<LOD	<LOD	<LOD	<LOD
Males, 20-39 years
2	170	100	--	<LOD	<LOD	<LOD	X
Males, 40-59 years
2	176	100	--	<LOD	<LOD	<LOD	X
Males, 60-79 years
2	165	100	--	<LOD	<LOD	<LOD	X
Females, Total 12-79 years
2	759	99.34	--	<LOD	<LOD	<LOD	<LOD
Females, 12-19 years
2	253	98.81	--	<LOD	<LOD	<LOD	<LOD
Females, 20-39 years
2	192	100	--	<LOD	<LOD	<LOD	X
Females, 40-59 years
2	158	100	--	<LOD	<LOD	<LOD	X
Females, 60-79 years
2	156	98.72	--	<LOD	<LOD	<LOD	X

Table 13.2.1: Perfluorohexanoic acid (PFHxA) -- Geometric means and selected percentiles of plasma concentrations ( μg/L) for the Canadian population aged 12-79 years by age group, Canadian Health Measures Survey cycle 2 (2009-2011).
Cycle	N	%<LOD^{Table c3 footnote a}	GM (95% CI)	10^th (95% CI)	50^th (95% CI)	75^th (95% CI)	95^th (95% CI)
Table c3 footnotes Table c3 footnote 1 If >40% of samples were below the LOD, the percentile distribution is reported but means were not calculated. Return to table c3 footnote a referrer
Total, 12-79 years
2	1524	98.10	--	<LOD	<LOD	<LOD	<LOD
12-19 years
2	507	98.22	--	<LOD	<LOD	<LOD	<LOD
20-39 years
2	362	98.07	--	<LOD	<LOD	<LOD	<LOD
40-59 years
2	334	98.20	--	<LOD	<LOD	<LOD	<LOD
60-79 years
2	321	97.82	--	<LOD	<LOD	<LOD	<LOD

Table 13.2.2: Perfluorohexanoic acid (PFHxA) -- Geometric means and selected percentiles of plasma concentrations ( μg/L) for the Canadian population aged 12-79 years by sex and age group, Canadian Health Measures Survey cycle 2 (2009-2011).
Cycle	N	%<LOD^{Table c4 footnote a}	GM (95% CI)	10^th (95% CI)	50^th (95% CI)	75^th (95% CI)	95^th (95% CI)
Table c4 footnotes Table c4 footnote 1 If >40% of samples were below the LOD, the percentile distribution is reported but means were not calculated. Return to table c4 footnote a referrer
Males, Total 12-79 years
2	765	98.30	--	<LOD	<LOD	<LOD	<LOD
Males, 12-19 years
2	254	99.21	--	<LOD	<LOD	<LOD	<LOD
Males, 20-39 years
2	170	98.24	--	<LOD	<LOD	<LOD	X
Males, 40-59 years
2	176	97.16	--	<LOD	<LOD	<LOD	X
Males, 60-79 years
2	165	98.18	--	<LOD	<LOD	<LOD	X
Females, Total 12-79 years
2	759	97.89	--	<LOD	<LOD	<LOD	<LOD
Females, 12-19 years
2	253	97.23	--	<LOD	<LOD	<LOD	<LOD
Females, 20-39 years
2	192	97.92	--	<LOD	<LOD	<LOD	X
Females, 40-59 years
2	158	99.37	--	<LOD	<LOD	<LOD	X
Females, 60-79 years
2	156	97.44	--	<LOD	<LOD	<LOD	X

Table 13.3.1: Perfluorooctanoic acid (PFOA) -- Geometric means and selected percentiles of plasma concentrations ( μg/L) for the Canadian population aged 20-79 years ^{Table c5 footnote a}, Canadian Health Measures Survey cycle 1 (2007-2009) and cycle 2 (2009-2011).
Cycle	N	%<LOD^{Table c5 footnote b}	GM (95% CI)	10^th (95% CI)	50^th (95% CI)	75^th (95% CI)	95^th (95% CI)
Table c5 footnotes Table c5 footnote 1 For the purpose of total population comparisons, only values from participants aged 20-79 years were included as participants under the age of 20 years were not included in cycle 1 (2007-2009). Return to table c5 footnote a referrer Table c5 footnote 2 If >40% of samples were below the LOD, the percentile distribution is reported but means were not calculated. Return to table c5 footnote b referrer
Total, 20-79 years
1	2880	1.11	2.5 (2.4 - 2.7)	1.3 (1.1 - 1.4)	2.6 (2.4 - 2.8)	3.6 (3.4 - 3.8)	5.5 (5.1 - 5.8)
2	1017	0	2.3 (2.1 - 2.5)	1.1 (0.91 - 1.2)	2.4 (2.1 - 2.6)	3.3 (2.9 - 3.7)	5.3 (3.9 - 6.7)
Males, 20-79 years
1	1376	0.51	2.9 (2.7 - 3.2)	1.6 (1.4 - 1.7)	3.1 (2.8 - 3.3)	4.0 (3.7 - 4.3)	5.9 (5.4 - 6.4)
2	511	0	2.6 (2.4 - 2.9)	1.3 (0.99 - 1.6)	2.7 (2.5 - 2.9)	3.5 (3.2 - 3.9)	6.0 (4.3 - 7.7)
Females, 20-79 years
1	1504	1.66	2.2 (2.0 - 2.4)	1.0 (0.92 - 1.2)	2.2 (2.1 - 2.4)	3.1 (2.9 - 3.3)	5.0 (4.4 - 5.5)
2	506	0	2.0 (1.8 - 2.2)	0.92 (0.73 - 1.1)	2.0 (1.7 - 2.3)	2.9 (2.2 - 3.5)	4.4 (3.8 - 5.1)

Table 13.3.2: Perfluorooctanoic acid (PFOA) -- Geometric means and selected percentiles of plasma concentrations ( μg/L) for the Canadian population aged 12-79 years by age group, Canadian Health Measures Survey cycle 1 (2007-2009) and Cycle 2 (2009-2011).
Cycle	N	%<LOD^{Table c6 footnote a}	GM (95% CI)	10^th (95% CI)	50^th (95% CI)	75^th (95% CI)	95^th (95% CI)
Table c6 footnotes Table c6 footnote 1 If >40% of samples were below the LOD, the percentile distribution is reported but means were not calculated. Return to table c6 footnote a referrer Table c6 footnote 2 Data not available as participants under the age of 20 years were not included in cycle 1 (2007-2009). Return to table c6 footnote b referrer
Total, 12-79 years
1^{Table c6 footnote b}	.	.	.	.	.	.	.
2	1524	0	2.3 (2.1 - 2.5)	1.1 (0.93 - 1.2)	2.3 (2.1 - 2.5)	3.2 (2.8 - 3.6)	5.0 (3.6 - 6.4)
12-19 years
1^{Table c6 footnote b}	.	.	.	.	.	.	.
2	507	0	2.1 (1.9 - 2.3)	1.2 (1.0 - 1.4)	2.1 (1.9 - 2.3)	2.6 (2.4 - 2.8)	4.1 (3.6 - 4.5)
20-39 years
1	979	1.12	2.4 (2.2 - 2.7)	1.1 (0.95 - 1.3)	2.5 (2.3 - 2.8)	3.6 (3.3 - 3.8)	5.4 (4.8 - 5.9)
2	362	0	2.2 (1.9 - 2.5)	0.88 (0.64 - 1.1)	2.3 (1.9 - 2.8)	3.2 (2.8 - 3.7)	5.8 (3.9 - 7.6)
40-59 years
1	983	1.02	2.5 (2.3 - 2.7)	1.3 (1.2 - 1.4)	2.5 (2.3 - 2.8)	3.5 (3.2 - 3.7)	5.4 (4.6 - 6.1)
2	334	0	2.2 (2.0 - 2.4)	1.1 (0.87 - 1.3)	2.1 (1.7 - 2.5)	3.1 (2.7 - 3.6)	4.4 (3.9 - 5.0)
60-79 years
1	918	1.20	2.8 (2.5 - 3.0)	1.5 (1.3 - 1.7)	2.8 (2.6 - 3.0)	3.9 (3.5 - 4.4)	6.3 (5.4 - 7.1)
2	321	0	2.8 (2.4 - 3.2)	1.5 (1.0 - 2.0)	2.7 (2.1 - 3.2)	3.7 (3.1 - 4.3)	6.4 (4.6 - 8.1)

Table 13.3.3: Perfluorooctanoic acid (PFOA) -- Geometric means and selected percentiles of plasma concentrations ( μg/L) for the Canadian population aged 12-79 years by sex and age group, Canadian Health Measures Survey cycle 1 (2007-2009) and cycle 2 (2009-2011).
Cycle	N	%<LOD^{Table c7 footnote a}	GM (95% CI)	10^th (95% CI)	50^th (95% CI)	75^th (95% CI)	95^th (95% CI)
Table c7 footnotes Table c7 footnote 1 If >40% of samples were below the LOD, the percentile distribution is reported but means were not calculated. Return to table c7 footnote a referrer Table c7 footnote 2 Data not available as participants under the age of 20 years were not included in cycle 1 (2007-2009). Return to table c7 footnote b referrer
Males, Total 12-79 years
1^{Table c7 footnote b}	.	.	.	.	.	.	.
2	765	0	2.6 (2.4 - 2.8)	1.3 (1.0 - 1.6)	2.7 (2.5 - 2.9)	3.4 (3.1 - 3.7)	5.9 (4.3 - 7.6)
Males, 12-19 years
1^{Table c7 footnote b}	.	.	.	.	.	.	.
2	254	0	2.2 (2.1 - 2.3)	1.5 (1.3 - 1.6)	2.2 (2.0 - 2.3)	2.7 (2.5 - 2.9)	4.3 (3.6 - 4.9)
Males, 20-39 years
1	435	0	3.1 (2.8 - 3.4)	1.7 (1.5 - 1.9)	3.2 (3.0 - 3.5)	4.1 (3.7 - 4.4)	5.8 (5.1 - 6.5)
2	170	0	2.9 (2.6 - 3.3)	1.7 (1.1 - 2.3)	2.8 (2.3 - 3.3)	3.9 (3.0 - 4.9)	X
Males, 40-59 years
1	480	0.42	2.9 (2.6 - 3.1)	1.5 (1.3 - 1.7)	2.9 (2.6 - 3.3)	3.9 (3.5 - 4.3)	5.7 (4.9 - 6.5)
2	176	0	2.3 (2.0 - 2.5)	1.0 (0.79 - 1.3)	2.4 (2.0 - 2.8)	3.3 (2.9 - 3.7)	X
Males, 60-79 years
1	461	1.08	2.8 (2.5 - 3.2)	1.5 (1.2 - 1.8)	2.9 (2.6 - 3.2)	4.1 (3.5 - 4.7)	6.4 (5.3 - 7.6)
2	165	0	2.8 (2.5 - 3.1)	1.7 (1.2 - 2.2)	2.9 (2.5 - 3.3)	3.5 (3.1 - 3.9)	X
Females, Total 12-79 years
1^{Table c7 footnote b}	.	.	.	.	.	.	.
2	759	0	2.0 (1.8 - 2.2)	0.99 (0.81 - 1.2)	2.0 (1.8 - 2.2)	2.8 (2.3 - 3.4)	4.4 (3.9 - 4.9)
Females, 12-19 years
1^{Table c7 footnote b}	.	.	.	.	.	.	.
2	253	0	2.0 (1.7 - 2.3)	1.1 (0.91 - 1.2)	2.0 (1.6 - 2.4)	2.5 (2.2 - 2.8)	3.9 (3.5 - 4.4)
Females, 20-39 years
1	544	2.02	1.9 (1.7 - 2.1)	0.95 (0.75 - 1.1)	2.1 (1.8 - 2.3)	2.8 (2.5 - 3.1)	4.3 (3.7 - 5.0)
2	192	0	1.5 (1.3 - 1.8)	0.70 (0.59 - 0.81)	1.5 (1.2 - 1.9)	2.3 (1.9 - 2.6)	X
Females, 40-59 years
1	503	1.59	2.2 (2.0 - 2.4)	1.1 (0.90 - 1.3)	2.2 (2.0 - 2.4)	3.0 (2.8 - 3.2)	4.9 (4.1 - 5.8)
2	158	0	2.1 (1.8 - 2.4)	1.1 (0.86 - 1.3)	2.0 (1.5 - 2.5)	3.0 (2.1 - 3.8)	X
Females, 60-79 years
1	457	1.31	2.7 (2.4 - 3.0)	1.4 (1.2 - 1.7)	2.7 (2.5 - 2.9)	3.7 (3.3 - 4.1)	5.9 (5.3 - 6.5)
2	156	0	2.7 (2.2 - 3.5)	1.4^E (0.85 - 2.0)	2.5 (1.7 - 3.3)	3.9 (3.1 - 4.8)	X

Table 13.4.1: Perfluorononanoic acid (PFNA) -- Geometric means and selected percentiles of plasma concentrations ( μg/L) for the Canadian population aged 12-79 years by age group, Canadian Health Measures Survey cycle 2 (2009-2011).
Cycle	N	%<LOD^{Table c8 footnote a}	GM (95% CI)	10^th (95% CI)	50^th (95% CI)	75^th (95% CI)	95^th (95% CI)
Table c8 footnotes Table c8 footnote 1 If >40% of samples were below the LOD, the percentile distribution is reported but means were not calculated. Return to table c8 footnote a referrer
Total, 12-79 years
2	1524	1.05	0.82 (0.75 - 0.91)	0.39 (0.33 - 0.44)	0.80 (0.70 - 0.90)	1.1 (0.96 - 1.2)	1.9^E (1.1 - 2.7)
12-19 years
2	507	1.18	0.71 (0.62 - 0.81)	0.33 (0.27 - 0.38)	0.69 (0.63 - 0.75)	0.94 (0.83 - 1.0)	1.7^E (0.47 - 2.9)
20-39 years
2	362	2.21	0.79 (0.72 - 0.87)	0.38 (0.30 - 0.46)	0.77 (0.62 - 0.92)	1.1 (0.93 - 1.2)	F
40-59 years
2	334	0.60	0.79 (0.69 - 0.91)	0.41 (0.32 - 0.50)	0.78 (0.65 - 0.91)	1.0 (0.86 - 1.1)	1.7 (1.1 - 2.2)
60-79 years
2	321	0	1.1 (0.87 - 1.3)	0.45^E (0.25 - 0.65)	1.0 (0.86 - 1.1)	1.5 (1.1 - 1.8)	2.7^E (1.5 - 3.8)

Table 13.4.2: Perfluorononanoic acid (PFNA) -- Geometric means and selected percentiles of plasma concentrations ( μg/L) for the Canadian population aged 12-79 years by sex and age group, Canadian Health Measures Survey cycle 2 (2009-2011).
Cycle	N	%<LOD^{Table c9 footnote a}	GM (95% CI)	10^th (95% CI)	50^th (95% CI)	75^th (95% CI)	95^th (95% CI)
Table c9 footnotes Table c9 footnote 1 If >40% of samples were below the LOD, the percentile distribution is reported but means were not calculated. Return to table c9 footnote a referrer
Males, Total 12-79 years
2	765	0.78	0.84 (0.75 - 0.94)	0.43 (0.37 - 0.48)	0.80 (0.69 - 0.91)	1.1 (0.94 - 1.3)	1.9 (1.5 - 2.2)
Males, 12-19 years
2	254	0.79	0.74 (0.63 - 0.86)	0.37 (0.29 - 0.44)	0.70 (0.65 - 0.75)	0.93 (0.80 - 1.1)	F
Males, 20-39 years
2	170	1.76	0.84 (0.71 - 1.0)	0.44^E (0.27 - 0.61)	0.84 (0.64 - 1.0)	1.1 (0.93 - 1.3)	X
Males, 40-59 years
2	176	0.57	0.77 (0.65 - 0.90)	0.40^E (0.20 - 0.61)	0.77 (0.65 - 0.89)	0.98 (0.81 - 1.1)	X
Males, 60-79 years
2	165	0	1.1 (0.90 - 1.2)	0.49^E (0.32 - 0.67)	0.99 (0.80 - 1.2)	1.5 (1.1 - 1.9)	X
Females, Total 12-79 years
2	759	1.32	0.81 (0.73 - 0.90)	0.35 (0.30 - 0.40)	0.79 (0.69 - 0.90)	1.1 (0.94 - 1.2)	2.3^E (1.2 - 3.4)
Females, 12-19 years
2	253	1.58	0.68 (0.57 - 0.80)	0.29 (0.22 - 0.37)	0.65 (0.52 - 0.78)	0.96 (0.76 - 1.2)	1.6 (1.2 - 2.0)
Females, 20-39 years
2	192	2.60	0.73 (0.64 - 0.83)	0.32 (0.24 - 0.39)	0.67 (0.53 - 0.81)	1.0 (0.88 - 1.2)	X
Females, 40-59 years
2	158	0.63	0.81 (0.69 - 0.96)	0.41 (0.32 - 0.50)	0.81 (0.62 - 1.0)	1.0 (0.81 - 1.2)	X
Females, 60-79 years
2	156	0	1.1 (0.81 - 1.4)	0.38^E (<LOD - 0.64)	1.0 (0.82 - 1.2)	1.5 (0.98 - 1.9)	X

Table 13.5.1: Perfluorodecanoic acid (PFDA) -- Geometric means and selected percentiles of plasma concentrations ( μg/L) for the Canadian population aged 12-79 years by age group, Canadian Health Measures Survey cycle 2 (2009-2011).
Cycle	N	%<LOD^{Table c10 footnote a}	GM (95% CI)	10^th (95% CI)	50^th (95% CI)	75^th (95% CI)	95^th (95% CI)
Table c10 footnotes Table c10 footnote 1 If >40% of samples were below the LOD, the percentile distribution is reported but means were not calculated. Return to table c10 footnote a referrer
Total, 12-79 years
2	1524	21.59	0.20 (0.17 - 0.22)	<LOD	0.17 (0.15 - 0.19)	0.27 (0.23 - 0.30)	0.66 (0.45 - 0.87)
12-19 years
2	507	26.43	0.15 (0.13 - 0.18)	<LOD	0.14 (0.12 - 0.16)	0.20 (0.16 - 0.23)	0.39^E (0.22 - 0.55)
20-39 years
2	362	20.72	0.22 (0.20 - 0.23)	<LOD	0.17 (0.16 - 0.19)	0.27 (0.23 - 0.32)	F
40-59 years
2	334	21.56	0.17 (0.14 - 0.21)	<LOD	0.16 (0.13 - 0.19)	0.24 (0.20 - 0.28)	0.51 (0.35 - 0.66)
60-79 years
2	321	14.95	0.25 (0.17 - 0.36)	<LOD	0.23 (0.17 - 0.29)	0.37^E (0.15 - 0.59)	F

Table 13.5.2: Perfluorodecanoic acid (PFDA) -- Geometric means and selected percentiles of plasma concentrations ( μg/L) for the Canadian population aged 12-79 years by sex and age group, Canadian Health Measures Survey cycle 2 (2009-2011).
Cycle	N	%<LOD^{Table c11 footnote a}	GM (95% CI)	10^th (95% CI)	50^th (95% CI)	75^th (95% CI)	95^th (95% CI)
Table c11 footnotes Table c11 footnote 1 If >40% of samples were below the LOD, the percentile distribution is reported but means were not calculated. Return to table c11 footnote a referrer
Males, Total 12-79 years
2	765	20.39	0.20 (0.18 - 0.23)	<LOD	0.18 (0.15 - 0.20)	0.26 (0.23 - 0.30)	0.55 (0.41 - 0.70)
Males, 12-19 years
2	254	25.98	0.15 (0.13 - 0.18)	<LOD	0.14 (0.12 - 0.16)	0.20 (0.16 - 0.24)	0.38 (0.25 - 0.50)
Males, 20-39 years
2	170	19.41	0.21 (0.18 - 0.24)	<LOD	0.18 (0.15 - 0.21)	0.26 (0.21 - 0.31)	X
Males, 40-59 years
2	176	19.89	0.18 (0.15 - 0.23)	<LOD	0.17 (0.13 - 0.20)	0.25 (0.21 - 0.29)	X
Males, 60-79 years
2	165	13.33	0.26 (0.19 - 0.34)	<LOD	0.23 (0.18 - 0.29)	0.36^E (0.14 - 0.59)	X
Females, Total 12-79 years
2	759	22.79	0.19 (0.16 - 0.23)	<LOD	0.17 (0.14 - 0.19)	0.27 (0.22 - 0.33)	F
Females, 12-19 years
2	253	26.88	0.15 (0.12 - 0.20)	<LOD	0.14 (0.11 - 0.17)	0.20 (0.15 - 0.25)	0.40^E (0.20 - 0.60)
Females, 20-39 years
2	192	21.88	0.22 (0.18 - 0.27)	<LOD	0.17 (0.15 - 0.19)	0.30 (0.21 - 0.40)	X
Females, 40-59 years
2	158	23.42	0.16 (0.12 - 0.21)	<LOD	0.15 (<LOD - 0.21)	0.24 (0.18 - 0.29)	X
Females, 60-79 years
2	156	16.67	0.24^E (0.15 - 0.39)	<LOD	0.23^E (0.14 - 0.31)	0.37^E (0.13 - 0.61)	X

Table 13.6.1: Perfluoroundecanoic acid (PFUnDA) -- Geometric means and selected percentiles of plasma concentrations ( μg/L) for the Canadian population aged 12-79 years by age group, Canadian Health Measures Survey cycle 2 (2009-2011).
Cycle	N	%<LOD^{Table c12 footnote a}	GM (95% CI)	10^th (95% CI)	50^th (95% CI)	75^th (95% CI)	95^th (95% CI)
Table c12 footnotes Table c12 footnote 1 If >40% of samples were below the LOD, the percentile distribution is reported but means were not calculated. Return to table c12 footnote a referrer
2	1522	39.29	0.12 (0.098 - 0.14)	<LOD	0.095 (<LOD - 0.10)	0.18 (0.14 - 0.22)	0.56^E (0.30 - 0.82)
12-19 years
2	506	58.30	--	<LOD	<LOD	0.098 (<LOD - 0.12)	0.30 (0.21 - 0.38)
20-39 years
2	362	37.02	0.13 (0.10 - 0.16)	<LOD	0.098 (<LOD - 0.12)	0.20 (0.15 - 0.25)	0.64^E (0.22 - 1.1)
40-59 years
2	334	26.35	0.11 (0.094 - 0.14)	<LOD	0.095 (<LOD - 0.10)	0.16 (0.10 - 0.22)	0.43 (0.28 - 0.58)
60-79 years
2	320	25.31	0.14^E (<LOD - 0.23)	<LOD	0.11^E (<LOD - 0.17)	0.28^E (0.14 - 0.42)	0.84^E (0.42 - 1.3)

Table 13.6.2: Perfluoroundecanoic acid (PFUnDA) -- Geometric means and selected percentiles of plasma concentrations ( μg/L) for the Canadian population aged 12-79 years by sex and age group, Canadian Health Measures Survey cycle 2 (2009-2011).
Cycle	N	%<LOD^{Table c13 footnote a}	GM (95% CI)	10^th (95% CI)	50^th (95% CI)	75^th (95% CI)	95^th (95% CI)
Table c13 footnotes Table c13 footnote 1 If >40% of samples were below the LOD, the percentile distribution is reported but means were not calculated. Return to table c13 footnote a referrer
Males, Total 12-79 years
2	765	40.39	--	<LOD	0.094 (<LOD - 0.11)	0.19 (0.13 - 0.24)	0.47^E (0.27 - 0.67)
Males, 12-19 years
2	254	60.63	--	<LOD	<LOD	0.098 (<LOD - 0.13)	0.32 (0.23 - 0.42)
Males, 20-39 years
2	170	38.24	0.11 (<LOD - 0.14)	<LOD	0.092^E (<LOD - 0.13)	0.18 (0.11 - 0.24)	X
Males, 40-59 years
2	176	28.98	0.12 (0.094 - 0.16)	<LOD	0.097^E (<LOD - 0.13)	0.19^E (0.091 - 0.29)	X
Males, 60-79 years
2	165	23.64	0.15^E (0.10 - 0.23)	<LOD	0.12^E (<LOD - 0.20)	0.32^E (0.16 - 0.48)	X
Females, Total 12-79 years
2	757	38.18	0.12 (0.10 - 0.15)	<LOD	0.096 (<LOD - 0.11)	0.18 (0.13 - 0.23)	0.63^E (0.24 - 1.0)
Females, 12-19 years
2	252	55.95	--	<LOD	<LOD	0.098 (<LOD - 0.12)	0.24 (0.16 - 0.33)
Females, 20-39 years
2	192	35.94	0.15 (0.12 - 0.20)	<LOD	0.12 (<LOD - 0.16)	0.26^E (0.15 - 0.37)	X
Females, 40-59 years
2	158	23.42	0.11 (<LOD - 0.13)	<LOD	0.095 (<LOD - 0.11)	0.12^E (<LOD - 0.18)	X
Females, 60-79 years
2	155	27.10	0.14^E (<LOD - 0.24)	<LOD	0.10^E (<LOD - 0.17)	0.24^E (<LOD - 0.39)	X

Table 13.7.1: Perfluorobutane sulfonate (PFBS) -- Geometric means and selected percentiles of plasma concentrations ( μg/L) for the Canadian population aged 12-79 years by age group, Canadian Health Measures Survey cycle 2 (2009-2011).
Cycle	N	%<LOD^{Table c14 footnote a}	GM (95% CI)	10^th (95% CI)	50^th (95% CI)	75^th (95% CI)	95^th (95% CI)
Table c14 footnotes Table c14 footnote 1 If >40% of samples were below the LOD, the percentile distribution is reported but means were not calculated. Return to table c14 footnote a referrer
Total, 12-79 years
2	1524	100	--	<LOD	<LOD	<LOD	<LOD
12-19 years
2	507	100	--	<LOD	<LOD	<LOD	<LOD
20-39 years
2	362	100	--	<LOD	<LOD	<LOD	<LOD
40-59 years
2	334	100	--	<LOD	<LOD	<LOD	<LOD
60-79 years
2	321	100	--	<LOD	<LOD	<LOD	<LOD

Table 13.7.2: Perfluorobutane sulfonate (PFBS) -- Geometric means and selected percentiles of plasma concentrations ( μg/L) for the Canadian population aged 12-79 years by sex and age group, Canadian Health Measures Survey cycle 2 (2009-2011).
Cycle	N	%<LOD^{Table c15 footnote a}	GM (95% CI)	10^th (95% CI)	50^th (95% CI)	75^th (95% CI)	95^th (95% CI)
Table c15 footnotes Table c15 footnote 1 If >40% of samples were below the LOD, the percentile distribution is reported but means were not calculated. Return to table c15 footnote a referrer
Males, Total 12-79 years
2	765	100	--	<LOD	<LOD	<LOD	<LOD
Males, 12-19 years
2	254	100	--	<LOD	<LOD	<LOD	<LOD
Males, 20-39 years
2	170	100	--	<LOD	<LOD	<LOD	X
Males, 40-59 years
2	176	100	--	<LOD	<LOD	<LOD	X
Males, 60-79 years
2	165	100	--	<LOD	<LOD	<LOD	X
Females, Total 12-79 years
2	759	100	--	<LOD	<LOD	<LOD	<LOD
Females, 12-19 years
2	253	100	--	<LOD	<LOD	<LOD	<LOD
Females, 20-39 years
2	192	100	--	<LOD	<LOD	<LOD	X
Females, 40-59 years
2	158	100	--	<LOD	<LOD	<LOD	X
Females, 60-79 years
2	156	100	--	<LOD	<LOD	<LOD	X

Table 13.8.1: Perfluorohexane sulfonate (PFHxS) -- Geometric means and selected percentiles of plasma concentrations ( μg/L) for the Canadian population aged 20-79 years ^{Table c16 footnote a}, Canadian Health Measures Survey cycle 1 (2007-2009) and cycle 2 (2009-2011).
Cycle	N	%<LOD^{Table c16 footnote b}	GM (95% CI)	10^th (95% CI)	50^th (95% CI)	75^th (95% CI)	95^th (95% CI)
Table c16 footnotes Table c16 footnote 1 For the purpose of total population comparisons, only values from participants aged 20-79 years were included as participants under the age of 20 years were not included in cycle 1 (2007-2009). Return to table c16 footnote a referrer Table c16 footnote 2 If >40% of samples were below the LOD, the percentile distribution is reported but means were not calculated. Return to table c16 footnote b referrer
Total, 20-79 years
1	2880	2.05	2.3 (2.0 - 2.6)	0.70 (0.50 - 0.89)	2.2 (1.8 - 2.5)	3.7 (3.2 - 4.1)	12 (9.2 - 15)
2	1015	1.38	1.7 (1.6 - 2.0)	0.55 (0.44 - 0.65)	1.7 (1.5 - 1.9)	2.7 (2.0 - 3.4)	8.9^E (4.6 - 13)
Males, 20-79 years
1	1376	0.58	3.2 (2.8 - 3.7)	1.3 (1.1 - 1.6)	2.8 (2.4 - 3.2)	4.6 (4.0 - 5.2)	16 (11 - 20)
2	510	0.59	2.4 (2.0 - 2.8)	0.94 (0.76 - 1.1)	2.1 (1.9 - 2.4)	3.6 (2.7 - 4.5)	9.4^E (4.9 - 14)
Females, 20-79 years
1	1504	3.39	1.6 (1.4 - 1.9)	0.50 (0.38 - 0.62)	1.5 (1.2 - 1.7)	2.7 (2.3 - 3.1)	8.5 (6.6 - 10)
2	505	2.18	1.3 (1.1 - 1.5)	0.40 (0.34 - 0.45)	1.2 (1.0 - 1.3)	2.0 (1.6 - 2.4)	8.2^E (3.4 - 13)

Table 13.8.2: Perfluorohexane sulfonate (PFHxS) - Geometric means and selected percentiles of plasma concentrations (μg/L) for the Canadian population aged 12-79 years by age group, Canadian Health Measures Survey cycle 1 (2007-2009) and Cycle 2 (2009-2011).
Cycle	N	%<LOD^{Table c17 footnote a}	GM (95% CI)	10^th (95% CI)	50^th (95% CI)	75^th (95% CI)	95^th (95% CI)
Table c17 footnotes Table c17 footnote 1 If >40% of samples were below the LOD, the percentile distribution is reported but means were not calculated. Return to table c17 footnote a referrer Table c17 footnote 2 Data not available as participants under the age of 20 years were not included in cycle 1 (2007-2009). Return to table c17 footnote b referrer
Total, 12-79 years
1^{Table c17 footnote b}	.	.	.	.	.	.	.
2	1521	1.25	1.8 (1.6 - 2.0)	0.55 (0.46 - 0.64)	1.7 (1.5 - 1.9)	2.8 (2.2 - 3.5)	9.0^E (4.9 - 13)
12-19 years
1^{Table c17 footnote b}	.	.	.	.	.	.	.
2	506	0.99	1.9 (1.6 - 2.3)	0.60 (0.50 - 0.70)	1.6 (1.3 - 1.9)	3.4 (2.3 - 4.5)	11^E (5.7 - 16)
20-39 years
1	979	3.06	2.1 (1.8 - 2.4)	0.61 (0.49 - 0.73)	1.9 (1.5 - 2.2)	3.6 (3.2 - 3.9)	16^E (10 - 23)
2	361	1.94	1.5 (1.3 - 1.9)	0.41 (0.28 - 0.54)	1.6 (1.1 - 2.1)	2.5^E (1.5 - 3.5)	6.0^E (2.1 - 9.9)
40-59 years
1	983	2.03	2.2 (1.9 - 2.5)	0.79 (0.54 - 1.0)	2.2 (1.8 - 2.5)	3.6 (3.0 - 4.2)	9.2 (7.4 - 11)
2	333	1.80	1.8 (1.4 - 2.3)	0.58^E (0.33 - 0.83)	1.7 (1.3 - 2.0)	2.6^E (1.5 - 3.6)	12^E (3.5 - 21)
60-79 years
1	918	0.98	2.8 (2.4 - 3.3)	1.1 (0.90 - 1.3)	2.6 (2.1 - 3.0)	4.3 (3.5 - 5.1)	13 (9.0 - 16)
2	321	0.31	2.2 (1.8 - 2.7)	0.86 (0.64 - 1.1)	2.0 (1.6 - 2.4)	3.4 (2.4 - 4.4)	9.8 (6.7 - 13)

Table 13.8.3: Perfluorohexane sulfonate (PFHxS) -- Geometric means and selected percentiles of plasma concentrations ( μg/L) for the Canadian population aged 12-79 years by sex and age group, Canadian Health Measures Survey cycle 1 (2007-2009) and cycle 2 (2009-2011).
Cycle	N	%<LOD^{Table c18 footnote a}	GM (95% CI)	10^th (95% CI)	50^th (95% CI)	75^th (95% CI)	95^th (95% CI)
Table c18 footnotes Table c18 footnote 1 If >40% of samples were below the LOD, the percentile distribution is reported but means were not calculated. Return to table c18 footnote a referrer Table c18 footnote 2 Data not available as participants under the age of 20 years were not included in cycle 1 (2007-2009). Return to table c18 footnote b referrer
Males, Total 12-79 years
1^{Table c18 footnote b}	.	.	.	.	.	.	.
2	763	0.66	2.4 (2.0 - 2.7)	0.92 (0.82 - 1.0)	2.1 (1.9 - 2.4)	3.6 (2.8 - 4.5)	9.9^E (5.5 - 14)
Males, 12-19 years
1^{Table c18 footnote b}	.	.	.	.	.	.	.
2	253	0.79	2.2 (1.8 - 2.8)	0.69 (0.49 - 0.90)	1.9 (1.3 - 2.4)	4.1^E (2.3 - 5.9)	F
Males, 20-39 years
1	435	0.23	3.3 (2.7 - 4.1)	1.2 (0.89 - 1.6)	2.8 (2.3 - 3.2)	4.7 (3.3 - 6.1)	F
2	169	0.59	2.4 (1.9 - 3.1)	0.91 (0.72 - 1.1)	2.1 (1.6 - 2.7)	3.7^E (2.2 - 5.3)	X
Males, 40-59 years
1	480	0.42	3.3 (2.8 - 3.8)	1.4 (1.1 - 1.7)	2.9 (2.4 - 3.4)	4.7 (3.4 - 6.0)	11^E (5.3 - 16)
2	176	1.14	2.2 (1.9 - 2.6)	1.2 (0.85 - 1.5)	2.2 (1.9 - 2.4)	3.0 (2.1 - 3.9)	X
Males, 60-79 years
1	461	1.08	3.0 (2.5 - 3.5)	1.2 (0.94 - 1.4)	2.8 (2.2 - 3.3)	4.3 (3.6 - 5.0)	12 (8.7 - 16)
2	165	0	2.4 (2.0 - 3.0)	0.92 (0.69 - 1.2)	2.2 (1.7 - 2.6)	3.8 (2.5 - 5.0)	X
Females, Total 12-79 years
1^{Table c18 footnote b}	.	.	.	.	.	.	.
2	758	1.85	1.3 (1.1 - 1.5)	0.41 (0.36 - 0.46)	1.2 (1.0 - 1.3)	2.1 (1.7 - 2.4)	8.5^E (3.7 - 13)
Females, 12-19 years
1^{Table c18 footnote b}	.	.	.	.	.	.	.
2	253	1.19	1.6 (1.2 - 2.0)	0.54 (0.41 - 0.68)	1.2 (0.89 - 1.6)	2.4^E (1.4 - 3.4)	9.0^E (3.5 - 14)
Females, 20-39 years
1	544	5.33	1.3 (1.1 - 1.6)	0.37^E (<LOD - 0.56)	1.2 (1.0 - 1.3)	2.1 (1.5 - 2.8)	8.0^E (4.2 - 12)
2	192	3.13	0.86 (0.68 - 1.1)	0.25^E (<LOD - 0.42)	0.99 (0.86 - 1.1)	1.3 (0.97 - 1.7)	X
Females, 40-59 years
1	503	3.58	1.5 (1.3 - 1.8)	0.47 (0.32 - 0.62)	1.4 (1.1 - 1.7)	2.5 (2.1 - 2.9)	6.6 (4.9 - 8.4)
2	157	2.55	1.5^E (0.95 - 2.3)	0.51 (0.34 - 0.69)	1.1 (0.78 - 1.5)	F	X
Females, 60-79 years
1	457	0.88	2.7 (2.2 - 3.3)	1.0 (0.78 - 1.3)	2.3 (1.9 - 2.8)	4.0 (2.7 - 5.2)	13^E (6.9 - 19)
2	156	0.64	2.0 (1.5 - 2.6)	0.68^E (0.27 - 1.1)	1.9 (1.3 - 2.4)	3.2 (2.2 - 4.3)	X

Table 13.9.1: Perfluorooctane sulfonate (PFOS) -- Geometric means and selected percentiles of plasma concentrations (μg/L) for the Canadian population aged 20-79 years ^{Table c19 footnote a}, Canadian Health Measures Survey cycle 1 (2007-2009) and cycle 2 (2009-2011).
Cycle	N	%<LOD^{Table c19 footnote b}	GM (95% CI)	10^th (95% CI)	50^th (95% CI)	75^th (95% CI)	95^th (95% CI)
Table c19 footnotes Table c19 footnote 1 For the purpose of total population comparisons, only values from participants aged 20-79 years were included as participants under the age of 20 years were not included in cycle 1 (2007-2009). Return to table c19 footnote a referrer Table c19 footnote 2 If >40% of samples were below the LOD, the percentile distribution is reported but means were not calculated. Return to table c19 footnote b referrer
Total, 20-79 years
1	2880	0.14	8.9 (8.0 - 9.8)	3.6 (3.1 - 4.1)	9.1 (8.1 - 10)	13 (12 - 15)	27 (22 - 32)
2	1017	0.39	6.9 (6.2 - 7.6)	2.6 (1.9 - 3.2)	6.8 (6.0 - 7.6)	11 (9.5 - 12)	19 (13 - 25)
Males, 20-79 years
1	1376	0.07	11 (10 - 12)	5.1 (4.3 - 6.0)	11 (9.5 - 12)	16 (14 - 18)	31 (23 - 39)
2	511	0.39	8.3 (7.4 - 9.3)	4.7 (3.6 - 5.8)	8.2 (6.6 - 9.8)	12 (9.9 - 14)	19 (14 - 25)
Females, 20-79 years
1	1504	0.20	7.1 (6.3 - 7.9)	3.0 (2.6 - 3.4)	7.4 (6.4 - 8.4)	11 (9.6 - 12)	20 (15 - 24)
2	506	0.40	5.7 (4.9 - 6.6)	2.0 (1.5 - 2.4)	6.0 (5.1 - 6.9)	9.0 (7.1 - 11)	19^E (7.8 - 30)

Table 13.9.2: Perfluorooctane sulfonate (PFOS) - Geometric means and selected percentiles of plasma concentrations (μg/L) for the Canadian population aged 12-79 years by age group, Canadian Health Measures Survey cycle 1 (2007-2009) and Cycle 2 (2009-2011).
Cycle	N	%<LOD^{Table c20 footnote a}	GM (95% CI)	10^th (95% CI)	50^th (95% CI)	75^th (95% CI)	95^th (95% CI)
Table c20 footnotes Table c20 footnote 1 If >40% of samples were below the LOD, the percentile distribution is reported but means were not calculated. Return to table c20 footnote a referrer Table c20 footnote 2 Data not available as participants under the age of 20 years were not included in cycle 1 (2007-2009). Return to table c20 footnote b referrer
Total, 12-79 years
1^{Table c20 footnote b}	.	.	.	.	.	.	.
2	1524	0.33	6.5 (5.9 - 7.2)	2.4 (2.0 - 2.8)	6.7 (6.1 - 7.3)	10 (9.3 - 11)	18 (13 - 23)
12-19 years
1^{Table c20 footnote b}	.	.	.	.	.	.	.
2	507	0.20	4.6 (4.0 - 5.2)	2.1 (1.9 - 2.4)	4.6 (3.9 - 5.3)	6.6 (5.7 - 7.5)	11 (9.2 - 13)
20-39 years
1	979	0.10	8.2 (7.2 - 9.3)	3.5 (2.8 - 4.1)	8.6 (7.3 - 9.9)	12 (11 - 14)	21 (19 - 24)
2	362	0.55	6.2 (5.4 - 7.1)	2.1^E (0.99 - 3.2)	6.7 (5.8 - 7.6)	10 (7.4 - 13)	19^E (9.6 - 29)
40-59 years
1	983	0.31	8.6 (7.7 - 9.5)	3.4 (2.8 - 4.0)	8.8 (7.9 - 9.7)	13 (11 - 15)	28 (19 - 37)
2	334	0.60	6.4 (5.7 - 7.2)	2.3 (1.6 - 3.0)	6.7 (5.7 - 7.7)	10 (8.7 - 11)	16 (13 - 19)
60-79 years
1	918	0	11 (9.6 - 13)	4.4 (3.3 - 5.5)	11 (9.6 - 13)	17 (14 - 19)	30 (24 - 35)
2	321	0	9.4 (8.3 - 11)	4.6 (3.9 - 5.3)	9.8 (8.1 - 11)	15 (13 - 16)	21^E (7.5 - 35)

Table 13.9.3: Perfluorooctane sulfonate (PFOS) -- Geometric means and selected percentiles of plasma concentrations (μg/L) for the Canadian population aged 12-79 years by sex and age group, Canadian Health Measures Survey cycle 1 (2007-2009) and cycle 2 (2009-2011).
Cycle	N	%<LOD^{Table c21 footnote a}	GM (95% CI)	10^th (95% CI)	50^th (95% CI)	75^th (95% CI)	95^th (95% CI)
Table c21 footnotes Table c21 footnote 1 If >40% of samples were below the LOD, the percentile distribution is reported but means were not calculated. Return to table c21 footnote a referrer Table c21 footnote 2 Data not available as participants under the age of 20 years were not included in cycle 1 (2007-2009). Return to table c21 footnote b referrer
Males, Total 12-79 years
1^{Table c21 footnote b}	.	.	.	.	.	.	.
2	765	0.26	7.8 (7.1 - 8.7)	3.8 (2.8 - 4.8)	7.6 (6.3 - 9.0)	11 (9.8 - 13)	19 (14 - 24)
Males, 12-19 years
1^{Table c21 footnote b}	.	.	.	.	.	.	.
2	254	0	5.1 (4.6 - 5.7)	2.4 (2.1 - 2.6)	5.2 (4.6 - 5.7)	7.1 (6.0 - 8.3)	13^E (7.5 - 18)
Males, 20-39 years
1	435	0	10 (9.2 - 12)	5.3 (4.3 - 6.2)	10 (9.2 - 11)	14 (13 - 16)	27 (20 - 35)
2	170	0.59	8.2 (6.8 - 10)	4.8 (4.1 - 5.4)	7.6^E (4.7 - 11)	12 (8.9 - 14)	X
Males, 40-59 years
1	480	0.21	11 (10 - 13)	5.0 (4.0 - 6.0)	11 (9.1 - 12)	16 (14 - 18)	34 (22 - 46)
2	176	0.57	7.5 (6.7 - 8.4)	3.2^E (1.8 - 4.7)	7.6 (6.7 - 8.5)	10 (9.2 - 12)	X
Males, 60-79 years
1	461	0	12 (10 - 14)	5.0^E (3.0 - 6.9)	12 (9.5 - 14)	18 (14 - 22)	35 (23 - 46)
2	165	0	10 (8.9 - 12)	4.7 (3.4 - 6.0)	11 (7.9 - 14)	15 (13 - 17)	X
Females, Total 12-79 years
1^{Table c21 footnote b}	.	.	.	.	.	.	.
2	759	0.40	5.5 (4.8 - 6.2)	2.0 (1.6 - 2.3)	5.7 (4.8 - 6.5)	8.4 (6.8 - 10)	18^E (9.7 - 27)
Females, 12-19 years
1^{Table c21 footnote b}	.	.	.	.	.	.	.
2	253	0.40	4.1 (3.4 - 4.8)	2.0 (1.7 - 2.3)	4.0 (3.2 - 4.8)	6.1 (5.0 - 7.3)	9.0 (7.3 - 11)
Females, 20-39 years
1	544	0.18	6.4 (5.4 - 7.5)	3.0 (2.6 - 3.4)	6.4 (5.1 - 7.7)	9.8 (7.7 - 12)	16 (14 - 19)
2	192	0.52	4.4 (3.5 - 5.6)	1.6^E (0.97 - 2.3)	4.3 (2.9 - 5.8)	6.7 (5.8 - 7.7)	X
Females, 40-59 years
1	503	0.40	6.5 (5.8 - 7.3)	2.8 (2.2 - 3.3)	6.9 (6.0 - 7.9)	9.9 (9.3 - 11)	17 (12 - 22)
2	158	0.63	5.6 (4.6 - 6.8)	2.2^E (1.4 - 3.0)	6.2 (4.5 - 7.9)	9.3 (6.6 - 12)	X
Females, 60-79 years
1	457	0	10 (8.6 - 12)	4.1 (3.0 - 5.1)	10 (8.8 - 12)	15 (12 - 17)	27 (22 - 31)
2	156	0	8.8 (7.2 - 11)	4.3 (2.9 - 5.6)	8.4 (5.5 - 11)	14 (9.9 - 18)	X

Table 14.1.1.1: Atrazine mercapturate (AM) -- Geometric means and selected percentiles of urine concentrations ( μg/L) for the Canadian population aged 3-79 years by age group, Canadian Health Measures Survey cycle 2 (2009-2011).
Cycle	N	%<LOD^{Table c22 footnote a}	GM (95% CI)	10^th (95% CI)	50^th (95% CI)	75^th (95% CI)	95^th (95% CI)
Table c22 footnotes Table c22 footnote 1 If >40% of samples were below the LOD, the percentile distribution is reported but means were not calculated. Return to table c22 footnote a referrer
Total, 3-79 years
2	2526	99.88	--	<LOD	<LOD	<LOD	<LOD
3-5 years
2	508	99.80	--	<LOD	<LOD	<LOD	<LOD
6-11 years
2	511	100	--	<LOD	<LOD	<LOD	<LOD
12-19 years
2	506	100	--	<LOD	<LOD	<LOD	<LOD
20-39 years
2	355	99.72	--	<LOD	<LOD	<LOD	<LOD
40-59 years
2	359	99.72	--	<LOD	<LOD	<LOD	<LOD
60-79 years
2	287	100	--	<LOD	<LOD	<LOD	<LOD

Table 14.1.1.2: Atrazine mercapturate (AM) -- Geometric means and selected percentiles of urine concentrations ( μg/L) for the Canadian population aged 3-79 years by sex and age group ^{Table c23 footnote a}, Canadian Health Measures Survey cycle 2 (2009-2011).
Cycle	N	%<LOD^{Table c23 footnote b}	GM (95% CI)	10^th (95% CI)	50^th (95% CI)	75^th (95% CI)	95^th (95% CI)
Table c23 footnotes Table c23 footnote 1 Breakdown by sex for the 3-5 year old age group is not recommended. Return to table c23 footnote a referrer Table c23 footnote 2 If >40% of samples were below the LOD, the percentile distribution is reported but means were not calculated. Return to table c23 footnote b referrer
Males, Total 3-79 years
2	1268	99.92	--	<LOD	<LOD	<LOD	<LOD
Males, 6-11 years
2	261	100	--	<LOD	<LOD	<LOD	<LOD
Males, 12-19 years
2	255	100	--	<LOD	<LOD	<LOD	<LOD
Males, 20-39 years
2	166	100	--	<LOD	<LOD	<LOD	X
Males, 40-59 years
2	193	99.48	--	<LOD	<LOD	<LOD	X
Males, 60-79 years
2	142	100	--	<LOD	<LOD	<LOD	X
Females, Total 3-79 years
2	1258	99.84	--	<LOD	<LOD	<LOD	<LOD
Females, 6-11 years
2	250	100	--	<LOD	<LOD	<LOD	<LOD
Females, 12-19 years
2	251	100	--	<LOD	<LOD	<LOD	<LOD
Females, 20-39 years
2	189	99.47	--	<LOD	<LOD	<LOD	X
Females, 40-59 years
2	166	100	--	<LOD	<LOD	<LOD	X
Females, 60-79 years
2	145	100	--	<LOD	<LOD	<LOD	X

Table 14.1.1.3: Atrazine mercapturate (AM) (creatinine adjusted) -- Geometric means and selected percentiles of urine concentrations ( μg/g creatinine) for the Canadian population aged 3-79 years by age group, Canadian Health Measures Survey cycle 2 (2009-2011).
Cycle	N	%<LOD^{Table c24 footnote a}	GM (95% CI)	10^th (95% CI)	50^th (95% CI)	75^th (95% CI)	95^th (95% CI)
Table c24 footnotes Table c24 footnote 1 If >40% of samples were below the LOD, the percentile distribution is reported but means were not calculated. Return to table c24 footnote a referrer
Total, 3-79 years
2	2516	100	--	<LOD	<LOD	<LOD	<LOD
3-5 years
2	507	100	--	<LOD	<LOD	<LOD	<LOD
6-11 years
2	509	100	--	<LOD	<LOD	<LOD	<LOD
12-19 years
2	504	100	--	<LOD	<LOD	<LOD	<LOD
20-39 years
2	353	100	--	<LOD	<LOD	<LOD	<LOD
40-59 years
2	357	100	--	<LOD	<LOD	<LOD	<LOD
60-79 years
2	286	100	--	<LOD	<LOD	<LOD	<LOD

Table 14.1.1.4: Atrazine mercapturate (AM) (creatinine adjusted) -- Geometric means and selected percentiles of urine concentrations ( μg/g creatinine) for the Canadian population aged 3-79 years by sex and age group ^{Table c25 footnote a}, Canadian Health Measures Survey cycle 2 (2009-2011).
Cycle	N	%<LOD^{Table c25 footnote b}	GM (95% CI)	10^th (95% CI)	50^th (95% CI)	75^th (95% CI)	95^th (95% CI)
Table c25 footnotes Table c25 footnote 1 Breakdown by sex for the 3-5 year old age group is not recommended. Return to table c25 footnote a referrer Table c25 footnote 2 If >40% of samples were below the LOD, the percentile distribution is reported but means were not calculated. Return to table c25 footnote b referrer
Males, Total 3-79 years
2	1264	100	--	<LOD	<LOD	<LOD	<LOD
Males, 6-11 years
2	260	100	--	<LOD	<LOD	<LOD	<LOD
Males, 12-19 years
2	254	100	--	<LOD	<LOD	<LOD	<LOD
Males, 20-39 years
2	165	100	--	<LOD	<LOD	<LOD	X
Males, 40-59 years
2	193	99.48	--	<LOD	<LOD	<LOD	X
Males, 60-79 years
2	142	100	--	<LOD	<LOD	<LOD	X
Females, Total 3-79 years
2	1252	100	--	<LOD	<LOD	<LOD	<LOD
Females, 6-11 years
2	249	100	--	<LOD	<LOD	<LOD	<LOD
Females, 12-19 years
2	250	100	--	<LOD	<LOD	<LOD	<LOD
Females, 20-39 years
2	188	100	--	<LOD	<LOD	<LOD	X
Females, 40-59 years
2	164	100	--	<LOD	<LOD	<LOD	X
Females, 60-79 years
2	144	100	--	<LOD	<LOD	<LOD	X

Table 14.1.2.1: Diaminochlorotriazine (DACT) -- Geometric means and selected percentiles of urine concentrations ( μg/L) for the Canadian population aged 3-79 years by age group, Canadian Health Measures Survey cycle 2 (2009-2011).
Cycle	N	%<LOD^{Table c26 footnote a}	GM (95% CI)	10^th (95% CI)	50^th (95% CI)	75^th (95% CI)	95^th (95% CI)
Table c26 footnotes Table c26 footnote 1 If >40% of samples were below the LOD, the percentile distribution is reported but means were not calculated. Return to table c26 footnote a referrer
Total, 3-79 years
2	2526	100	--	<LOD	<LOD	<LOD	<LOD
3-5 years
2	508	100	--	<LOD	<LOD	<LOD	<LOD
6-11 years
2	511	100	--	<LOD	<LOD	<LOD	<LOD
12-19 years
2	506	100	--	<LOD	<LOD	<LOD	<LOD
20-39 years
2	355	100	--	<LOD	<LOD	<LOD	<LOD
40-59 years
2	359	100	--	<LOD	<LOD	<LOD	<LOD
60-79 years
2	287	100	--	<LOD	<LOD	<LOD	<LOD

Table 14.1.2.2: Diaminochlorotriazine (DACT) -- Geometric means and selected percentiles of urine concentrations ( μg/L) for the Canadian population aged 3-79 years by sex and age group ^{Table c27 footnote a}, Canadian Health Measures Survey cycle 2 (2009-2011).
Cycle	N	%<LOD^{Table c27 footnote b}	GM (95% CI)	10^th (95% CI)	50^th (95% CI)	75^th (95% CI)	95^th (95% CI)
Table c27 footnotes Table c27 footnote 1 Breakdown by sex for the 3-5 year old age group is not recommended. Return to table c27 footnote a referrer Table c27 footnote 2 If >40% of samples were below the LOD, the percentile distribution is reported but means were not calculated. Return to table c27 footnote b referrer
Males, Total 3-79 years
2	1268	100	--	<LOD	<LOD	<LOD	<LOD
Males, 6-11 years
2	261	100	--	<LOD	<LOD	<LOD	<LOD
Males, 12-19 years
2	255	100	--	<LOD	<LOD	<LOD	<LOD
Males, 20-39 years
2	166	100	--	<LOD	<LOD	<LOD	X
Males, 40-59 years
2	193	100	--	<LOD	<LOD	<LOD	X
Males, 60-79 years
2	142	100	--	<LOD	<LOD	<LOD	X
Females, Total 3-79 years
2	1258	100	--	<LOD	<LOD	<LOD	<LOD
Females, 6-11 years
2	250	100	--	<LOD	<LOD	<LOD	<LOD
Females, 12-19 years
2	251	100	--	<LOD	<LOD	<LOD	<LOD
Females, 20-39 years
2	189	100	--	<LOD	<LOD	<LOD	X
Females, 40-59 years
2	166	100	--	<LOD	<LOD	<LOD	X
Females, 60-79 years
2	145	100	--	<LOD	<LOD	<LOD	X

Table 14.1.2.3: Diaminochlorotriazine (DACT) (creatinine adjusted) - Geometric means and selected percentiles of urine concentrations (μg/g creatinine) for the Canadian population aged 3-79 years by age group, Canadian Health Measures Survey cycle 2 (2009-2011).
Cycle	N	%<LOD^{Table c28 footnote a}	GM (95% CI)	10^th (95% CI)	50^th (95% CI)	75^th (95% CI)	95^th (95% CI)
Table c28 footnotes Table c28 footnote 1 If >40% of samples were below the LOD, the percentile distribution is reported but means were not calculated. Return to table c28 footnote a referrer
Total, 3-79 years
2	2516	100	--	<LOD	<LOD	<LOD	<LOD
3-5 years
2	507	100	--	<LOD	<LOD	<LOD	<LOD
6-11 years
2	509	100	--	<LOD	<LOD	<LOD	<LOD
12-19 years
2	504	100	--	<LOD	<LOD	<LOD	<LOD
20-39 years
2	353	100	--	<LOD	<LOD	<LOD	<LOD
40-59 years
2	357	100	--	<LOD	<LOD	<LOD	<LOD
60-79 years
2	286	100	--	<LOD	<LOD	<LOD	<LOD

Table 14.1.2.4: Diaminochlorotriazine (DACT) (creatinine adjusted) -- Geometric means and selected percentiles of urine concentrations ( μg/g creatinine) for the Canadian population aged 3-79 years by sex and age group ^{Table c29 footnote a}, Canadian Health Measures Survey cycle 2 (2009-2011).
Cycle	N	%<LOD^{Table c29 footnote b}	GM (95% CI)	10^th (95% CI)	50^th (95% CI)	75^th (95% CI)	95^th (95% CI)
Table c29 footnotes Table c29 footnote 1 Breakdown by sex for the 3-5 year old age group is not recommended. Return to table c29 footnote a referrer Table c29 footnote 2 If >40% of samples were below the LOD, the percentile distribution is reported but means were not calculated. Return to table c29 footnote b referrer
Males, Total 3-79 years
2	1264	100	--	<LOD	<LOD	<LOD	<LOD
Males, 6-11 years
2	260	100	--	<LOD	<LOD	<LOD	<LOD
Males, 12-19 years
2	254	100	--	<LOD	<LOD	<LOD	<LOD
Males, 20-39 years
2	165	100	--	<LOD	<LOD	<LOD	X
Males, 40-59 years
2	193	100	--	<LOD	<LOD	<LOD	X
Males, 60-79 years
2	142	100	--	<LOD	<LOD	<LOD	X
Females, Total 3-79 years
2	1252	100	--	<LOD	<LOD	<LOD	<LOD
Females, 6-11 years
2	249	100	--	<LOD	<LOD	<LOD	<LOD
Females, 12-19 years
2	250	100	--	<LOD	<LOD	<LOD	<LOD
Females, 20-39 years
2	188	100	--	<LOD	<LOD	<LOD	X
Females, 40-59 years
2	164	100	--	<LOD	<LOD	<LOD	X
Females, 60-79 years
2	144	100	--	<LOD	<LOD	<LOD	X

Table 14.1.3.1: Desethylatrazine (DEA) -- Geometric means and selected percentiles of urine concentrations ( μg/L) for the Canadian population aged 3-79 years by age group, Canadian Health Measures Survey cycle 2 (2009-2011).
Cycle	N	%<LOD^{Table c30 footnote a}	GM (95% CI)	10^th (95% CI)	50^th (95% CI)	75^th (95% CI)	95^th (95% CI)
Table c30 footnotes Table c30 footnote 1 If >40% of samples were below the LOD, the percentile distribution is reported but means were not calculated. Return to table c30 footnote a referrer
Total, 3-79 years
2	2526	100	--	<LOD	<LOD	<LOD	<LOD
3-5 years
2	508	100	--	<LOD	<LOD	<LOD	<LOD
6-11 years
2	511	100	--	<LOD	<LOD	<LOD	<LOD
12-19 years
2	506	100	--	<LOD	<LOD	<LOD	<LOD
20-39 years
2	355	100	--	<LOD	<LOD	<LOD	<LOD
40-59 years
2	359	100	--	<LOD	<LOD	<LOD	<LOD
60-79 years
2	287	100	--	<LOD	<LOD	<LOD	<LOD

Table 14.1.3.2: Desethylatrazine (DEA) -- Geometric means and selected percentiles of urine concentrations ( μg/L) for the Canadian population aged 3-79 years by sex and age group ^{Table c31 footnote a}, Canadian Health Measures Survey cycle 2 (2009-2011).
Cycle	N	%<LOD^{Table c31 footnote b}	GM (95% CI)	10^th (95% CI)	50^th (95% CI)	75^th (95% CI)	95^th (95% CI)
Table c31 footnotes Table c31 footnote 1 Breakdown by sex for the 3-5 year old age group is not recommended. Return to table c31 footnote a referrer Table c31 footnote 2 If >40% of samples were below the LOD, the percentile distribution is reported but means were not calculated. Return to table c31 footnote b referrer
Males, Total 3-79 years
2	1268	100	--	<LOD	<LOD	<LOD	<LOD
Males, 6-11 years
2	261	100	--	<LOD	<LOD	<LOD	<LOD
Males, 12-19 years
2	255	100	--	<LOD	<LOD	<LOD	<LOD
Males, 20-39 years
2	166	100	--	<LOD	<LOD	<LOD	X
Males, 40-59 years
2	193	100	--	<LOD	<LOD	<LOD	X
Males, 60-79 years
2	142	100	--	<LOD	<LOD	<LOD	X
Females, Total 3-79 years
2	1258	100	--	<LOD	<LOD	<LOD	<LOD
Females, 6-11 years
2	250	100	--	<LOD	<LOD	<LOD	<LOD
Females, 12-19 years
2	251	100	--	<LOD	<LOD	<LOD	<LOD
Females, 20-39 years
2	189	100	--	<LOD	<LOD	<LOD	X
Females, 40-59 years
2	166	100	--	<LOD	<LOD	<LOD	X
Females, 60-79 years
2	145	100	--	<LOD	<LOD	<LOD	X

Table 14.1.3.3: Desethylatrazine (DEA) (creatinine adjusted) -- Geometric means and selected percentiles of urine concentrations ( μg/g creatinine) for the Canadian population aged 3-79 years by age group, Canadian Health Measures Survey cycle 2 (2009-2011).
Cycle	N	%<LOD^{Table c32 footnote a}	GM (95% CI)	10^th (95% CI)	50^th (95% CI)	75^th (95% CI)	95^th (95% CI)
Table c32 footnotes Table c32 footnote 1 If >40% of samples were below the LOD, the percentile distribution is reported but means were not calculated. Return to table c32 footnote a referrer
2	2516	100	--	<LOD	<LOD	<LOD	<LOD
3-5 years
2	507	100	--	<LOD	<LOD	<LOD	<LOD
6-11 years
2	509	100	--	<LOD	<LOD	<LOD	<LOD
12-19 years
2	504	100	--	<LOD	<LOD	<LOD	<LOD
20-39 years
2	353	100	--	<LOD	<LOD	<LOD	<LOD
40-59 years
2	357	100	--	<LOD	<LOD	<LOD	<LOD
60-79 years
2	286	100	--	<LOD	<LOD	<LOD	<LOD

Table 14.1.3.4: Desethylatrazine (DEA) (creatinine adjusted) -- Geometric means and selected percentiles of urine concentrations ( μg/g creatinine) for the Canadian population aged 3-79 years by sex and age group ^{Table c33 footnote a}, Canadian Health Measures Survey cycle 2 (2009-2011).
Cycle	N	%<LOD^{Table c33 footnote b}	GM (95% CI)	10^th (95% CI)	50^th (95% CI)	75^th (95% CI)	95^th (95% CI)
Table c33 footnotes Table c33 footnote 1 Breakdown by sex for the 3-5 year old age group is not recommended. Return to table c33 footnote a referrer Table c33 footnote 2 If >40% of samples were below the LOD, the percentile distribution is reported but means were not calculated. Return to table c33 footnote b referrer
Males, Total 3-79 years
2	1264	100	--	<LOD	<LOD	<LOD	<LOD
Males, 6-11 years
2	260	100	--	<LOD	<LOD	<LOD	<LOD
Males, 12-19 years
2	254	100	--	<LOD	<LOD	<LOD	<LOD
Males, 20-39 years
2	165	100	--	<LOD	<LOD	<LOD	X
Males, 40-59 years
2	193	100	--	<LOD	<LOD	<LOD	X
Males, 60-79 years
2	142	100	--	<LOD	<LOD	<LOD	X
Females, Total 3-79 years
2	1252	100	--	<LOD	<LOD	<LOD	<LOD
Females, 6-11 years
2	249	100	--	<LOD	<LOD	<LOD	<LOD
Females, 12-19 years
2	250	100	--	<LOD	<LOD	<LOD	<LOD
Females, 20-39 years
2	188	100	--	<LOD	<LOD	<LOD	X
Females, 40-59 years
2	164	100	--	<LOD	<LOD	<LOD	X
Females, 60-79 years
2	144	100	--	<LOD	<LOD	<LOD	X

Table 14.2.1.1: Carbofuranphenol -- Geometric means and selected percentiles of urine concentrations ( μg/L) for the Canadian population aged 3-79 years by age group, Canadian Health Measures Survey cycle 2 (2009-2011).
Cycle	N	%<LOD^{Table c34 footnote a}	GM (95% CI)	10^th (95% CI)	50^th (95% CI)	75^th (95% CI)	95^th (95% CI)
Table c34 footnotes Table c34 footnote 1 If >40% of samples were below the LOD, the percentile distribution is reported but means were not calculated. Return to table c34 footnote a referrer
Total, 3-79 years
2	2557	99.96	--	<LOD	<LOD	<LOD	<LOD
3-5 years
2	522	100	--	<LOD	<LOD	<LOD	<LOD
6-11 years
2	516	100	--	<LOD	<LOD	<LOD	<LOD
12-19 years
2	511	100	--	<LOD	<LOD	<LOD	<LOD
20-39 years
2	357	99.72	--	<LOD	<LOD	<LOD	<LOD
40-59 years
2	360	100	--	<LOD	<LOD	<LOD	<LOD
60-79 years
2	291	100	--	<LOD	<LOD	<LOD	<LOD

Table 14.2.1.2: Carbofuranphenol -- Geometric means and selected percentiles of urine concentrations ( μg/L) for the Canadian population aged 3-79 years by sex and age group ^{Table c35 footnote a}, Canadian Health Measures Survey cycle 2 (2009-2011).
Cycle	N	%<LOD^{Table c35 footnote b}	GM (95% CI)	10^th (95% CI)	50^th (95% CI)	75^th (95% CI)	95^th (95% CI)
Table c35 footnotes Table c35 footnote 1 Breakdown by sex for the 3-5 year old age group is not recommended. Return to table c35 footnote a referrer Table c35 footnote 2 If >40% of samples were below the LOD, the percentile distribution is reported but means were not calculated. Return to table c35 footnote b referrer
Males, Total 3-79 years
2	1279	100	--	<LOD	<LOD	<LOD	<LOD
Males, 6-11 years
2	262	100	--	<LOD	<LOD	<LOD	<LOD
Males, 12-19 years
2	256	100	--	<LOD	<LOD	<LOD	<LOD
Males, 20-39 years
2	167	100	--	<LOD	<LOD	<LOD	X
Males, 40-59 years
2	194	100	--	<LOD	<LOD	<LOD	X
Males, 60-79 years
2	142	100	--	<LOD	<LOD	<LOD	X
Females, Total 3-79 years
2	1278	99.92	--	<LOD	<LOD	<LOD	<LOD
Females, 6-11 years
2	254	100	--	<LOD	<LOD	<LOD	<LOD
Females, 12-19 years
2	255	100	--	<LOD	<LOD	<LOD	<LOD
Females, 20-39 years
2	190	99.47	--	<LOD	<LOD	<LOD	X
Females, 40-59 years
2	166	100	--	<LOD	<LOD	<LOD	X
Females, 60-79 years
2	149	100	--	<LOD	<LOD	<LOD	X

Table 14.2.1.3: Carbofuranphenol (creatinine adjusted) -- Geometric means and selected percentiles of urine concentrations ( μg/g creatinine) for the Canadian population aged 3-79 years by age group, Canadian Health Measures Survey cycle 2 (2009-2011).
Cycle	N	%<LOD^{Table c36 footnote a}	GM (95% CI)	10^th (95% CI)	50^th (95% CI)	75^th (95% CI)	95^th (95% CI)
Table c36 footnotes Table c36 footnote 1 If >40% of samples were below the LOD, the percentile distribution is reported but means were not calculated. Return to table c36 footnote a referrer
Total, 3-79 years
2	2547	100	--	<LOD	<LOD	<LOD	<LOD
3-5 years
2	521	100	--	<LOD	<LOD	<LOD	<LOD
6-11 years
2	514	100	--	<LOD	<LOD	<LOD	<LOD
12-19 years
2	509	100	--	<LOD	<LOD	<LOD	<LOD
20-39 years
2	355	100	--	<LOD	<LOD	<LOD	<LOD
40-59 years
2	358	100	--	<LOD	<LOD	<LOD	<LOD
60-79 years
2	290	100	--	<LOD	<LOD	<LOD	<LOD

Table 14.2.1.4: Carbofuranphenol (creatinine adjusted) -- Geometric means and selected percentiles of urine concentrations ( μg/g creatinine) for the Canadian population aged 3-79 years by sex and age group ^{Table c37 footnote a}, Canadian Health Measures Survey cycle 2 (2009-2011).
Cycle	N	%<LOD^{Table c37 footnote b}	GM (95% CI)	10^th (95% CI)	50^th (95% CI)	75^th (95% CI)	95^th (95% CI)
Table c37 footnotes Table c37 footnote 1 Breakdown by sex for the 3-5 year old age group is not recommended. Return to table c37 footnote a referrer Table c37 footnote 2 If >40% of samples were below the LOD, the percentile distribution is reported but means were not calculated. Return to table c37 footnote b referrer
Males, Total 3-79 years
2	1275	100	--	<LOD	<LOD	<LOD	<LOD
Males, 6-11 years
2	261	100	--	<LOD	<LOD	<LOD	<LOD
Males, 12-19 years
2	255	100	--	<LOD	<LOD	<LOD	<LOD
Males, 20-39 years
2	166	100	--	<LOD	<LOD	<LOD	X
Males, 40-59 years
2	194	100	--	<LOD	<LOD	<LOD	X
Males, 60-79 years
2	142	100	--	<LOD	<LOD	<LOD	X
Females, Total 3-79 years
2	1272	100	--	<LOD	<LOD	<LOD	<LOD
Females, 6-11 years
2	253	100	--	<LOD	<LOD	<LOD	<LOD
Females, 12-19 years
2	254	100	--	<LOD	<LOD	<LOD	<LOD
Females, 20-39 years
2	189	100	--	<LOD	<LOD	<LOD	X
Females, 40-59 years
2	164	100	--	<LOD	<LOD	<LOD	X
Females, 60-79 years
2	148	100	--	<LOD	<LOD	<LOD	X

Table 14.2.2.1: 2-Isopropoxyphenol -- Geometric means and selected percentiles of urine concentrations ( μg/L) for the Canadian population aged 3-79 years by age group, Canadian Health Measures Survey cycle 2 (2009-2011).
Cycle	N	%<LOD^{Table c38 footnote a}	GM (95% CI)	10^th (95% CI)	50^th (95% CI)	75^th (95% CI)	95^th (95% CI)
Table c38 footnotes Table c38 footnote 1 If >40% of samples were below the LOD, the percentile distribution is reported but means were not calculated. Return to table c38 footnote a referrer
Total, 3-79 years
2	2560	99.8	--	<LOD	<LOD	<LOD	<LOD
3-5 years
2	524	100	--	<LOD	<LOD	<LOD	<LOD
6-11 years
2	516	100	--	<LOD	<LOD	<LOD	<LOD
12-19 years
2	512	99.41	--	<LOD	<LOD	<LOD	<LOD
20-39 years
2	357	99.44	--	<LOD	<LOD	<LOD	<LOD
40-59 years
2	360	100	--	<LOD	<LOD	<LOD	<LOD
60-79 years
2	291	100	--	<LOD	<LOD	<LOD	<LOD

Table 14.2.2.2: 2-Isopropoxyphenol -- Geometric means and selected percentiles of urine concentrations ( μg/L) for the Canadian population aged 3-79 years by sex and age group ^{Table c39 footnote a}, Canadian Health Measures Survey cycle 2 (2009-2011).
Cycle	N	%<LOD^{Table c39 footnote b}	GM (95% CI)	10^th (95% CI)	50^th (95% CI)	75^th (95% CI)	95^th (95% CI)
Table c39 footnotes Table c39 footnote 1 Breakdown by sex for the 3-5 year old age group is not recommended. Return to table c39 footnote a referrer Table c39 footnote 2 If >40% of samples were below the LOD, the percentile distribution is reported but means were not calculated. Return to table c39 footnote b referrer
Males, Total 3-79 years
2	1281	99.69	--	<LOD	<LOD	<LOD	<LOD
Males, 6-11 years
2	262	100	--	<LOD	<LOD	<LOD	<LOD
Males, 12-19 years
2	256	99.22	--	<LOD	<LOD	<LOD	<LOD
Males, 20-39 years
2	167	98.80	--	<LOD	<LOD	<LOD	X
Males, 40-59 years
2	194	100	--	<LOD	<LOD	<LOD	X
Males, 60-79 years
2	142	100	--	<LOD	<LOD	<LOD	X
Females, Total 3-79 years
2	1279	99.92	--	<LOD	<LOD	<LOD	<LOD
Females, 6-11 years
2	254	100	--	<LOD	<LOD	<LOD	<LOD
Females, 12-19 years
2	256	99.61	--	<LOD	<LOD	<LOD	<LOD
Females, 20-39 years
2	190	100	--	<LOD	<LOD	<LOD	X
Females, 40-59 years
2	166	100	--	<LOD	<LOD	<LOD	X
Females, 60-79 years
2	149	100	--	<LOD	<LOD	<LOD	X

Table 14.2.2.3: 2-Isopropoxyphenol (creatinine adjusted) -- Geometric means and selected percentiles of urine concentrations ( μg/g creatinine) for the Canadian population aged 3-79 years by age group, Canadian Health Measures Survey cycle 2 (2009-2011).
Cycle	N	%<LOD^{Table c40 footnote a}	GM (95% CI)	10^th (95% CI)	50^th (95% CI)	75^th (95% CI)	95^th (95% CI)
Table c40 footnotes Table c40 footnote 1 If >40% of samples were below the LOD, the percentile distribution is reported but means were not calculated. Return to table c40 footnote a referrer
Total, 3-79 years
2	2550	100	--	<LOD	<LOD	<LOD	<LOD
3-5 years
2	523	100	--	<LOD	<LOD	<LOD	<LOD
6-11 years
2	514	100	--	<LOD	<LOD	<LOD	<LOD
12-19 years
2	510	99.80	--	<LOD	<LOD	<LOD	<LOD
20-39 years
2	355	100	--	<LOD	<LOD	<LOD	<LOD
40-59 years
2	358	100	--	<LOD	<LOD	<LOD	<LOD
60-79 years
2	290	100	--	<LOD	<LOD	<LOD	<LOD

Table 14.2.2.4: 2-Isopropoxyphenol (creatinine adjusted) -- Geometric means and selected percentiles of urine concentrations ( μg/g creatinine) for the Canadian population aged 3-79 years by sex and age group ^{Table c41 footnote a}, Canadian Health Measures Survey cycle 2 (2009-2011).
Cycle	N	%<LOD^{Table c41 footnote b}	GM (95% CI)	10^th (95% CI)	50^th (95% CI)	75^th (95% CI)	95^th (95% CI)
Table c41 footnotes Table c41 footnote 1 Breakdown by sex for the 3-5 year old age group is not recommended. Return to table c41 footnote a referrer Table c41 footnote 2 If >40% of samples were below the LOD, the percentile distribution is reported but means were not calculated. Return to table c41 footnote b referrer
Males, Total 3-79 years
2	1277	100	--	<LOD	<LOD	<LOD	<LOD
Males, 6-11 years
2	261	100	--	<LOD	<LOD	<LOD	<LOD
Males, 12-19 years
2	255	99.61	--	<LOD	<LOD	<LOD	<LOD
Males, 20-39 years
2	166	99.40	--	<LOD	<LOD	<LOD	X
Males, 40-59 years
2	194	100	--	<LOD	<LOD	<LOD	X
Males, 60-79 years
2	142	100	--	<LOD	<LOD	<LOD	X
Females, Total 3-79 years
2	1273	100	--	<LOD	<LOD	<LOD	<LOD
Females, 6-11 years
2	253	100	--	<LOD	<LOD	<LOD	<LOD
Females, 12-19 years
2	255	100	--	<LOD	<LOD	<LOD	<LOD
Females, 20-39 years
2	189	100	--	<LOD	<LOD	<LOD	X
Females, 40-59 years
2	164	100	--	<LOD	<LOD	<LOD	X
Females, 60-79 years
2	148	100	--	<LOD	<LOD	<LOD	X

Table 14.3.1: 2,4-Dichlorophenoxyacetic acid (2,4-D) -- Geometric means and selected percentiles of urine concentrations ( μg/L) for the Canadian population aged 6-79 years ^{Table c42 footnote a}, Canadian Health Measures Survey cycle 1 (2007-2009) and cycle 2 (2009-2011).
Cycle	N	%<LOD^{Table c42 footnote b}	GM (95% CI)	10^th (95% CI)	50^th (95% CI)	75^th (95% CI)	95^th (95% CI)
Table c42 footnotes Table c42 footnote 1 For the purpose of total population comparisons, only values from participants aged 6-79 years were included as participants under the age of 6 years were not included in cycle 1 (2007-2009). Return to table c42 footnote a referrer Table c42 footnote 2 If >40% of samples were below the LOD, the percentile distribution is reported but means were not calculated. Return to table c42 footnote b referrer
Total, 6-79 years
1	5480	58.10	--	<LOD	<LOD	0.29 (0.21 - 0.36)	0.91 (0.73 - 1.1)
2	2028	43.44	--	<LOD	0.22 (<LOD - 0.26)	0.40 (0.34 - 0.45)	1.0 (0.86 - 1.2)
Males, 6-79 years
1	2661	55.20	--	<LOD	<LOD	0.33 (0.25 - 0.40)	1.0 (0.71 - 1.3)
2	1016	37.20	0.26 (0.22 - 0.30)	<LOD	0.24 (0.21 - 0.28)	0.46 (0.37 - 0.55)	1.2 (0.96 - 1.5)
Females, 6-79 years
1	2819	60.84	--	<LOD	<LOD	0.26 (<LOD - 0.34)	0.75 (0.63 - 0.87)
2	1012	49.70	--	<LOD	<LOD	0.34 (0.28 - 0.40)	0.80 (0.56 - 1.0)

Table 14.3.2: 2,4-Dichlorophenoxyacetic acid (2,4-D) -- Geometric means and selected percentiles of urine concentrations ( μg/L) for the Canadian population aged 3-79 years by age group, Canadian Health Measures Survey cycle 1 (2007-2009) and cycle 2 (2009-2011).
Cycle	N	%<LOD^{Table c43 footnote a}	GM (95% CI)	10^th (95% CI)	50^th (95% CI)	75^th (95% CI)	95^th (95% CI)
Table c43 footnotes Table c43 footnote 1 If >40% of samples were below the LOD, the percentile distribution is reported but means were not calculated. Return to table c43 footnote a referrer Table c43 footnote 2 Data not available as participants under the age of 6 years were not included in cycle 1 (2007-2009). Return to table c43 footnote b referrer
Total, 3-79 years
1^{Table c43 footnote b}	.	.	.	.	.	.	.
2	2551	41.98	--	<LOD	0.22 (<LOD - 0.26)	0.40 (0.35 - 0.45)	1.0 (0.87 - 1.2)
3-5 years
1^{Table c43 footnote b}	.	.	.	.	.	.	.
2	523	36.33	0.26 (0.23 - 0.30)	<LOD	0.26 (0.20 - 0.31)	0.46 (0.37 - 0.55)	1.1 (0.81 - 1.4)
6-11 years
1	1030	57.48	--	<LOD	<LOD	0.32 (0.22 - 0.42)	0.92 (0.66 - 1.2)
2	512	42.38	--	<LOD	0.26 (0.22 - 0.30)	0.45 (0.38 - 0.53)	1.2^E (0.78 - 1.7)
12-19 years
1	981	56.17	--	<LOD	<LOD	0.30^E (<LOD - 0.41)	0.75 (0.66 - 0.84)
2	511	41.68	--	<LOD	0.23 (<LOD - 0.26)	0.40 (0.30 - 0.50)	0.98 (0.73 - 1.2)
20-39 years
1	1166	61.66	--	<LOD	<LOD	0.26 (<LOD - 0.33)	0.73 (0.55 - 0.90)
2	357	46.22	--	<LOD	0.21 (<LOD - 0.25)	0.34 (0.26 - 0.41)	0.69^E (0.34 - 1.0)
40-59 years
1	1222	60.31	--	<LOD	<LOD	0.28 (0.20 - 0.36)	0.99 (0.64 - 1.3)
2	357	43.70	--	<LOD	0.24 (<LOD - 0.32)	0.42 (0.32 - 0.51)	1.1 (0.77 - 1.4)
60-79 years
1	1081	54.12	--	<LOD	<LOD	0.36 (0.30 - 0.43)	1.1^E (0.72 - 1.6)
2	291	44.67	--	<LOD	<LOD	0.43 (0.29 - 0.56)	1.2^E (0.54 - 1.9)

Table 14.3.3: 2,4-Dichlorophenoxyacetic acid (2,4-D) -- Geometric means and selected percentiles of urine concentrations (μg/L) for the Canadian population aged 3-79 years by sex and age group3, Canadian Health Measures Survey cycle 1 (2007-2009) and cycle 2 (2009-2011).
Cycle	N	%<LOD^{Table c44 footnote b}	GM (95% CI)	10^th (95% CI)	50^th (95% CI)	75^th (95% CI)	95^th (95% CI)
Table c44 footnotes Table c44 footnote 1 Breakdown by sex for the 3-5 year old age group is not recommended. Return to table c44 footnote a referrer Table c44 footnote 2 If >40% of samples were below the LOD, the percentile distribution is reported but means were not calculated. Return to table c44 footnote b referrer Table c44 footnote 3 Data not available as participants under the age of 6 years were not included in cycle 1 (2007-2009). Return to table c44 footnote c referrer
Males, Total 3-79 years
1^{Table c44 footnote c}	.	.	.	.	.	.	.
2	1275	36.16	0.26 (0.22 - 0.30)	<LOD	0.24 (0.21 - 0.28)	0.46 (0.37 - 0.54)	1.2 (0.98 - 1.5)
Males, 6-11 years
1	525	56.57	--	<LOD	<LOD	0.32 (0.22 - 0.43)	1.0 (0.73 - 1.3)
2	260	36.54	0.25 (0.21 - 0.29)	<LOD	0.26 (0.20 - 0.33)	0.44 (0.35 - 0.53)	1.2^E (0.74 - 1.7)
Males, 12-19 years
1	504	54.76	--	<LOD	<LOD	0.27 (<LOD - 0.36)	0.70 (0.48 - 0.92)
2	255	40.39	--	<LOD	0.24 (<LOD - 0.29)	0.40 (0.27 - 0.53)	0.96 (0.71 - 1.2)
Males, 20-39 years
1	513	57.70	--	<LOD	<LOD	0.28 (0.20 - 0.36)	0.90 (0.69 - 1.1)
2	167	33.53	0.24 (0.20 - 0.29)	<LOD	0.24 (0.21 - 0.28)	0.38 (0.27 - 0.50)	X
Males, 40-59 years
1	578	57.61	--	<LOD	<LOD	0.33 (0.26 - 0.40)	1.2^E (0.70 - 1.6)
2	192	33.33	0.29 (0.21 - 0.39)	<LOD	0.26^E (<LOD - 0.36)	0.59^E (0.31 - 0.88)	X
Males, 60-79 years
1	541	49.35	--	<LOD	F	0.41 (0.32 - 0.49)	1.3^E (0.70 - 2.0)
2	142	42.25	--	<LOD	0.21^E (<LOD - 0.30)	0.54^E (0.26 - 0.82)	X
Females, Total 3-79 years
1^{Table c44 footnote c}	.	.	.	.	.	.	.
2	1276	47.81	--	<LOD	<LOD	0.35 (0.29 - 0.40)	0.80 (0.57 - 1.0)
Females, 6-11 years
1	505	58.42	--	<LOD	<LOD	0.31^E (<LOD - 0.44)	0.89^E (0.52 - 1.3)
2	252	48.41	--	<LOD	0.26 (0.20 - 0.31)	0.48 (0.35 - 0.60)	1.2^E (0.75 - 1.7)
Females, 12-19 years
1	477	57.65	--	<LOD	<LOD	0.37^E (0.20 - 0.54)	0.79 (0.70 - 0.87)
2	256	42.97	--	<LOD	0.21 (<LOD - 0.26)	0.39 (0.27 - 0.51)	1.2^E (0.63 - 1.8)
Females, 20-39 years
1	653	64.78	--	<LOD	<LOD	0.24 (<LOD - 0.31)	0.57 (0.43 - 0.70)
2	190	57.37	--	<LOD	<LOD	0.32 (0.23 - 0.41)	X
Females, 40-59 years
1	644	62.73	--	<LOD	<LOD	0.22^E (<LOD - 0.32)	0.72^E (0.46 - 0.99)
2	165	55.76	--	<LOD	<LOD	0.35 (0.25 - 0.46)	X
Females, 60-79 years
1	540	58.89	--	<LOD	<LOD	0.31^E (<LOD - 0.43)	0.99 (0.82 - 1.2)
2	149	46.98	--	<LOD	<LOD	0.35^E (0.20 - 0.50)	X

Table 14.3.4: 2,4-Dichlorophenoxyacetic acid (2,4-D) (creatinine adjusted) -- Geometric means and selected percentiles of urine concentrations ( μg/g creatinine) for the Canadian population aged 6-79 years ^{Table c45 footnote a}, Canadian Health Measures Survey cycle 1 (2007-2009) and cycle 2 (2009-2011).
Cycle	N	%<LOD^{Table c45 footnote b}	GM (95% CI)	10^th (95% CI)	50^th (95% CI)	75^th (95% CI)	95^th (95% CI)
Table c45 footnotes Table c45 footnote 1 For the purpose of total population comparisons, only values from participants aged 6-79 years were included as participants under the age of 6 years were not included in cycle 1 (2007-2009). Return to table c45 footnote a referrer Table c45 footnote 2 If >40% of samples were below the LOD, the percentile distribution is reported but means were not calculated. Return to table c45 footnote b referrer
Total, 6-79 years
1	5466	58.25	--	<LOD	<LOD	0.39 (0.36 - 0.42)	1.0 (0.93 - 1.2)
2	2019	43.64	--	<LOD	0.21 (<LOD - 0.23)	0.38 (0.34 - 0.42)	1.0 (0.82 - 1.2)
Males, 6-79 years
1	2652	55.39	--	<LOD	<LOD	0.34 (0.29 - 0.38)	0.95 (0.78 - 1.1)
2	1013	37.31	0.21 (0.19 - 0.24)	<LOD	0.20 (0.15 - 0.24)	0.38 (0.33 - 0.42)	1.2 (0.85 - 1.5)
Females, 6-79 years
1	2814	60.95	--	<LOD	<LOD	0.45 (<LOD - 0.49)	1.1 (1.0 - 1.2)
2	1006	50.00	--	<LOD	<LOD	0.40 (0.33 - 0.47)	0.88 (0.65 - 1.1)

Table 14.3.5: 2,4-Dichlorophenoxyacetic acid (2,4-D) (creatinine adjusted) -- Geometric means and selected percentiles of urine concentrations ( μg/g creatinine) for the Canadian population aged 3-79 years by age group, Canadian Health Measures Survey cycle 1 (2007-2009) and cycle 2 (2009-2011).
Cycle	N	%<LOD^{Table c46 footnote a}	GM (95% CI)	10^th (95% CI)	50^th (95% CI)	75^th (95% CI)	95^th (95% CI)
Table c46 footnotes Table c46 footnote 1 If >40% of samples were below the LOD, the percentile distribution is reported but means were not calculated. Return to table c46 footnote a referrer Table c46 footnote 2 Data not available as participants under the age of 6 years were not included in cycle 1 (2007-2009). Return to table c46 footnote b referrer
Total, 3-79 years
1^{Table c46 footnote b}	.	.	.	.	.	.	.
2	2541	42.15	--	<LOD	0.21 (<LOD - 0.24)	0.40 (0.36 - 0.44)	1.1 (0.87 - 1.2)
3-5 years
1^{Table c46 footnote b}	.	.	.	.	.	.	.
2	522	36.40	0.45 (0.39 - 0.52)	<LOD	0.40 (0.30 - 0.51)	0.82 (0.68 - 0.96)	2.2 (1.5 - 2.9)
6-11 years
1	1027	57.64	--	<LOD	<LOD	0.51 (0.44 - 0.58)	1.5 (1.2 - 1.8)
2	510	42.55	--	<LOD	0.28 (0.24 - 0.31)	0.51 (0.42 - 0.60)	1.2 (0.79 - 1.6)
12-19 years
1	979	56.28	--	<LOD	<LOD	0.29 (<LOD - 0.34)	0.67 (0.58 - 0.76)
2	509	41.85	--	<LOD	0.16 (<LOD - 0.20)	0.30 (0.21 - 0.40)	0.68^E (0.43 - 0.93)
20-39 years
1	1162	61.88	--	<LOD	<LOD	0.33 (<LOD - 0.36)	0.91 (0.65 - 1.2)
2	355	46.48	--	<LOD	0.16 (<LOD - 0.19)	0.32 (0.24 - 0.40)	0.74 (0.51 - 0.96)
40-59 years
1	1217	60.56	--	<LOD	<LOD	0.41 (0.35 - 0.47)	1.1 (0.87 - 1.3)
2	355	43.94	--	<LOD	0.25 (<LOD - 0.32)	0.40 (0.33 - 0.48)	0.88^E (0.54 - 1.2)
60-79 years
1	1081	54.12	--	<LOD	<LOD	0.52 (0.45 - 0.59)	1.4 (1.1 - 1.7)
2	290	44.83	--	<LOD	<LOD	0.49 (0.38 - 0.60)	1.7^E (1.1 - 2.3)

Table 14.3.6: 2,4-Dichlorophenoxyacetic acid (2,4-D) (creatinine adjusted) -- Geometric means and selected percentiles of urine concentrations (μg/g creatinine) for the Canadian population aged 3-79 years by sex and age group3, Canadian Health Measures Survey cycle 1 (2007-2009) and cycle 2 (2009-2011).
Cycle	N	%<LOD^{Table c47 footnote b}	GM (95% CI)	10^th (95% CI)	50^th (95% CI)	75^th (95% CI)	95^th (95% CI)
Table c47 footnotes Table c47 footnote 1 Breakdown by sex for the 3-5 year old age group is not recommended. Return to table c47 footnote a referrer Table c47 footnote 2 If >40% of samples were below the LOD, the percentile distribution is reported but means were not calculated. Return to table c47 footnote b referrer Table c47 footnote 3 Data not available as participants under the age of 6 years were not included in cycle 1 (2007-2009). Return to table c47 footnote c referrer
Males, Total 3-79 years
1^{Table c47 footnote c}	.	.	.	.	.	.	.
2	1271	36.27	0.22 (0.20 - 0.24)	<LOD	0.20 (0.16 - 0.24)	0.38 (0.35 - 0.42)	1.2 (0.94 - 1.4)
Males, 6-11 years
1	523	56.79	--	<LOD	<LOD	0.51 (0.39 - 0.63)	1.5 (1.1 - 1.9)
2	259	36.68	0.28 (0.22 - 0.36)	<LOD	0.28 (0.23 - 0.33)	0.55 (0.42 - 0.68)	1.2 (0.82 - 1.5)
Males, 12-19 years
1	503	54.87	--	<LOD	<LOD	0.27 (<LOD - 0.32)	0.57 (0.50 - 0.63)
2	254	40.55	--	<LOD	0.16 (<LOD - 0.20)	0.30 (0.20 - 0.41)	0.63 (0.43 - 0.82)
Males, 20-39 years
1	511	57.93	--	<LOD	<LOD	0.30 (0.24 - 0.36)	0.78 (0.57 - 0.99)
2	166	33.73	0.18 (0.14 - 0.22)	<LOD	0.15 (0.12 - 0.19)	0.27^E (0.14 - 0.39)	X
Males, 40-59 years
1	574	58.01	--	<LOD	<LOD	0.33 (0.28 - 0.38)	0.99^E (0.56 - 1.4)
2	192	33.33	0.24 (0.19 - 0.31)	<LOD	0.25 (<LOD - 0.34)	0.39 (0.30 - 0.49)	X
Males, 60-79 years
1	541	49.35	--	<LOD	<LOD (<LOD - 0.26)	0.40 (0.28 - 0.51)	1.2^E (0.71 - 1.7)
2	142	42.25	--	<LOD	0.20^E (<LOD - 0.31)	0.44 (0.31 - 0.58)	X
Females, Total 3-79 years
1^{Table c47 footnote c}	.	.	.	.	.	.	.
2	1270	48.03	--	<LOD	<LOD	0.42 (0.35 - 0.49)	0.91 (0.67 - 1.2)
Females, 6-11 years
1	504	58.53	--	<LOD	<LOD	0.51 (<LOD - 0.61)	1.5^E (0.88 - 2.1)
2	251	48.61	--	<LOD	0.28 (0.24 - 0.31)	0.48 (0.39 - 0.57)	1.5^E (0.80 - 2.2)
Females, 12-19 years
1	476	57.77	--	<LOD	<LOD	0.31 (0.26 - 0.36)	0.71 (0.58 - 0.84)
2	255	43.14	--	<LOD	0.17 (<LOD - 0.20)	0.31^E (0.20 - 0.43)	0.88^E (0.46 - 1.3)
Females, 20-39 years
1	651	64.98	--	<LOD	<LOD	0.38 (<LOD - 0.43)	0.98 (0.71 - 1.3)
2	189	57.67	--	<LOD	<LOD	0.36^E (0.23 - 0.49)	X
Females, 40-59 years
1	643	62.83	--	<LOD	<LOD	0.47 (<LOD - 0.52)	1.2 (0.98 - 1.3)
2	163	56.44	--	<LOD	<LOD	0.42 (0.31 - 0.53)	X
Females, 60-79 years
1	540	58.89	--	<LOD	<LOD	0.61 (<LOD - 0.72)	1.6 (1.3 - 1.9)
2	148	47.30	--	<LOD	<LOD	0.51 (0.38 - 0.64)	X

Table 14.4.1.1: Dimethylphosphate (DMP) -- Geometric means and selected percentiles of urine concentrations ( μg/L) for the Canadian population aged 6-79 years ^{Table c48 footnote a}, Canadian Health Measures Survey cycle 1 (2007-2009) and cycle 2 (2009-2011).
Cycle	N	%<LOD^{Table c48 footnote b}	GM (95% CI)	10^th (95% CI)	50^th (95% CI)	75^th (95% CI)	95^th (95% CI)
Table c48 footnotes Table c48 footnote 1 For the purpose of total population comparisons, only values from participants aged 6-79 years were included as participants under the age of 6 years were not included in cycle 1 (2007-2009). Return to table c48 footnote a referrer Table c48 footnote 2 If >40% of samples were below the LOD, the percentile distribution is reported but means were not calculated. Return to table c48 footnote b referrer
Total, 6-79 years
1	5467	20.27	2.8 (2.4 - 3.3)	<LOD	3.0 (2.5 - 3.6)	7.3 (6.6 - 7.9)	25 (21 - 28)
2	2034	15.19	3.2 (2.8 - 3.7)	<LOD	3.4 (2.9 - 4.0)	7.3 (6.4 - 8.2)	25 (21 - 29)
Males, 6-79 years
1	2653	19.68	2.8 (2.4 - 3.4)	<LOD	3.1 (2.4 - 3.8)	7.3 (6.6 - 8.1)	25 (20 - 30)
2	1020	15.39	3.2 (2.7 - 3.7)	<LOD	3.3 (2.7 - 4.0)	6.9 (5.5 - 8.4)	26 (21 - 30)
Females, 6-79 years
1	2814	20.82	2.7 (2.2 - 3.3)	<LOD	3.0 (2.4 - 3.6)	7.2 (6.1 - 8.2)	24 (20 - 29)
2	1014	14.99	3.3 (2.8 - 3.9)	<LOD	3.6 (2.7 - 4.4)	7.4 (6.2 - 8.7)	24 (17 - 31)

Table 14.4.1.2: Dimethylphosphate (DMP) -- Geometric means and selected percentiles of urine concentrations ( μg/L) for the Canadian population aged 3-79 years by age group, Canadian Health Measures Survey cycle 1 (2007-2009) and cycle 2 (2009-2011).
Cycle	N	%<LOD^{Table c49 footnote a}	GM (95% CI)	10^th (95% CI)	50^th (95% CI)	75^th (95% CI)	95^th (95% CI)
Table c49 footnotes Table c49 footnote 1 If >40% of samples were below the LOD, the percentile distribution is reported but means were not calculated. Return to table c49 footnote a referrer Table c49 footnote 2 Data not available as participants under the age of 6 years were not included in cycle 1 (2007-2009). Return to table c49 footnote b referrer
Total, 3-79 years
1^{Table c49 footnote b}	.	.	.	.	.	.	.
2	2556	13.58	3.3 (2.9 - 3.8)	<LOD	3.5 (3.0 - 4.0)	7.4 (6.6 - 8.2)	26 (22 - 29)
3-5 years
1^{Table c49 footnote b}	.	.	.	.	.	.	.
2	522	7.28	6.7 (5.6 - 8.1)	1.4 (1.0 - 1.8)	6.8 (4.9 - 8.6)	15 (12 - 17)	F
6-11 years
1	1028	17.51	3.7 (3.1 - 4.4)	<LOD	4.3 (3.9 - 4.8)	11 (9.3 - 13)	29 (23 - 36)
2	516	10.27	6.1 (5.1 - 7.2)	1.3^E (<LOD - 2.0)	5.9 (4.6 - 7.3)	13 (9.5 - 17)	F
12-19 years
1	980	15.71	3.8 (3.1 - 4.6)	<LOD	4.1 (3.3 - 4.9)	10 (8.7 - 11)	28 (23 - 32)
2	512	10.74	3.8 (3.2 - 4.5)	<LOD	4.0 (3.2 - 4.8)	8.2 (6.6 - 9.7)	30 (19 - 41)
20-39 years
1	1162	23.06	2.6 (2.1 - 3.1)	<LOD	2.9 (2.2 - 3.7)	6.2 (5.3 - 7.0)	23^E (10 - 36)
2	356	22.19	3.1 (2.4 - 4.0)	<LOD	3.5 (2.6 - 4.5)	6.5 (4.4 - 8.5)	29 (20 - 39)
40-59 years
1	1221	26.29	2.5 (2.0 - 3.2)	<LOD	2.9^E (1.4 - 4.4)	6.7 (5.3 - 8.2)	24 (18 - 31)
2	360	19.44	2.8 (2.2 - 3.7)	<LOD	2.8 (2.1 - 3.5)	6.3 (4.9 - 7.6)	20^E (12 - 27)
60-79 years
1	1076	17.19	2.9 (2.5 - 3.4)	<LOD	3.3 (2.7 - 3.9)	7.7 (6.8 - 8.5)	20 (15 - 26)
2	290	17.93	3.1 (2.5 - 3.8)	<LOD	3.4 (2.7 - 4.2)	7.1 (5.7 - 8.5)	19^E (9.9 - 28)
F Data is too unreliable to be published.

Table 14.4.1.3: Dimethylphosphate (DMP) -- Geometric means and selected percentiles of urine concentrations (μg/L) for the Canadian population aged 3-79 years by sex and age group ^{Table c50 footnote a}, Canadian Health Measures Survey cycle 1 (2007-2009) and cycle 2 (2009-2011).
Cycle	N	%<LOD^{Table c50 footnote b}	GM (95% CI)	10^th (95% CI)	50^th (95% CI)	75^th (95% CI)	95^th (95% CI)
Table c50 footnotes Table c50 footnote 1 Breakdown by sex for the 3-5 year old age group is not recommended. Return to table c50 footnote a referrer Table c50 footnote 2 If >40% of samples were below the LOD, the percentile distribution is reported but means were not calculated. Return to table c50 footnote b referrer Table c50 footnote 3 Data not available as participants under the age of 6 years were not included in cycle 1 (2007-2009). Return to table c50 footnote c referrer
Males, Total 3-79 years
1^{Table c50 footnote c}	.	.	.	.	.	.	.
2	1280	13.59	3.3 (2.8 - 3.8)	<LOD	3.4 (2.8 - 4.0)	7.3 (6.0 - 8.6)	26 (21 - 31)
Males, 6-11 years
1	524	18.13	3.4 (2.7 - 4.4)	<LOD	3.8 (2.6 - 5.0)	11 (9.2 - 13)	31 (22 - 41)
2	262	13.36	5.8 (4.3 - 7.9)	F	5.6 (3.7 - 7.5)	14^E (7.3 - 20)	F
Males, 12-19 years
1	503	17.69	3.4 (2.6 - 4.4)	<LOD	3.7 (2.7 - 4.6)	9.9 (8.4 - 11)	25 (23 - 28)
2	256	10.16	3.5 (3.0 - 4.0)	<LOD	3.8 (3.0 - 4.6)	7.4 (6.0 - 8.9)	29^E (11 - 48)
Males, 20-39 years
1	511	22.70	2.5 (2.1 - 3.0)	<LOD	2.9^E (1.8 - 4.1)	6.3 (5.4 - 7.2)	F
2	166	22.29	3.0 (2.2 - 4.2)	<LOD	3.0^E (1.8 - 4.1)	F	X
Males, 40-59 years
1	577	25.13	2.7 (2.0 - 3.6)	<LOD	3.0^E (1.7 - 4.3)	7.1 (4.9 - 9.2)	27^E (15 - 38)
2	194	17.01	2.8^E (1.9 - 4.3)	<LOD	2.8^E (1.7 - 3.9)	6.5^E (3.9 - 9.2)	X
Males, 60-79 years
1	538	14.31	3.3 (2.5 - 4.3)	<LOD	3.5 (2.6 - 4.3)	8.3 (6.7 - 10)	24 (18 - 31)
2	142	18.31	3.1 (2.2 - 4.3)	<LOD	3.7^E (2.3 - 5.0)	6.8 (5.3 - 8.2)	X
Females, Total 3-79 years
1^{Table c50 footnote c}	.	.	.	.	.	.	.
2	1276	13.56	3.4 (2.9 - 4.0)	<LOD	3.6 (2.8 - 4.5)	7.4 (6.3 - 8.6)	24 (17 - 31)
Females, 6-11 years
1	504	16.87	4.0 (3.0 - 5.2)	<LOD	4.7 (3.6 - 5.9)	11 (7.7 - 14)	28 (21 - 36)
2	254	7.09	6.4 (5.3 - 7.6)	1.5^E (<LOD - 2.1)	6.5 (4.7 - 8.3)	13 (9.8 - 16)	41^E (26 - 56)
Females, 12-19 years
1	477	13.63	4.2 (3.3 - 5.4)	<LOD	4.3 (3.2 - 5.4)	10 (8.0 - 12)	38^E (23 - 53)
2	256	11.33	4.3 (3.1 - 5.9)	<LOD	4.6 (3.0 - 6.3)	9.5^E (5.9 - 13)	31^E (15 - 47)
Females, 20-39 years
1	651	23.35	2.6 (2.1 - 3.4)	<LOD	3.0 (2.3 - 3.6)	6.2 (4.8 - 7.5)	29^E (17 - 41)
2	190	22.11	3.2^E (2.1 - 4.8)	<LOD	3.9^E (2.4 - 5.4)	7.5^E (4.6 - 10)	X
Females, 40-59 years
1	644	27.33	2.3 (1.7 - 3.1)	<LOD	F	6.5 (4.6 - 8.3)	21 (16 - 26)
2	166	22.29	2.9 (2.1 - 4.0)	<LOD	2.8^E (1.0 - 4.5)	5.7 (4.0 - 7.4)	X
Females, 60-79 years
1	538	20.07	2.6 (2.2 - 3.1)	<LOD	3.0 (2.3 - 3.6)	6.7 (5.4 - 7.9)	16^E (10 - 23)
2	148	17.57	3.0 (2.4 - 3.9)	<LOD	3.2 (2.3 - 4.0)	7.4^E (4.4 - 10)	X

Table 14.4.1.4: Dimethylphosphate (DMP) (creatinine adjusted) -- Geometric means and selected percentiles of urine concentrations ( μg/g creatinine) for the Canadian population aged 6-79 years ^{Table c51 footnote a}, Canadian Health Measures Survey cycle 1 (2007-2009) and cycle 2 (2009-2011).
Cycle	N	%<LOD^{Table c51 footnote b}	GM (95% CI)	10^th (95% CI)	50^th (95% CI)	75^th (95% CI)	95^th (95% CI)
Table c51 footnotes Table c51 footnote 1 For the purpose of total population comparisons, only values from participants aged 6-79 years were included as participants under the age of 6 years were not included in cycle 1 (2007-2009). Return to table c51 footnote a referrer Table c51 footnote 2 If >40% of samples were below the LOD, the percentile distribution is reported but means were not calculated. Return to table c51 footnote b referrer
Total, 6-79 years
1	5453	20.32	3.4 (2.9 - 4.0)	<LOD	3.5 (3.0 - 4.1)	7.6 (6.5 - 8.7)	24 (20 - 28)
2	2025	15.26	3.1 (2.8 - 3.5)	<LOD	3.0 (2.6 - 3.4)	6.8 (6.1 - 7.5)	22 (17 - 27)
Males, 6-79 years
1	2644	19.74	2.9 (2.4 - 3.4)	<LOD	2.9 (2.4 - 3.4)	6.4 (5.5 - 7.3)	19 (15 - 23)
2	1017	15.44	2.6 (2.3 - 3.0)	<LOD	2.5 (2.1 - 2.8)	5.4 (4.2 - 6.6)	20 (16 - 25)
Females, 6-79 years
1	2809	20.86	4.1 (3.5 - 4.8)	<LOD	4.2 (3.5 - 5.0)	8.9 (7.6 - 10)	27 (23 - 31)
2	1008	15.08	3.7 (3.1 - 4.5)	<LOD	3.3 (2.7 - 4.0)	8.0 (6.8 - 9.2)	28 (19 - 37)

Table 14.4.1.5: Dimethylphosphate (DMP) (creatinine adjusted) -- Geometric means and selected percentiles of urine concentrations ( μg/g creatinine) for the Canadian population aged 3-79 years by age group, Canadian Health Measures Survey cycle 1 (2007-2009) and cycle 2 (2009-2011).
Cycle	N	%<LOD^{Table c52 footnote a}	GM (95% CI)	10^th (95% CI)	50^th (95% CI)	75^th (95% CI)	95^th (95% CI)
Table c52 footnotes Table c52 footnote 1 If >40% of samples were below the LOD, the percentile distribution is reported but means were not calculated. Return to table c52 footnote a referrer Table c52 footnote 2 Data not available as participants under the age of 6 years were not included in cycle 1 (2007-2009). Return to table c52 footnote b referrer
Total, 3-79 years
1^{Table c52 footnote b}	.	.	.	.	.	.	.
2	2546	13.63	3.3 (2.9 - 3.7)	<LOD	3.2 (2.8 - 3.5)	7.0 (6.3 - 7.7)	25 (19 - 31)
3-5 years
1^{Table c52 footnote b}	.	.	.	.	.	.	.
2	521	7.29	12 (9.8 - 14)	2.6 (1.9 - 3.3)	12 (8.8 - 16)	22 (16 - 28)	100^E (40 - 170)
6-11 years
1	1025	17.56	5.7 (5.0 - 6.6)	<LOD	6.3 (5.0 - 7.5)	14 (13 - 16)	40 (36 - 45)
2	514	10.31	6.9 (6.0 - 8.0)	1.6 (<LOD - 1.9)	7.2 (6.0 - 8.4)	15 (11 - 18)	52^E (22 - 83)
12-19 years
1	978	15.75	3.3 (2.8 - 4.0)	<LOD	3.7 (2.9 - 4.4)	7.8 (6.9 - 8.8)	20 (15 - 24)
2	510	10.78	2.9 (2.5 - 3.4)	<LOD	2.8 (2.3 - 3.3)	6.0 (4.3 - 7.7)	18^E (9.9 - 27)
20-39 years
1	1158	23.14	2.9 (2.5 - 3.4)	<LOD	2.9 (2.4 - 3.4)	6.1 (5.1 - 7.0)	22^E (13 - 30)
2	354	22.32	2.7 (2.1 - 3.4)	<LOD	2.5 (1.8 - 3.1)	5.5 (3.8 - 7.2)	23 (16 - 31)
40-59 years
1	1216	26.40	3.2 (2.6 - 4.0)	<LOD	3.4 (2.6 - 4.1)	7.1 (5.8 - 8.4)	24 (15 - 32)
2	358	19.55	2.9 (2.4 - 3.5)	<LOD	2.8 (2.3 - 3.2)	5.4^E (3.3 - 7.5)	17^E (7.7 - 26)
60-79 years
1	1076	17.19	4.2 (3.5 - 5.0)	<LOD	4.3 (3.6 - 5.0)	9.4 (8.2 - 11)	23 (18 - 27)
2	289	17.99	3.6 (2.9 - 4.4)	<LOD	3.8 (2.8 - 4.7)	7.6 (6.2 - 9.0)	19 (14 - 24)

Table 14.4.1.6: Dimethylphosphate (DMP) (creatinine adjusted) -- Geometric means and selected percentiles of urine concentrations (μg/g creatinine) for the Canadian population aged 3-79 years by sex and age group ^{Table c53 footnote a}, Canadian Health Measures Survey cycle 1 (2007-2009) and cycle 2 (2009-2011).
Cycle	N	%<LOD^{Table c53 footnote b}	GM (95% CI)	10^th (95% CI)	50^th (95% CI)	75^th (95% CI)	95^th (95% CI)
Table c53 footnotes Table c53 footnote 1 Breakdown by sex for the 3-5 year old age group is not recommended. Return to table c53 footnote a referrer Table c53 footnote 2 If >40% of samples were below the LOD, the percentile distribution is reported but means were not calculated. Return to table c53 footnote b referrer Table c53 footnote 3 Data not available as participants under the age of 6 years were not included in cycle 1 (2007-2009). Return to table c53 footnote c referrer
Males, Total 3-79 years
1^{Table c53 footnote c}	.	.	.	.	.	.	.
2	1276	13.64	2.8 (2.5 - 3.1)	<LOD	2.5 (2.2 - 2.9)	6.0 (4.9 - 7.0)	21 (17 - 25)
Males, 6-11 years
1	522	18.20	5.3 (4.4 - 6.3)	<LOD	5.6 (3.7 - 7.6)	13 (10 - 16)	40 (33 - 46)
2	261	13.41	6.6 (5.1 - 8.6)	<LOD (<LOD - 2.0)	6.9 (5.0 - 8.7)	16^E (9.1 - 24)	62^E (<LOD - 99)
Males, 12-19 years
1	502	17.73	2.9 (2.3 - 3.6)	<LOD	3.4 (2.5 - 4.3)	7.3 (6.0 - 8.6)	16 (12 - 20)
2	255	10.20	2.5 (2.1 - 2.8)	<LOD	2.4 (2.0 - 2.8)	5.1 (3.6 - 6.7)	16^E (9.2 - 23)
Males, 20-39 years
1	509	22.79	2.3 (2.0 - 2.8)	<LOD	2.3 (1.9 - 2.6)	4.7 (3.9 - 5.5)	14^E (<LOD - 22)
2	165	22.42	2.2 (1.7 - 2.8)	<LOD	2.0 (1.4 - 2.7)	4.8^E (<LOD - 6.6)	X
Males, 40-59 years
1	573	25.31	2.7 (2.0 - 3.5)	<LOD	2.9 (1.9 - 3.9)	5.8 (4.5 - 7.1)	19 (13 - 24)
2	194	17.01	2.4 (1.9 - 3.2)	<LOD	2.4 (1.8 - 3.0)	4.1^E (2.0 - 6.2)	X
Males, 60-79 years
1	538	14.31	3.6 (2.9 - 4.4)	<LOD	3.7 (2.7 - 4.7)	8.2 (6.6 - 9.8)	20 (14 - 27)
2	142	18.31	2.9 (2.2 - 3.8)	<LOD	3.5^E (2.0 - 5.0)	6.4 (5.3 - 7.5)	X
Females, Total 3-79 years
1^{Table c53 footnote c}	.	.	.	.	.	.	.
2	1270	13.62	3.8 (3.2 - 4.6)	<LOD	3.4 (2.6 - 4.2)	8.5 (7.3 - 9.7)	28 (20 - 37)
Females, 6-11 years
1	503	16.90	6.3 (5.2 - 7.6)	<LOD	7.2 (5.1 - 9.3)	15 (13 - 16)	42 (33 - 50)
2	253	7.11	7.3 (6.2 - 8.6)	1.7^E (<LOD - 2.5)	7.4 (5.4 - 9.4)	14 (11 - 17)	F
Females, 12-19 years
1	476	13.66	3.9 (3.2 - 4.7)	<LOD	4.0 (2.8 - 5.1)	8.6 (7.2 - 9.9)	24 (17 - 31)
2	255	11.37	3.5 (2.7 - 4.6)	<LOD	3.3 (2.4 - 4.3)	7.5 (4.8 - 10)	24^E (9.7 - 39)
Females, 20-39 years
1	649	23.42	3.6 (2.9 - 4.4)	<LOD	3.9 (3.1 - 4.7)	7.5 (6.0 - 9.0)	26^E (15 - 36)
2	189	22.22	3.2^E (2.0 - 5.1)	<LOD	3.2^E (1.9 - 4.5)	6.7^E (3.3 - 10)	X
Females, 40-59 years
1	643	27.37	3.9 (3.2 - 4.8)	<LOD	4.0 (<LOD - 5.1)	8.4 (6.3 - 10)	28^E (18 - 39)
2	164	22.56	3.5 (2.7 - 4.4)	<LOD	3.2 (2.3 - 4.1)	7.2^E (4.3 - 10)	X
Females, 60-79 years
1	538	20.07	4.8 (4.0 - 5.8)	<LOD	4.8 (3.9 - 5.7)	10 (9.0 - 12)	24 (19 - 30)
2	147	17.69	4.3 (3.3 - 5.5)	<LOD	4.4^E (1.7 - 7.0)	8.6 (5.8 - 11)	X

Table 14.4.2.1: Dimethylthiophosphate (DMTP) -- Geometric means and selected percentiles of urine concentrations ( μg/L) for the Canadian population aged 6-79 years ^{Table c54 footnote a}, Canadian Health Measures Survey cycle 1 (2007-2009) and cycle 2 (2009-2011).
Cycle	N	%<LOD^{Table c54 footnote b}	GM (95% CI)	10^th (95% CI)	50^th (95% CI)	75^th (95% CI)	95^th (95% CI)
Table c54 footnotes Table c54 footnote 1 For the purpose of total population comparisons, only values from participants aged 6-79 years were included as participants under the age of 6 years were not included in cycle 1 (2007-2009). Return to table c54 footnote a referrer Table c54 footnote 2 If >40% of samples were below the LOD, the percentile distribution is reported but means were not calculated. Return to table c54 footnote b referrer
Total, 6-79 years
1	5474	30.76	2.0 (1.7 - 2.4)	<LOD	2.0^E (1.1 - 2.8)	6.9 (5.6 - 8.3)	40 (37 - 43)
2	2035	18.03	2.6 (2.2 - 3.1)	<LOD	2.8 (2.1 - 3.4)	7.4^E (4.6 - 10)	37 (27 - 46)
Males, 6-79 years
1	2659	30.24	2.1 (1.8 - 2.4)	<LOD	2.0 (1.5 - 2.6)	6.6 (5.2 - 7.9)	40 (36 - 44)
2	1021	18.32	2.4 (2.0 - 2.9)	<LOD	2.3 (1.7 - 2.8)	6.4 (4.3 - 8.4)	36^E (17 - 56)
Females, 6-79 years
1	2815	31.26	2.0 (1.5 - 2.6)	<LOD	1.8^E (0.63 - 3.0)	7.2 (5.4 - 9.0)	39 (30 - 49)
2	1014	17.75	2.8 (2.3 - 3.6)	<LOD	3.2 (2.3 - 4.1)	9.4^E (5.7 - 13)	37 (28 - 45)

Table 14.4.2.2: Dimethylthiophosphate (DMTP) -- Geometric means and selected percentiles of urine concentrations ( μg/L) for the Canadian population aged 3-79 years by age group, Canadian Health Measures Survey cycle 1 (2007-2009) and cycle 2 (2009-2011).
Cycle	N	%<LOD^{Table c55 footnote a}	GM (95% CI)	10^th (95% CI)	50^th (95% CI)	75^th (95% CI)	95^th (95% CI)
Table c55 footnotes Table c55 footnote 1 If >40% of samples were below the LOD, the percentile distribution is reported but means were not calculated. Return to table c55 footnote a referrer Table c55 footnote 2 Data not available as participants under the age of 6 years were not included in cycle 1 (2007-2009). Return to table c55 footnote b referrer
Total, 3-79 years
1^{Table c55 footnote b}	.	.	.	.	.	.	.
2	2559	15.87	2.7 (2.3 - 3.2)	<LOD	2.8 (2.2 - 3.5)	8.1 (5.4 - 11)	37 (27 - 47)
3-5 years
1^{Table c55 footnote b}	.	.	.	.	.	.	.
2	524	7.44	6.3 (5.1 - 7.8)	0.72 (<LOD - 0.97)	6.4 (4.5 - 8.3)	18 (13 - 23)	89 (60 - 120)
6-11 years
1	1029	27.89	2.5 (1.9 - 3.2)	<LOD	2.5^E (1.4 - 3.5)	10 (7.2 - 13)	54 (45 - 64)
2	516	11.82	5.0 (4.2 - 6.0)	0.64 (<LOD - 0.80)	5.3 (3.7 - 6.9)	14 (9.8 - 18)	66^E (31 - 100)
12-19 years
1	980	27.65	2.3 (1.8 - 2.8)	<LOD	2.1 (1.4 - 2.8)	8.1 (6.0 - 10)	44 (30 - 58)
2	512	16.21	2.6 (2.1 - 3.3)	<LOD	2.7 (2.0 - 3.3)	7.7 (5.0 - 10)	36^E (22 - 50)
20-39 years
1	1163	34.48	1.8 (1.3 - 2.4)	<LOD	1.6^E (<LOD - 2.6)	5.7^E (3.6 - 7.7)	36^E (19 - 53)
2	356	23.60	2.4 (1.8 - 3.2)	<LOD	2.7 (1.8 - 3.7)	6.2^E (3.1 - 9.2)	29^E (17 - 41)
40-59 years
1	1223	36.22	1.8 (1.5 - 2.2)	<LOD	1.4^E (<LOD - 2.3)	6.2 (4.5 - 7.9)	38 (27 - 49)
2	360	21.94	2.4 (1.8 - 3.2)	<LOD	2.2^E (1.2 - 3.1)	F	F
60-79 years
1	1079	26.14	2.6 (2.2 - 3.2)	<LOD	3.0 (2.1 - 3.8)	9.0 (6.6 - 11)	40 (35 - 45)
2	291	20.62	2.8 (2.1 - 3.8)	<LOD	3.3^E (2.1 - 4.6)	8.8^E (5.5 - 12)	44^E (20 - 68)

Table 14.4.2.3: Dimethylthiophosphate (DMTP) -- Geometric means and selected percentiles of urine concentrations ( μg/L) for the Canadian population aged 3-79 years by sex and age group ^{Table c56 footnote a}, Canadian Health Measures Survey cycle 1 (2007-2009) and cycle 2 (2009-2011).
Cycle	N	%<LOD^{Table c56 footnote b}	GM (95% CI)	10^th (95% CI)	50^th (95% CI)	75^th (95% CI)	95^th (95% CI)
Table c56 footnotes Table c56 footnote 1 Breakdown by sex for the 3-5 year old age group is not recommended. Return to table c56 footnote a referrer Table c56 footnote 2 If >40% of samples were below the LOD, the percentile distribution is reported but means were not calculated. Return to table c56 footnote b referrer Table c56 footnote 3 Data not available as participants under the age of 6 years were not included in cycle 1 (2007-2009). Return to table c56 footnote c referrer
Males, Total 3-79 years
1^{Table c56 footnote c}	.	.	.	.	.	.	.
2	1281	16.00	2.5 (2.1 - 3.0)	<LOD	2.4 (1.8 - 3.0)	6.7 (4.3 - 9.1)	37^E (17 - 57)
Males, 6-11 years
1	525	29.33	2.5 (1.8 - 3.5)	<LOD	2.3^E (0.95 - 3.7)	12^E (6.0 - 18)	55 (39 - 72)
2	262	14.50	4.6 (3.4 - 6.2)	0.62^E (<LOD - 0.95)	4.3^E (2.7 - 5.9)	10^E (4.7 - 16)	F
Males, 12-19 years
1	503	28.03	2.2 (1.7 - 2.7)	<LOD	2.0^E (1.1 - 2.9)	8.1 (5.4 - 11)	39 (28 - 49)
2	256	15.63	2.4 (1.8 - 3.1)	<LOD	2.3^E (1.3 - 3.4)	6.2 (4.4 - 8.0)	22 (14 - 30)
Males, 20-39 years
1	512	34.38	1.8 (1.4 - 2.3)	<LOD	1.6^E (0.81 - 2.4)	5.1^E (2.7 - 7.5)	39^E (15 - 63)
2	167	25.75	2.2^E (1.4 - 3.5)	<LOD	1.8^E (<LOD - 3.1)	F	X
Males, 40-59 years
1	578	34.60	1.9 (1.5 - 2.4)	<LOD	1.9^E (1.1 - 2.7)	6.1 (4.1 - 8.0)	33^E (19 - 47)
2	194	19.07	2.4^E (1.5 - 3.7)	<LOD	1.9^E (<LOD - 3.2)	F	X
Males, 60-79 years
1	541	24.58	2.7 (2.1 - 3.5)	<LOD	3.0^E (1.8 - 4.1)	9.2^E (4.8 - 13)	43 (35 - 50)
2	142	20.42	2.4^E (1.5 - 3.9)	<LOD	2.7^E (1.4 - 4.1)	6.7^E (3.2 - 10)	X
Females, Total 3-79 years
1^{Table c56 footnote c}	.	.	.	.	.	.	.
2	1278	15.73	2.9 (2.3 - 3.6)	<LOD	3.2 (2.4 - 4.1)	9.5^E (6.0 - 13)	37 (29 - 45)
Females, 6-11 years
1	504	26.39	2.5 (1.9 - 3.4)	<LOD	2.6^E (1.1 - 4.2)	9.4 (6.9 - 12)	54 (43 - 66)
2	254	9.06	5.5 (4.1 - 7.4)	0.66^E (<LOD - 0.91)	6.0^E (3.2 - 8.8)	16 (13 - 20)	66^E (29 - 100)
Females, 12-19 years
1	477	27.25	2.3 (1.6 - 3.4)	<LOD	2.3^E (1.0 - 3.6)	8.1 (5.3 - 11)	55^E (23 - 86)
2	256	16.80	2.9 (2.1 - 4.1)	<LOD	2.7^E (1.6 - 3.8)	9.6^E (5.5 - 14)	43^E (26 - 59)
Females, 20-39 years
1	651	34.56	1.8^E (1.2 - 2.6)	<LOD	F	6.1 (3.9 - 8.4)	34^E (10 - 58)
2	189	21.69	2.6^E (1.7 - 4.0)	<LOD	3.3^E (2.1 - 4.5)	5.9^E (2.8 - 9.1)	X
Females, 40-59 years
1	645	37.67	1.7 (1.3 - 2.2)	<LOD	F	6.6^E (3.8 - 9.3)	44^E (21 - 66)
2	166	25.30	2.5^E (1.6 - 3.9)	<LOD	2.6^E (1.3 - 3.9)	F	X
Females, 60-79 years
1	538	27.70	2.6 (2.0 - 3.2)	<LOD	3.0 (2.1 - 3.9)	8.9 (6.0 - 12)	34 (26 - 43)
2	149	20.81	3.2 (2.2 - 4.5)	<LOD	3.6^E (1.5 - 5.7)	F	X

Table 14.4.2.4: Dimethylthiophosphate (DMTP) (creatinine adjusted) -- Geometric means and selected percentiles of urine concentrations ( μg/g creatinine) for the Canadian population aged 6-79 years ^{Table c57 footnote a}, Canadian Health Measures Survey cycle 1 (2007-2009) and cycle 2 (2009-2011).
Cycle	N	%<LOD^{Table c57 footnote b}	GM (95% CI)	10^th (95% CI)	50^th (95% CI)	75^th (95% CI)	95^th (95% CI)
Table c57 footnotes Table c57 footnote 1 For the purpose of total population comparisons, only values from participants aged 6-79 years were included as participants under the age of 6 years were not included in cycle 1 (2007-2009). Return to table c57 footnote a referrer Table c57 footnote 2 If >40% of samples were below the LOD, the percentile distribution is reported but means were not calculated. Return to table c57 footnote b referrer
Total, 6-79 years
1	5460	30.84	2.5 (2.1 - 2.9)	<LOD	2.1 (1.6 - 2.5)	8.0 (6.6 - 9.4)	45 (38 - 52)
2	2026	18.11	2.6 (2.2 - 3.0)	<LOD	2.5 (1.9 - 3.0)	7.5 (6.0 - 8.9)	34 (29 - 40)
Males, 6-79 years
1	2650	30.34	2.1 (1.8 - 2.3)	<LOD	1.8 (1.5 - 2.2)	6.2 (4.9 - 7.6)	34 (24 - 43)
2	1018	18.37	2.0 (1.7 - 2.4)	<LOD	1.9 (1.4 - 2.4)	6.1 (4.7 - 7.5)	24 (16 - 32)
Females, 6-79 years
1	2810	31.32	3.0 (2.4 - 3.7)	<LOD	2.5 (1.8 - 3.2)	9.5 (7.8 - 11)	51 (43 - 60)
2	1008	17.86	3.2 (2.5 - 4.0)	<LOD	3.1^E (2.0 - 4.2)	9.4 (7.0 - 12)	35 (27 - 43)

Table 14.4.2.5: Dimethylthiophosphate (DMTP) (creatinine adjusted) -- Geometric means and selected percentiles of urine concentrations ( μg/g creatinine) for the Canadian population aged 3-79 years by age group, Canadian Health Measures Survey cycle 1 (2007-2009) and cycle 2 (2009-2011).
Cycle	N	%<LOD^{Table c58 footnote a}	GM (95% CI)	10^th (95% CI)	50^th (95% CI)	75^th (95% CI)	95^th (95% CI)
Table c58 footnotes Table c58 footnote 1 If >40% of samples were below the LOD, the percentile distribution is reported but means were not calculated. Return to table c58 footnote a referrer Table c58 footnote 2 Data not available as participants under the age of 6 years were not included in cycle 1 (2007-2009). Return to table c58 footnote b referrer
Total, 3-79 years
1^{Table c58 footnote b}	.	.	.	.	.	.	.
2	2549	15.93	2.7 (2.3 - 3.1)	<LOD	2.5 (1.9 - 3.2)	7.8 (6.0 - 9.5)	35 (31 - 38)
3-5 years
1^{Table c58 footnote b}	.	.	.	.	.	.	.
2	523	7.46	11 (9.1 - 13)	1.5 (<LOD - 1.9)	11 (8.2 - 14)	33 (24 - 41)	110 (89 - 140)
6-11 years
1	1026	27.97	3.9 (3.2 - 4.8)	<LOD	3.7 (2.7 - 4.7)	14 (10 - 17)	70 (52 - 88)
2	514	11.87	5.7 (4.7 - 7.0)	0.84 (<LOD - 0.99)	5.9^E (3.4 - 8.4)	16^E (10 - 23)	90^E (29 - 150)
12-19 years
1	978	27.71	2.0 (1.6 - 2.4)	<LOD	2.0 (1.6 - 2.3)	6.2 (4.6 - 7.9)	30 (23 - 36)
2	510	16.27	2.0 (1.6 - 2.5)	<LOD	1.7 (1.1 - 2.3)	5.7 (4.6 - 6.7)	25^E (12 - 38)
20-39 years
1	1159	34.60	2.0 (1.6 - 2.6)	<LOD	1.8 (<LOD - 2.2)	5.8 (3.9 - 7.6)	34^E (18 - 51)
2	354	23.73	2.1 (1.6 - 2.7)	<LOD	2.1 (1.5 - 2.7)	6.5 (4.2 - 8.7)	33^E (17 - 49)
40-59 years
1	1218	36.37	2.3 (2.0 - 2.7)	<LOD	1.9 (<LOD - 2.4)	7.5 (5.6 - 9.3)	45 (37 - 54)
2	358	22.07	2.5 (1.9 - 3.2)	<LOD	2.4^E (1.4 - 3.5)	7.3^E (3.7 - 11)	30^E (18 - 41)
60-79 years
1	1079	26.14	3.7 (3.1 - 4.4)	<LOD	3.8 (2.7 - 4.9)	13 (10 - 15)	53 (40 - 67)
2	290	20.69	3.3 (2.4 - 4.4)	<LOD	3.5^E (2.2 - 4.9)	11^E (6.0 - 17)	F

Table 14.4.2.6: Dimethylthiophosphate (DMTP) (creatinine adjusted) -- Geometric means and selected percentiles of urine concentrations (μg/g creatinine) for the Canadian population aged 3-79 years by sex and age group ^{Table c59 footnote a}, Canadian Health Measures Survey cycle 1 (2007-2009) and cycle 2 (2009-2011).
Cycle	N	%<LOD^{Table c59 footnote b}	GM (95% CI)	10^th (95% CI)	50^th (95% CI)	75^th (95% CI)	95^th (95% CI)
Table c59 footnotes Table c59 footnote 1 Breakdown by sex for the 3-5 year old age group is not recommended. Return to table c59 footnote a referrer Table c59 footnote 2 If >40% of samples were below the LOD, the percentile distribution is reported but means were not calculated. Return to table c59 footnote b referrer Table c59 footnote 3 Data not available as participants under the age of 6 years were not included in cycle 1 (2007-2009). Return to table c59 footnote c referrer
Males, Total 3-79 years
1^{Table c59 footnote c}	.	.	.	.	.	.	.
2	1277	16.05	2.2 (1.8 - 2.6)	<LOD	2.0 (1.4 - 2.5)	6.6 (5.3 - 7.9)	29^E (19 - 40)
Males, 6-11 years
1	523	29.45	3.8 (2.8 - 5.2)	<LOD	3.3^E (1.7 - 5.0)	15^E (9.6 - 21)	63^E (38 - 89)
2	261	14.56	5.2 (3.8 - 7.3)	0.79^E (<LOD - 1.1)	4.7^E (2.4 - 7.0)	14^E (6.9 - 21)	F
Males, 12-19 years
1	502	28.09	1.9 (1.5 - 2.3)	<LOD	1.8 (1.3 - 2.3)	5.5 (3.5 - 7.4)	28 (21 - 36)
2	255	15.69	1.7 (1.3 - 2.2)	<LOD	1.6^E (0.96 - 2.2)	5.1 (3.7 - 6.6)	19^E (9.1 - 28)
Males, 20-39 years
1	510	34.51	1.7 (1.4 - 2.1)	<LOD	1.5 (1.2 - 1.8)	4.7^E (3.0 - 6.5)	F
2	166	25.9	1.6^E (1.1 - 2.4)	<LOD	1.6 (<LOD - 1.9)	F	X
Males, 40-59 years
1	574	34.84	1.9 (1.5 - 2.4)	<LOD	1.7 (1.2 - 2.2)	5.3^E (2.4 - 8.2)	23^E (14 - 33)
2	194	19.07	2.0 (1.4 - 2.9)	<LOD	1.9^E (<LOD - 2.9)	5.9^E (<LOD - 9.1)	X
Males, 60-79 years
1	541	24.58	2.9 (2.4 - 3.5)	<LOD	3.1 (2.1 - 4.0)	10^E (5.5 - 15)	41 (26 - 56)
2	142	20.42	2.3 (1.6 - 3.3)	<LOD	2.5^E (1.3 - 3.7)	6.7^E (3.2 - 10)	X
Females, Total 3-79 years
1^{Table c59 footnote c}	.	.	.	.	.	.	.
2	1272	15.80	3.3 (2.6 - 4.2)	<LOD	3.4 (2.3 - 4.5)	9.5 (7.1 - 12)	38 (25 - 50)
Females, 6-11 years
1	503	26.44	4.0 (3.2 - 5.1)	<LOD	4.1 (2.7 - 5.5)	13 (9.3 - 17)	80 (53 - 110)
2	253	9.09	6.4 (4.8 - 8.4)	0.90 (<LOD - 1.2)	6.7^E (3.3 - 10)	18 (12 - 25)	F
Females, 12-19 years
1	476	27.31	2.2 (1.6 - 2.8)	<LOD	2.0 (1.7 - 2.4)	7.2 (5.3 - 9.1)	F
2	255	16.86	2.4 (1.8 - 3.3)	<LOD	2.1^E (1.2 - 3.0)	6.2 (4.0 - 8.3)	38^E (13 - 62)
Females, 20-39 years
1	649	34.67	2.5 (1.8 - 3.4)	<LOD	2.0 (<LOD - 2.7)	7.0^E (4.0 - 10)	F
2	188	21.81	2.6^E (1.7 - 4.0)	<LOD	2.7^E (1.2 - 4.3)	6.8 (4.6 - 9.0)	X
Females, 40-59 years
1	644	37.73	2.8 (2.3 - 3.5)	<LOD	2.2^E (<LOD - 3.0)	9.2 (7.2 - 11)	50^E (19 - 81)
2	164	25.61	3.0 (2.1 - 4.3)	<LOD	2.7^E (0.90 - 4.5)	10^E (3.8 - 16)	X
Females, 60-79 years
1	538	27.70	4.7 (3.8 - 5.9)	<LOD	4.8^E (2.6 - 6.9)	14 (9.8 - 18)	54 (43 - 66)
2	148	20.95	4.5^E (3.0 - 6.7)	<LOD	6.1^E (2.9 - 9.3)	18^E (11 - 24)	X

Table 14.4.3.1: Dimethyldithiophosphate (DMDTP) -- Geometric means and selected percentiles of urine concentrations ( μg/L) for the Canadian population aged 6-79 years ^{Table c60 footnote a}, Canadian Health Measures Survey cycle 1 (2007-2009) and cycle 2 (2009-2011).
Cycle	N	%<LOD^{Table c60 footnote b}	GM (95% CI)	10^th (95% CI)	50^th (95% CI)	75^th (95% CI)	95^th (95% CI)
Table c60 footnotes Table c60 footnote 1 For the purpose of total population comparisons, only values from participants aged 6-79 years were included as participants under the age of 6 years were not included in cycle 1 (2007-2009). Return to table c60 footnote a referrer Table c60 footnote 2 If >40% of samples were below the LOD, the percentile distribution is reported but means were not calculated. Return to table c60 footnote b referrer
Total, 6-79 years
1	5475	61.95	--	<LOD	<LOD	0.63 (0.42 - 0.85)	5.9 (5.0 - 6.8)
2	2014	51.64	--	<LOD	<LOD	0.85 (0.66 - 1.0)	6.3 (4.8 - 7.8)
Males, 6-79 years
1	2659	62.24	--	<LOD	<LOD	0.59 (0.39 - 0.79)	5.5 (4.4 - 6.7)
2	1011	54.60	--	<LOD	<LOD	0.70 (0.47 - 0.93)	5.4^E (3.4 - 7.4)
Females, 6-79 years
1	2816	61.68	--	<LOD	<LOD	0.67^E (0.40 - 0.95)	6.6 (4.8 - 8.4)
2	1003	48.65	--	<LOD	0.33 (<LOD - 0.42)	0.93^E (0.55 - 1.3)	7.6 (5.0 - 10)

Table 14.4.3.2: Dimethyldithiophosphate (DMDTP) -- Geometric means and selected percentiles of urine concentrations ( μg/L) for the Canadian population aged 3-79 years by age group, Canadian Health Measures Survey cycle 1 (2007-2009) and cycle 2 (2009-2011).
Cycle	N	%<LOD^{Table c61 footnote a}	GM (95% CI)	10^th (95% CI)	50^th (95% CI)	75^th (95% CI)	95^th (95% CI)
Table c61 footnotes Table c61 footnote 1 If >40% of samples were below the LOD, the percentile distribution is reported but means were not calculated. Return to table c61 footnote a referrer Table c61 footnote 2 Data not available as participants under the age of 6 years were not included in cycle 1 (2007-2009). Return to table c61 footnote b referrer
Total, 3-79 years
1^{Table c61 footnote b}	.	.	.	.	.	.	.
2	2537	49.11	--	<LOD	<LOD	0.87 (0.68 - 1.1)	6.5 (5.2 - 7.8)
3-5 years
1^{Table c61 footnote b}	.	.	.	.	.	.	.
2	523	39.39	0.85 (0.68 - 1.1)	<LOD	0.57^E (0.32 - 0.83)	2.3^E (1.1 - 3.4)	18^E (9.6 - 26)
6-11 years
1	1029	57.92	--	<LOD	<LOD	0.88 (0.61 - 1.2)	7.2 (4.8 - 9.5)
2	512	45.12	--	<LOD	0.49^E (<LOD - 0.75)	1.3 (0.88 - 1.7)	9.3^E (5.6 - 13)
12-19 years
1	980	62.04	--	<LOD	<LOD	0.56^E (0.30 - 0.82)	7.0 (4.9 - 9.1)
2	512	50.59	--	<LOD	<LOD	0.68 (0.48 - 0.88)	F
20-39 years
1	1163	66.98	--	<LOD	<LOD	0.52^E (0.29 - 0.74)	4.6^E (2.4 - 6.7)
2	357	60.22	--	<LOD	<LOD	0.59 (0.41 - 0.77)	4.4^E (2.3 - 6.4)
40-59 years
1	1223	66.56	--	<LOD	<LOD	0.56^E (0.33 - 0.79)	5.8 (4.3 - 7.4)
2	353	58.64	--	<LOD	<LOD	0.86^E (0.32 - 1.4)	6.1^E (2.7 - 9.5)
60-79 years
1	1080	55.09	--	<LOD	<LOD	1.0 (0.67 - 1.3)	7.5 (5.0 - 9.9)
2	280	45.71	--	<LOD	F	1.1^E (0.34 - 1.9)	9.5^E (3.7 - 15)

Table 14.4.3.3: Dimethyldithiophosphate (DMDTP) -- Geometric means and selected percentiles of urine concentrations ( μg/L) for the Canadian population aged 3-79 years by sex and age group ^{Table c62 footnote a}, Canadian Health Measures Survey cycle 1 (2007-2009) and cycle 2 (2009-2011).
Cycle	N	%<LOD^{Table c62 footnote b}	GM (95% CI)	10^th (95% CI)	50^th (95% CI)	75^th (95% CI)	95^th (95% CI)
Table c62 footnotes Table c62 footnote 1 Breakdown by sex for the 3-5 year old age group is not recommended. Return to table c62 footnote a referrer Table c62 footnote 2 If >40% of samples were below the LOD, the percentile distribution is reported but means were not calculated. Return to table c62 footnote b referrer Table c62 footnote 3 Data not available as participants under the age of 6 years were not included in cycle 1 (2007-2009). Return to table c62 footnote c referrer
Males, Total 3-79 years
1^{Table c62 footnote c}	.	.	.	.	.	.	.
2	1271	51.30	--	<LOD	<LOD	0.73 (0.49 - 0.98)	5.7 (3.8 - 7.6)
Males, 6-11 years
1	525	59.62	--	<LOD	<LOD	0.82^E (0.38 - 1.3)	8.5^E (4.0 - 13)
2	262	50.38	--	<LOD	F	1.2 (0.82 - 1.7)	F
Males, 12-19 years
1	503	62.03	--	<LOD	<LOD	0.53^E (0.27 - 0.79)	F
2	256	53.52	--	<LOD	<LOD	0.54^E (0.30 - 0.78)	F
Males, 20-39 years
1	512	67.97	--	<LOD	<LOD	0.50^E (0.26 - 0.74)	4.5^E (2.0 - 7.0)
2	167	67.07	--	<LOD	<LOD	F	X
Males, 40-59 years
1	578	66.26	--	<LOD	<LOD	0.60^E (0.36 - 0.84)	5.7 (4.4 - 6.9)
2	189	57.14	--	<LOD	<LOD	F	X
Males, 60-79 years
1	541	55.27	--	<LOD	<LOD	0.99 (0.71 - 1.3)	7.4^E (2.6 - 12)
2	137	45.99	--	<LOD	F	0.92^E (0.34 - 1.5)	X
Females, Total 3-79 years
1^{Table c62 footnote c}	.	.	.	.	.	.	.
2	1266	46.92	--	<LOD	0.33 (<LOD - 0.42)	0.96^E (0.58 - 1.3)	7.8 (5.5 - 10)
Females, 6-11 years
1	504	56.15	--	<LOD	<LOD	0.96^E (0.57 - 1.4)	5.7^E (3.2 - 8.2)
2	250	39.60	0.68 (0.50 - 0.92)	<LOD	0.50^E (<LOD - 0.75)	1.4^E (0.65 - 2.1)	8.8^E (4.8 - 13)
Females, 12-19 years
1	477	62.05	--	<LOD	<LOD	0.66^E (0.21 - 1.1)	7.9^E (3.2 - 13)
2	256	47.66	--	<LOD	<LOD^E (<LOD - 0.34)	0.86^E (0.53 - 1.2)	7.2^E (2.3 - 12)
Females, 20-39 years
1	651	66.21	--	<LOD	<LOD	0.57^E (0.33 - 0.80)	F
2	190	54.21	--	<LOD	0.30 (<LOD - 0.40)	0.59^E (0.37 - 0.81)	X
Females, 40-59 years
1	645	66.82	--	<LOD	<LOD	0.51^E (0.15 - 0.87)	F
2	164	60.37	--	<LOD	F	F	X
Females, 60-79 years
1	539	54.92	--	<LOD	<LOD	1.0^E (0.41 - 1.7)	7.3^E (3.9 - 11)
2	143	45.45	--	<LOD	0.54^E (<LOD - 0.81)	2.0^E (0.79 - 3.2)	X

Table 14.4.3.4: Dimethyldithiophosphate (DMDTP) (creatinine adjusted) -- Geometric means and selected percentiles of urine concentrations ( μg/g creatinine) for the Canadian population aged 6-79 years ^{Table c63 footnote a}, Canadian Health Measures Survey cycle 1 (2007-2009) and cycle 2 (2009-2011).
Cycle	N	%<LOD^{Table c63 footnote b}	GM (95% CI)	10^th (95% CI)	50^th (95% CI)	75^th (95% CI)	95^th (95% CI)
Table c63 footnotes Table c63 footnote 1 For the purpose of total population comparisons, only values from participants aged 6-79 years were included as participants under the age of 6 years were not included in cycle 1 (2007-2009). Return to table c63 footnote a referrer Table c63 footnote 2 If >40% of samples were below the LOD, the percentile distribution is reported but means were not calculated. Return to table c63 footnote b referrer
Total, 6-79 years
1	5461	62.11	--	<LOD	<LOD	0.62^E (0.38 - 0.87)	7.3 (5.6 - 9.1)
2	2005	51.87	--	<LOD	<LOD	0.95 (0.76 - 1.1)	6.8 (4.7 - 8.9)
Males, 6-79 years
1	2650	62.45	--	<LOD	<LOD	0.47 (0.31 - 0.64)	5.5^E (2.8 - 8.3)
2	1008	54.76	--	<LOD	<LOD	0.58^E (0.37 - 0.79)	3.8^E (2.4 - 5.2)
Females, 6-79 years
1	2811	61.79	--	<LOD	<LOD	0.78^E (0.42 - 1.1)	8.7 (6.4 - 11)
2	997	48.95	--	<LOD	0.40 (<LOD - 0.54)	1.2 (0.82 - 1.5)	9.1 (7.0 - 11)

Table 14.4.3.5: Dimethyldithiophosphate (DMDTP) (creatinine adjusted) -- Geometric means and selected percentiles of urine concentrations ( μg/g creatinine) for the Canadian population aged 3-79 years by age group, Canadian Health Measures Survey cycle 1 (2007-2009) and cycle 2 (2009-2011).
Cycle	N	%<LOD^{Table c64 footnote a}	GM (95% CI)	10^th (95% CI)	50^th (95% CI)	75^th (95% CI)	95^th (95% CI)
Table c64 footnotes Table c64 footnote 1 If >40% of samples were below the LOD, the percentile distribution is reported but means were not calculated. Return to table c64 footnote a referrer Table c64 footnote 2 Data not available as participants under the age of 6 years were not included in cycle 1 (2007-2009). Return to table c64 footnote b referrer
Total, 3-79 years
1^{Table c64 footnote b}	.	.	.	.	.	.	.
2	2527	49.31	--	<LOD	<LOD	0.96 (0.80 - 1.1)	7.3 (5.3 - 9.3)
3-5 years
1^{Table c64 footnote b}	.	.	.	.	.	.	.
2	522	39.46	1.3 (1.0 - 1.7)	<LOD	0.96 (0.70 - 1.2)	3.7^E (1.9 - 5.5)	27^E (16 - 38)
6-11 years
1	1026	58.09	--	<LOD	<LOD	1.1^E (0.63 - 1.5)	11 (8.5 - 13)
2	510	45.29	--	<LOD	0.52^E (<LOD - 0.72)	1.5^E (0.93 - 2.1)	9.7^E (5.2 - 14)
12-19 years
1	978	62.17	--	<LOD	<LOD	0.43^E (0.19 - 0.67)	5.3^E (3.2 - 7.4)
2	510	50.78	--	<LOD	<LOD	0.49 (0.33 - 0.65)	F
20-39 years
1	1159	67.21	--	<LOD	<LOD	0.46^E (0.27 - 0.64)	4.8^E (2.6 - 6.9)
2	355	60.56	--	<LOD	<LOD	0.55^E (0.17 - 0.93)	4.2^E (1.3 - 7.0)
40-59 years
1	1218	66.83	--	<LOD	<LOD	0.54^E (0.29 - 0.79)	8.7 (6.1 - 11)
2	351	58.97	--	<LOD	<LOD	0.95^E (0.51 - 1.4)	6.7^E (3.1 - 10)
60-79 years
1	1080	55.09	--	<LOD	<LOD	1.4 (0.94 - 1.8)	9.3^E (3.8 - 15)
2	279	45.88	--	<LOD	0.51^E (<LOD - 0.71)	1.8 (1.2 - 2.4)	10^E (6.0 - 15)

Table 14.4.3.6: Dimethyldithiophosphate (DMDTP) (creatinine adjusted) -- Geometric means and selected percentiles of urine concentrations (μg/g creatinine) for the Canadian population aged 3-79 years by sex and age group ^{Table c65 footnote a}, Canadian Health Measures Survey cycle 1 (2007-2009) and cycle 2 (2009-2011).
Cycle	N	%<LOD^{Table c65 footnote b}	GM (95% CI)	10^th (95% CI)	50^th (95% CI)	75^th (95% CI)	95^th (95% CI)
Table c65 footnotes Table c65 footnote 1 Breakdown by sex for the 3-5 year old age group is not recommended. Return to table c65 footnote a referrer Table c65 footnote 2 If >40% of samples were below the LOD, the percentile distribution is reported but means were not calculated. Return to table c65 footnote b referrer Table c65 footnote 3 Data not available as participants under the age of 6 years were not included in cycle 1 (2007-2009). Return to table c65 footnote c referrer
Males, Total 3-79 years
1^{Table c65 footnote c}	.	.	.	.	.	.	.
2	1267	51.46	--	<LOD	<LOD	0.64^E (0.40 - 0.88)	4.5 (3.0 - 5.9)
Males, 6-11 years
1	523	59.85	--	<LOD	<LOD	F	12^E (7.1 - 16)
2	261	50.57	--	<LOD	0.52^E (<LOD - 0.89)	1.5^E (0.78 - 2.2)	F
Males, 12-19 years
1	502	62.15	--	<LOD	<LOD	0.34^E (0.14 - 0.53)	F
2	255	53.73	--	<LOD	<LOD	0.33^E (0.19 - 0.48)	F
Males, 20-39 years
1	510	68.24	--	<LOD	<LOD	0.42^E (0.24 - 0.60)	F
2	166	67.47	--	<LOD	<LOD	F	X
Males, 40-59 years
1	574	66.72	--	<LOD	<LOD	0.46^E (0.27 - 0.66)	5.1^E (1.4 - 8.8)
2	189	57.14	--	<LOD	<LOD	0.57^E (<LOD - 0.80)	X
Males, 60-79 years
1	541	55.27	--	<LOD	<LOD	0.95 (0.64 - 1.3)	8.1^E (3.4 - 13)
2	137	45.99	--	<LOD	<LOD (<LOD - 0.45)	0.95^E (0.40 - 1.5)	X
Females, Total 3-79 years
1^{Table c65 footnote c}	.	.	.	.	.	.	.
2	1260	47.14	--	<LOD	0.41 (<LOD - 0.55)	1.3 (0.93 - 1.7)	9.4 (7.3 - 11)
Females, 6-11 years
1	503	56.26	--	<LOD	<LOD	1.2^E (0.66 - 1.7)	9.9 (7.4 - 12)
2	249	39.76	0.71 (0.51 - 0.97)	<LOD	0.52^E (<LOD - 0.74)	1.5^E (0.70 - 2.2)	10^E (5.6 - 15)
Females, 12-19 years
1	476	62.18	--	<LOD	<LOD	0.63^E (0.22 - 1.0)	F
2	255	47.84	--	<LOD	<LOD (<LOD - 0.40)	0.79^E (0.42 - 1.2)	4.3^E (1.5 - 7.1)
Females, 20-39 years
1	649	66.41	--	<LOD	<LOD	0.57^E (0.29 - 0.86)	F
2	189	54.50	--	<LOD	0.29 (<LOD - 0.38)	0.83^E (0.50 - 1.2)	X
Females, 40-59 years
1	644	66.93	--	<LOD	<LOD	0.68^E (0.31 - 1.0)	11 (<LOD - 14)
2	162	61.11	--	<LOD	0.57^E (<LOD - 0.87)	1.3^E (<LOD - 2.0)	X
Females, 60-79 years
1	539	54.92	--	<LOD	<LOD	2.0^E (0.92 - 3.0)	11^E (3.2 - 19)
2	142	45.77	--	<LOD	0.83^E (<LOD - 1.3)	F	X

Table 14.4.4.1: Diethylphosphate (DEP) -- Geometric means and selected percentiles of urine concentrations ( μg/L) for the Canadian population aged 6-79 years ^{Table c66 footnote a}, Canadian Health Measures Survey cycle 1 (2007-2009) and cycle 2 (2009-2011).
Cycle	N	%<LOD^{Table c66 footnote b}	GM (95% CI)	10^th (95% CI)	50^th (95% CI)	75^th (95% CI)	95^th (95% CI)
Table c66 footnotes Table c66 footnote 1 For the purpose of total population comparisons, only values from participants aged 6-79 years were included as participants under the age of 6 years were not included in cycle 1 (2007-2009). Return to table c66 footnote a referrer Table c66 footnote 2 If >40% of samples were below the LOD, the percentile distribution is reported but means were not calculated. Return to table c66 footnote b referrer
Total, 6-79 years
1	5475	20.40	2.0 (1.7 - 2.4)	<LOD	2.3 (2.0 - 2.6)	4.7 (4.4 - 5.0)	12 (11 - 14)
2	2033	14.85	2.7 (2.5 - 3.0)	<LOD	2.7 (2.4 - 3.0)	5.6 (5.0 - 6.3)	18 (16 - 21)
Males, 6-79 years
1	2659	19.03	2.1 (1.8 - 2.5)	<LOD	2.4 (2.0 - 2.7)	4.8 (4.5 - 5.1)	13 (11 - 15)
2	1019	13.54	2.8 (2.5 - 3.2)	<LOD	2.9 (2.4 - 3.4)	5.6 (4.5 - 6.8)	17^E (9.8 - 25)
Females, 6-79 years
1	2816	21.70	2.0 (1.6 - 2.4)	<LOD	2.2 (1.9 - 2.5)	4.6 (4.2 - 5.0)	12 (9.9 - 14)
2	1014	16.17	2.7 (2.3 - 3.1)	<LOD	2.6 (2.2 - 2.9)	5.6 (4.7 - 6.6)	19 (15 - 22)

Table 14.4.4.2: Diethylphosphate (DEP) -- Geometric means and selected percentiles of urine concentrations ( μg/L) for the Canadian population aged 3-79 years by age group, Canadian Health Measures Survey cycle 1 (2007-2009) and cycle 2 (2009-2011).
Cycle	N	%<LOD^{Table c67 footnote a}	GM (95% CI)	10^th (95% CI)	50^th (95% CI)	75^th (95% CI)	95^th (95% CI)
Table c67 footnotes Table c67 footnote 1 If >40% of samples were below the LOD, the percentile distribution is reported but means were not calculated. Return to table c67 footnote a referrer Table c67 footnote 2 Data not available as participants under the age of 6 years were not included in cycle 1 (2007-2009). Return to table c67 footnote b referrer
Total, 3-79 years
1^{Table c67 footnote b}	.	.	.	.	.	.	.
2	2556	13.58	2.8 (2.6 - 3.1)	<LOD	2.8 (2.5 - 3.1)	5.7 (5.1 - 6.4)	19 (16 - 21)
3-5 years
1^{Table c67 footnote b}	.	.	.	.	.	.	.
2	523	8.60	4.9 (4.1 - 5.9)	1.2 (<LOD - 1.6)	5.1 (4.1 - 6.1)	9.3 (7.2 - 12)	29^E (9.9 - 48)
6-11 years
1	1029	17.88	2.6 (1.9 - 3.5)	<LOD	3.0 (2.3 - 3.6)	6.4 (5.5 - 7.3)	17 (14 - 20)
2	515	11.26	4.1 (3.7 - 4.7)	1.1 (<LOD - 1.3)	4.0 (3.5 - 4.5)	8.1 (6.6 - 9.7)	23^E (12 - 33)
12-19 years
1	980	17.35	2.7 (2.1 - 3.4)	<LOD	3.1 (2.4 - 3.7)	6.2 (5.2 - 7.2)	18 (14 - 22)
2	512	12.30	3.4 (3.0 - 3.9)	<LOD	3.1 (2.6 - 3.7)	7.4 (5.8 - 8.9)	23^E (14 - 31)
20-39 years
1	1163	22.96	1.9 (1.5 - 2.4)	<LOD	2.1 (1.8 - 2.5)	4.1 (3.6 - 4.6)	12 (8.6 - 14)
2	357	16.81	2.7 (2.3 - 3.2)	<LOD	2.6 (2.2 - 3.0)	5.3 (4.3 - 6.2)	20^E (7.9 - 32)
40-59 years
1	1223	25.35	1.8 (1.5 - 2.2)	<LOD	2.1 (1.8 - 2.4)	4.5 (3.8 - 5.1)	11 (8.2 - 13)
2	360	19.72	2.5 (2.0 - 3.1)	<LOD	2.5 (1.9 - 3.1)	5.0 (3.5 - 6.4)	16^E (8.6 - 23)
60-79 years
1	1080	17.22	2.2 (1.9 - 2.5)	<LOD	2.3 (2.0 - 2.7)	4.8 (4.3 - 5.3)	12 (9.8 - 13)
2	289	17.30	2.6 (2.0 - 3.3)	<LOD	2.6 (1.9 - 3.4)	5.6 (3.9 - 7.4)	16 (12 - 21)

Table 14.4.4.3: Diethylphosphate (DEP) -- Geometric means and selected percentiles of urine concentrations (μg/L) for the Canadian population aged 3-79 years by sex and age group ^{Table c68 footnote a}, Canadian Health Measures Survey cycle 1 (2007-2009) and cycle 2 (2009-2011).
Cycle	N	%<LOD^{Table c68 footnote b}	GM (95% CI)	10^th (95% CI)	50^th (95% CI)	75^th (95% CI)	95^th (95% CI)
Table c68 footnotes Table c68 footnote 1 Breakdown by sex for the 3-5 year old age group is not recommended. Return to table c68 footnote a referrer Table c68 footnote 2 If >40% of samples were below the LOD, the percentile distribution is reported but means were not calculated. Return to table c68 footnote b referrer Table c68 footnote 3 Data not available as participants under the age of 6 years were not included in cycle 1 (2007-2009). Return to table c68 footnote c referrer
Males, Total 3-79 years
1^{Table c68 footnote c}	.	.	.	.	.	.	.
2	1279	12.51	2.9 (2.6 - 3.3)	<LOD	2.9 (2.5 - 3.4)	5.7 (4.6 - 6.9)	18^E (11 - 26)
Males, 6-11 years
1	525	18.67	2.6 (1.8 - 3.7)	<LOD	2.9 (1.9 - 3.8)	6.5 (5.3 - 7.7)	18 (12 - 24)
2	261	10.73	4.0 (3.2 - 4.9)	1.2 (<LOD - 1.5)	3.6 (2.5 - 4.7)	7.5 (5.1 - 9.9)	21^E (7.1 - 34)
Males, 12-19 years
1	503	16.30	2.6 (2.1 - 3.4)	<LOD	2.9 (2.1 - 3.7)	6.1 (4.9 - 7.4)	17 (13 - 21)
2	256	12.50	3.3 (2.6 - 4.2)	<LOD	3.0 (1.9 - 4.0)	7.0 (4.8 - 9.3)	F
Males, 20-39 years
1	512	22.66	1.8 (1.4 - 2.4)	<LOD	2.1 (1.7 - 2.6)	4.1 (3.3 - 4.8)	11 (7.8 - 15)
2	167	13.77	2.9 (2.1 - 4.2)	<LOD	2.8 (2.1 - 3.5)	5.6 (4.0 - 7.2)	X
Males, 40-59 years
1	578	21.45	2.0 (1.6 - 2.5)	<LOD	2.3 (1.8 - 2.7)	4.6 (3.8 - 5.5)	12 (7.6 - 16)
2	194	18.04	2.3 (1.8 - 3.1)	<LOD	2.6^E (1.5 - 3.7)	4.7^E (2.8 - 6.6)	X
Males, 60-79 years
1	541	15.90	2.4 (2.0 - 3.0)	<LOD	2.6 (1.9 - 3.3)	5.3 (4.3 - 6.3)	13 (9.2 - 16)
2	141	14.18	3.0 (2.1 - 4.3)	<LOD	3.1^E (1.9 - 4.3)	5.9^E (3.1 - 8.6)	X
Females, Total 3-79 years
1^{Table c68 footnote c}	.	.	.	.	.	.	.
2	1277	14.64	2.7 (2.3 - 3.1)	<LOD	2.6 (2.2 - 2.9)	5.7 (4.8 - 6.7)	19 (15 - 23)
Females, 6-11 years
1	504	17.06	2.6 (1.9 - 3.5)	<LOD	3.0 (2.4 - 3.7)	6.3 (5.2 - 7.4)	16 (13 - 20)
2	254	11.81	4.3 (3.4 - 5.6)	<LOD	4.4 (3.3 - 5.4)	9.0 (6.8 - 11)	F
Females, 12-19 years
1	477	18.45	2.7 (2.1 - 3.6)	<LOD	3.2 (2.4 - 3.9)	6.4 (5.1 - 7.7)	21 (15 - 28)
2	256	12.11	3.5 (2.8 - 4.4)	1.0^E (<LOD - 1.5)	3.2 (2.4 - 3.9)	7.5 (5.3 - 9.8)	21^E (13 - 29)
Females, 20-39 years
1	651	23.20	2.0 (1.5 - 2.6)	<LOD	2.1 (1.8 - 2.5)	4.2 (3.7 - 4.7)	12^E (7.6 - 17)
2	190	19.47	2.5 (1.9 - 3.3)	<LOD	2.5 (1.7 - 3.3)	5.2 (3.7 - 6.6)	X
Females, 40-59 years
1	645	28.84	1.7 (1.3 - 2.1)	<LOD	2.0 (1.7 - 2.3)	4.2 (3.3 - 5.0)	10 (8.0 - 12)
2	166	21.69	2.6 (1.9 - 3.7)	<LOD	2.5 (1.7 - 3.2)	5.5^E (3.5 - 7.5)	X
Females, 60-79 years
1	539	18.55	1.9 (1.7 - 2.2)	<LOD	2.1 (1.9 - 2.3)	4.1 (3.3 - 4.9)	10 (8.3 - 13)
2	148	20.27	2.2 (1.6 - 3.0)	<LOD	2.1^E (1.3 - 2.8)	5.5^E (2.5 - 8.5)	X

Table 14.4.4.4: Diethylphosphate (DEP) (creatinine adjusted) -- Geometric means and selected percentiles of urine concentrations ( μg/g creatinine) for the Canadian population aged 6-79 years ^{Table c69 footnote a}, Canadian Health Measures Survey cycle 1 (2007-2009) and cycle 2 (2009-2011).
Cycle	N	%<LOD^{Table c69 footnote b}	GM (95% CI)	10^th (95% CI)	50^th (95% CI)	75^th (95% CI)	95^th (95% CI)
Table c69 footnotes Table c69 footnote 1 For the purpose of total population comparisons, only values from participants aged 6-79 years were included as participants under the age of 6 years were not included in cycle 1 (2007-2009). Return to table c69 footnote a referrer Table c69 footnote 2 If >40% of samples were below the LOD, the percentile distribution is reported but means were not calculated. Return to table c69 footnote b referrer
Total, 6-79 years
1	5461	20.45	2.4 (2.0 - 2.8)	<LOD	2.6 (2.3 - 3.0)	5.2 (4.8 - 5.5)	12 (11 - 13)
2	2024	14.92	2.6 (2.4 - 2.8)	<LOD	2.5 (2.3 - 2.8)	4.6 (4.2 - 5.0)	14 (12 - 16)
Males, 6-79 years
1	2650	19.09	2.0 (1.7 - 2.4)	<LOD	2.3 (2.0 - 2.6)	4.4 (4.1 - 4.7)	11 (10 - 12)
2	1016	13.58	2.3 (2.0 - 2.6)	<LOD	2.2 (1.9 - 2.5)	4.2 (3.5 - 4.9)	14 (9.7 - 18)
Females, 6-79 years
1	2811	21.74	2.8 (2.4 - 3.3)	<LOD	3.1 (2.5 - 3.6)	5.8 (5.3 - 6.3)	14 (12 - 16)
2	1008	16.27	3.0 (2.6 - 3.4)	<LOD	2.8 (2.4 - 3.3)	5.0 (4.0 - 6.0)	14 (10 - 18)

Table 14.4.4.5: Diethylphosphate (DEP) (creatinine adjusted) -- Geometric means and selected percentiles of urine concentrations ( μg/g creatinine) for the Canadian population aged 3-79 years by age group, Canadian Health Measures Survey cycle 1 (2007-2009) and cycle 2 (2009-2011).
Cycle	N	%<LOD^{Table c70 footnote a}	GM (95% CI)	10^th (95% CI)	50^th (95% CI)	75^th (95% CI)	95^th (95% CI)
Table c70 footnotes Table c70 footnote 1 If >40% of samples were below the LOD, the percentile distribution is reported but means were not calculated. Return to table c70 footnote a referrer Table c70 footnote 2 Data not available as participants under the age of 6 years were not included in cycle 1 (2007-2009). Return to table c70 footnote b referrer
Total, 3-79 years
1^{Table c70 footnote b}	.	.	.	.	.	.	.
2	2546	13.63	2.7 (2.5 - 3.0)	<LOD	2.6 (2.3 - 2.9)	4.8 (4.4 - 5.2)	15 (12 - 17)
3-5 years
1^{Table c70 footnote b}	.	.	.	.	.	.	.
2	522	8.62	8.5 (7.3 - 9.9)	2.6 (<LOD - 3.3)	8.6 (7.2 - 10)	15 (10 - 19)	44 (33 - 56)
6-11 years
1	1026	17.93	3.9 (3.0 - 5.0)	<LOD	4.0 (3.3 - 4.8)	8.4 (7.0 - 9.8)	24 (20 - 29)
2	513	11.31	4.8 (4.3 - 5.3)	1.6 (<LOD - 1.8)	4.6 (3.9 - 5.2)	8.8 (7.0 - 11)	25^E (12 - 38)
12-19 years
1	978	17.38	2.3 (1.8 - 2.9)	<LOD	2.5 (2.0 - 3.0)	5.1 (4.6 - 5.6)	12 (10 - 13)
2	510	12.35	2.6 (2.3 - 3.0)	<LOD	2.5 (2.0 - 3.0)	4.7 (3.9 - 5.5)	16^E (9.9 - 21)
20-39 years
1	1159	23.04	2.1 (1.7 - 2.6)	<LOD	2.2 (1.9 - 2.6)	4.3 (3.6 - 4.9)	10 (8.3 - 12)
2	355	16.90	2.2 (1.9 - 2.7)	<LOD	2.1 (1.5 - 2.7)	3.7 (3.2 - 4.3)	F
40-59 years
1	1218	25.45	2.3 (1.9 - 2.7)	<LOD	2.5 (2.2 - 2.9)	5.0 (4.5 - 5.5)	11 (10 - 13)
2	358	19.83	2.5 (2.2 - 2.9)	<LOD	2.4 (2.0 - 2.8)	4.6 (3.7 - 5.5)	11 (7.6 - 15)
60-79 years
1	1080	17.22	3.0 (2.6 - 3.4)	<LOD	3.4 (3.1 - 3.8)	6.2 (5.5 - 6.9)	13 (11 - 16)
2	288	17.36	3.0 (2.5 - 3.7)	<LOD	2.9 (2.2 - 3.6)	5.4 (4.0 - 6.7)	14 (10 - 17)

Table 14.4.4.6: Diethylphosphate (DEP) (creatinine adjusted) -- Geometric means and selected percentiles of urine concentrations ( μg/g creatinine) for the Canadian population aged 3-79 years by sex and age group ^{Table c71 footnote a}, Canadian Health Measures Survey cycle 1 (2007-2009) and cycle 2 (2009-2011).
Cycle	N	%<LOD^{Table c71 footnote b}	GM (95% CI)	10^th (95% CI)	50^th (95% CI)	75^th (95% CI)	95^th (95% CI)
Table c71 footnotes Table c71 footnote 1 Breakdown by sex for the 3-5 year old age group is not recommended. Return to table c71 footnote a referrer Table c71 footnote 2 If >40% of samples were below the LOD, the percentile distribution is reported but means were not calculated. Return to table c71 footnote b referrer Table c71 footnote 3 Data not available as participants under the age of 6 years were not included in cycle 1 (2007-2009). Return to table c71 footnote c referrer
Males, Total 3-79 years
1^{Table c71 footnote c}	.	.	.	.	.	.	.
2	1275	12.55	2.4 (2.1 - 2.7)	<LOD	2.2 (1.8 - 2.6)	4.6 (3.9 - 5.3)	14 (9.6 - 19)
Males, 6-11 years
1	523	18.74	3.8 (2.9 - 5.0)	<LOD	4.1 (3.0 - 5.2)	8.2 (7.0 - 9.4)	25 (17 - 32)
2	260	10.77	4.5 (3.7 - 5.5)	1.5 (<LOD - 1.9)	4.6 (3.2 - 6.0)	8.2^E (5.1 - 11)	22 (17 - 28)
Males, 12-19 years
1	502	16.33	2.2 (1.8 - 2.7)	<LOD	2.5 (2.0 - 2.9)	5.1 (4.5 - 5.6)	11 (8.4 - 14)
2	255	12.55	2.3 (1.9 - 2.9)	<LOD	1.9^E (1.1 - 2.8)	4.4^E (2.6 - 6.2)	17^E (9.6 - 25)
Males, 20-39 years
1	510	22.75	1.6 (1.3 - 2.1)	<LOD	1.8 (1.4 - 2.1)	3.3 (2.7 - 4.0)	7.6 (6.4 - 8.8)
2	166	13.86	2.0 (1.4 - 2.8)	<LOD	1.7^E (1.0 - 2.4)	3.2 (2.2 - 4.3)	X
Males, 40-59 years
1	574	21.60	1.9 (1.6 - 2.3)	<LOD	2.2 (1.8 - 2.6)	4.0 (3.3 - 4.7)	11 (9.8 - 12)
2	194	18.04	2.0 (1.6 - 2.5)	<LOD	2.0 (1.5 - 2.4)	3.6 (2.6 - 4.7)	X
Males, 60-79 years
1	541	15.90	2.5 (2.1 - 3.0)	<LOD	3.0 (2.5 - 3.4)	5.2 (4.5 - 6.0)	11 (8.6 - 13)
2	141	14.18	2.8 (2.3 - 3.6)	<LOD	2.9 (2.3 - 3.5)	4.9 (3.9 - 5.8)	X
Females, Total 3-79 years
1^{Table c71 footnote c}	.	.	.	.	.	.	.
2	1271	14.71	3.1 (2.7 - 3.5)	<LOD	2.9 (2.5 - 3.4)	5.4 (4.3 - 6.5)	15 (11 - 19)
Females, 6-11 years
1	503	17.10	3.9 (3.0 - 5.1)	<LOD	4.0 (3.4 - 4.6)	8.7 (6.4 - 11)	24 (19 - 30)
2	253	11.86	5.1 (4.1 - 6.2)	<LOD	4.4 (3.0 - 5.8)	9.1 (6.8 - 11)	28^E (13 - 44)
Females, 12-19 years
1	476	18.49	2.4 (1.9 - 3.1)	<LOD	2.6 (1.9 - 3.3)	5.1 (4.3 - 6.0)	12 (11 - 14)
2	255	12.16	2.9 (2.3 - 3.6)	1.0 (<LOD - 1.3)	2.9 (2.0 - 3.8)	4.9 (4.1 - 5.7)	13^E (7.8 - 18)
Females, 20-39 years
1	649	23.27	2.6 (2.1 - 3.3)	<LOD	2.7 (2.2 - 3.2)	5.3 (4.5 - 6.1)	12 (9.2 - 16)
2	189	19.58	2.5 (1.9 - 3.3)	<LOD	2.5 (1.6 - 3.3)	4.0 (3.1 - 4.9)	X
Females, 40-59 years
1	644	28.88	2.7 (2.2 - 3.2)	<LOD	3.1 (2.4 - 3.8)	5.5 (4.8 - 6.1)	12 (9.5 - 14)
2	164	21.95	3.1 (2.6 - 3.8)	<LOD	2.8 (2.3 - 3.3)	5.7 (4.1 - 7.4)	X
Females, 60-79 years
1	539	18.55	3.5 (3.0 - 4.0)	<LOD	4.0 (3.3 - 4.7)	7.1 (5.9 - 8.2)	17^E (9.3 - 25)
2	147	20.41	3.2 (2.4 - 4.2)	<LOD	2.6^E (1.5 - 3.7)	6.1^E (2.6 - 9.5)	X

Table 14.4.5.1: Diethylthiophosphate (DETP) -- Geometric means and selected percentiles of urine concentrations ( μg/L) for the Canadian population aged 6-79 years ^{Table c72 footnote a}, Canadian Health Measures Survey cycle 1 (2007-2009) and cycle 2 (2009-2011).
Cycle	N	%<LOD^{Table c72 footnote b}	GM (95% CI)	10^th (95% CI)	50^th (95% CI)	75^th (95% CI)	95^th (95% CI)
Table c72 footnotes Table c72 footnote 1 For the purpose of total population comparisons, only values from participants aged 6-79 years were included as participants under the age of 6 years were not included in cycle 1 (2007-2009). Return to table c72 footnote a referrer Table c72 footnote 2 If >40% of samples were below the LOD, the percentile distribution is reported but means were not calculated. Return to table c72 footnote b referrer
Total, 6-79 years
1	5474	59.77	--	<LOD	<LOD	0.98 (0.82 - 1.1)	4.0 (3.1 - 4.8)
2	1999	25.46	0.65 (0.59 - 0.71)	<LOD	0.59 (0.49 - 0.69)	1.1 (1.0 - 1.3)	5.2^E (3.0 - 7.4)
Males, 6-79 years
1	2658	58.50	--	<LOD	<LOD	0.98 (0.82 - 1.1)	4.0 (2.8 - 5.2)
2	1006	25.05	0.62 (0.55 - 0.70)	<LOD	0.56 (0.46 - 0.66)	1.1 (0.92 - 1.3)	3.5^E (1.7 - 5.3)
Females, 6-79 years
1	2816	60.97	--	<LOD	<LOD	0.99 (0.81 - 1.2)	3.8 (2.9 - 4.8)
2	993	25.88	0.68 (0.58 - 0.79)	<LOD	0.61 (0.45 - 0.77)	1.2 (0.96 - 1.4)	F

Table 14.4.5.2: Diethylthiophosphate (DETP) -- Geometric means and selected percentiles of urine concentrations ( μg/L) for the Canadian population aged 3-79 years by age group, Canadian Health Measures Survey cycle 1 (2007-2009) and cycle 2 (2009-2011).
Cycle	N	%<LOD^{Table c73 footnote a}	GM (95% CI)	10^th (95% CI)	50^th (95% CI)	75^th (95% CI)	95^th (95% CI)
Table c73 footnotes Table c73 footnote 1 If >40% of samples were below the LOD, the percentile distribution is reported but means were not calculated. Return to table c73 footnote a referrer Table c73 footnote 2 Data not available as participants under the age of 6 years were not included in cycle 1 (2007-2009). Return to table c73 footnote b referrer
Total, 3-79 years
1^{Table c73 footnote b}	.	.	.	.	.	.	.
2	2511	23.26	0.66 (0.60 - 0.72)	<LOD	0.60 (0.51 - 0.70)	1.2 (1.0 - 1.3)	5.3^E (3.2 - 7.4)
3-5 years
1^{Table c73 footnote b}	.	.	.	.	.	.	.
2	512	14.65	1.0 (0.92 - 1.2)	<LOD	1.0 (0.91 - 1.1)	1.9 (1.5 - 2.4)	6.7^E (3.4 - 10)
6-11 years
1	1029	54.71	--	<LOD	<LOD	1.1 (0.89 - 1.3)	4.8 (3.9 - 5.7)
2	508	22.05	0.85 (0.74 - 0.98)	<LOD	0.78 (0.68 - 0.88)	1.5 (1.2 - 1.9)	F
12-19 years
1	979	54.55	--	<LOD	<LOD	1.1 (0.84 - 1.4)	4.1 (3.1 - 5.1)
2	504	22.82	0.67 (0.57 - 0.78)	<LOD	0.59 (0.47 - 0.71)	1.3 (1.0 - 1.6)	4.1^E (2.5 - 5.7)
20-39 years
1	1163	64.14	--	<LOD	<LOD	0.88 (0.69 - 1.1)	2.9 (1.9 - 3.8)
2	349	29.23	0.57 (0.48 - 0.69)	<LOD	0.47^E (<LOD - 0.64)	1.0 (0.81 - 1.2)	5.4^E (1.6 - 9.1)
40-59 years
1	1223	65.74	--	<LOD	<LOD	0.98 (0.72 - 1.2)	4.6^E (2.8 - 6.5)
2	352	28.41	0.66 (0.53 - 0.83)	<LOD	0.65 (0.46 - 0.84)	1.1 (0.84 - 1.5)	F
60-79 years
1	1080	57.87	--	<LOD	<LOD	1.1 (0.88 - 1.2)	4.1 (3.5 - 4.7)
2	286	27.97	0.67 (0.55 - 0.83)	<LOD	0.59 (0.41 - 0.76)	1.2 (0.90 - 1.6)	F

Table 14.4.5.3: Diethylthiophosphate (DETP) -- Geometric means and selected percentiles of urine concentrations ( μg/L) for the Canadian population aged 3-79 years by sex and age group ^{Table c74 footnote a}, Canadian Health Measures Survey cycle 1 (2007-2009) and cycle 2 (2009-2011).
Cycle	N	%<LOD^{Table c74 footnote b}	GM (95% CI)	10^th (95% CI)	50^th (95% CI)	75^th (95% CI)	95^th (95% CI)
Table c74 footnotes Table c74 footnote 1 Breakdown by sex for the 3-5 year old age group is not recommended. Return to table c74 footnote a referrer Table c74 footnote 2 If >40% of samples were below the LOD, the percentile distribution is reported but means were not calculated. Return to table c74 footnote b referrer Table c74 footnote 3 Data not available as participants under the age of 6 years were not included in cycle 1 (2007-2009). Return to table c74 footnote c referrer
Males, Total 3-79 years
1^{Table c74 footnote c}	.	.	.	.	.	.	.
2	1261	22.84	0.63 (0.56 - 0.71)	<LOD	0.58 (0.49 - 0.67)	1.1 (0.96 - 1.3)	3.5^E (1.6 - 5.5)
Males, 6-11 years
1	525	53.90	--	<LOD	<LOD	1.2 (0.84 - 1.5)	5.4^E (2.5 - 8.2)
2	260	22.69	0.80 (0.68 - 0.95)	<LOD	0.81 (0.65 - 0.97)	1.5 (1.1 - 2.0)	4.0 (3.1 - 5.0)
Males, 12-19 years
1	502	54.38	--	<LOD	<LOD	1.1 (0.82 - 1.3)	4.4^E (2.2 - 6.5)
2	250	23.20	0.68 (0.56 - 0.82)	<LOD	0.64 (0.45 - 0.83)	1.3 (0.90 - 1.7)	3.5^E (2.1 - 4.9)
Males, 20-39 years
1	512	64.06	--	<LOD	<LOD	0.86 (0.60 - 1.1)	2.8^E (1.4 - 4.2)
2	164	27.44	0.51 (0.38 - 0.66)	<LOD	0.44^E (<LOD - 0.61)	0.79^E (0.37 - 1.2)	X
Males, 40-59 years
1	578	65.92	--	<LOD	<LOD	0.96 (0.71 - 1.2)	4.6^E (2.7 - 6.5)
2	192	27.60	0.63 (0.46 - 0.87)	<LOD	0.57^E (0.32 - 0.81)	1.2^E (0.57 - 1.8)	X
Males, 60-79 years
1	541	53.60	--	<LOD	<LOD	1.2 (0.98 - 1.5)	4.1^E (1.9 - 6.4)
2	140	26.43	0.73 (0.51 - 1.0)	<LOD	0.67 (0.48 - 0.86)	F	X
Females, Total 3-79 years
1^{Table c74 footnote c}	.	.	.	.	.	.	.
2	1250	23.68	0.68 (0.59 - 0.79)	<LOD	0.61 (0.46 - 0.76)	1.2 (0.97 - 1.4)	5.6^E (1.6 - 9.5)
Females, 6-11 years
1	504	55.56	--	<LOD	<LOD	1.1 (0.69 - 1.4)	4.3 (3.2 - 5.3)
2	248	21.37	0.91 (0.68 - 1.2)	<LOD	0.77 (0.62 - 0.92)	F	F
Females, 12-19 years
1	477	54.72	--	<LOD	<LOD	1.2 (0.80 - 1.6)	4.0 (3.2 - 4.7)
2	254	22.44	0.66 (0.52 - 0.83)	<LOD	0.55 (0.39 - 0.71)	1.3^E (0.78 - 1.8)	5.0^E (1.6 - 8.5)
Females, 20-39 years
1	651	64.21	--	<LOD	<LOD	0.94 (0.70 - 1.2)	3.5^E (2.0 - 4.9)
2	185	30.81	0.65 (0.49 - 0.86)	<LOD	0.60^E (0.31 - 0.90)	1.1^E (0.39 - 1.8)	X
Females, 40-59 years
1	645	65.58	--	<LOD	<LOD	0.99 (0.69 - 1.3)	5.2^E (2.5 - 7.9)
2	160	29.38	0.70 (0.51 - 0.95)	<LOD	0.66 (0.43 - 0.90)	1.1 (0.79 - 1.5)	X
Females, 60-79 years
1	539	62.15	--	<LOD	<LOD	0.94 (0.77 - 1.1)	3.6 (2.4 - 4.7)
2	146	29.45	0.63 (0.45 - 0.88)	<LOD	0.49^E (<LOD - 0.72)	1.3^E (0.73 - 1.8)	X

Table 14.4.5.4: Diethylthiophosphate (DETP) (creatinine adjusted) -- Geometric means and selected percentiles of urine concentrations ( μg/g creatinine) for the Canadian population aged 6-79 years ^{Table c75 footnote a}, Canadian Health Measures Survey cycle 1 (2007-2009) and cycle 2 (2009-2011).
Cycle	N	%<LOD^{Table c75 footnote b}	GM (95% CI)	10^th (95% CI)	50^th (95% CI)	75^th (95% CI)	95^th (95% CI)
Table c75 footnotes Table c75 footnote 1 For the purpose of total population comparisons, only values from participants aged 6-79 years were included as participants under the age of 6 years were not included in cycle 1 (2007-2009). Return to table c75 footnote a referrer Table c75 footnote 2 If >40% of samples were below the LOD, the percentile distribution is reported but means were not calculated. Return to table c75 footnote b referrer
Total, 6-79 years
1	5460	59.93	--	<LOD	<LOD	0.85 (0.62 - 1.1)	4.2 (3.4 - 5.1)
2	1990	25.58	0.58 (0.52 - 0.65)	<LOD	0.55 (0.45 - 0.65)	1.2 (1.1 - 1.4)	3.9 (3.2 - 4.5)
Males, 6-79 years
1	2649	58.70	--	<LOD	<LOD	0.72 (0.53 - 0.92)	3.5 (2.9 - 4.0)
2	1003	25.12	0.48 (0.42 - 0.55)	<LOD	0.41 (0.31 - 0.52)	0.96 (0.81 - 1.1)	3.0^E (1.8 - 4.2)
Females, 6-79 years
1	2811	61.08	--	<LOD	<LOD	0.99 (0.72 - 1.3)	4.7 (3.8 - 5.7)
2	987	26.04	0.71 (0.59 - 0.86)	<LOD	0.68 (0.54 - 0.83)	1.4 (1.1 - 1.7)	4.8^E (2.4 - 7.3)

Table 14.4.5.5: Diethylthiophosphate (DETP) (creatinine adjusted) -- Geometric means and selected percentiles of urine concentrations ( μg/g creatinine) for the Canadian population aged 3-79 years by age group, Canadian Health Measures Survey cycle 1 (2007-2009) and cycle 2 (2009-2011).
Cycle	N	%<LOD^{Table c76 footnote a}	GM (95% CI)	10^th (95% CI)	50^th (95% CI)	75^th (95% CI)	95^th (95% CI)
Table c76 footnotes Table c76 footnote 1 If >40% of samples were below the LOD, the percentile distribution is reported but means were not calculated. Return to table c76 footnote a referrer Table c76 footnote 2 Data not available as participants under the age of 6 years were not included in cycle 1 (2007-2009). Return to table c76 footnote b referrer
Total, 3-79 years
1^{Table c76 footnote b}	.	.	.	.	.	.	.
2	2501	23.35	0.61 (0.55 - 0.67)	<LOD	0.59 (0.50 - 0.68)	1.3 (1.2 - 1.4)	4.2 (3.6 - 4.8)
3-5 years
1^{Table c76 footnote b}	.	.	.	.	.	.	.
2	511	14.68	1.7 (1.5 - 2.0)	<LOD	1.7 (1.4 - 2.0)	3.5 (2.9 - 4.1)	9.6^E (5.1 - 14)
6-11 years
1	1026	54.87	--	<LOD	<LOD	1.3^E (0.72 - 1.8)	6.4 (4.3 - 8.4)
2	506	22.13	0.93 (0.78 - 1.1)	<LOD	0.89 (0.75 - 1.0)	1.9 (1.5 - 2.3)	F
12-19 years
1	977	54.66	--	<LOD	<LOD	0.78 (0.56 - 0.99)	3.1 (2.1 - 4.1)
2	502	22.91	0.47 (0.40 - 0.56)	<LOD	0.48 (0.37 - 0.59)	0.93 (0.77 - 1.1)	2.8^E (1.6 - 4.1)
20-39 years
1	1159	64.37	--	<LOD	<LOD	0.67 (0.42 - 0.91)	3.0 (1.9 - 4.1)
2	347	29.39	0.46 (0.40 - 0.53)	<LOD	0.39 (<LOD - 0.49)	1.0 (0.85 - 1.2)	3.7^E (2.4 - 5.1)
40-59 years
1	1218	66.01	--	<LOD	<LOD	0.77^E (0.40 - 1.1)	5.4^E (3.4 - 7.5)
2	350	28.57	0.62 (0.48 - 0.80)	<LOD	0.62 (0.45 - 0.80)	1.3^E (0.71 - 1.8)	4.0^E (<LOD - 6.2)
60-79 years
1	1080	57.87	--	<LOD	<LOD	1.2 (0.93 - 1.4)	4.1 (2.7 - 5.4)
2	285	28.07	0.72 (0.58 - 0.88)	<LOD	0.69 (0.54 - 0.85)	1.4 (1.1 - 1.6)	F

Table 14.4.5.6: Diethylthiophosphate (DETP) (creatinine adjusted) -- Geometric means and selected percentiles of urine concentrations ( μg/g creatinine) for the Canadian population aged 3-79 years by sex and age group ^{Table c77 footnote a}, Canadian Health Measures Survey cycle 1 (2007-2009) and cycle 2 (2009-2011).
Cycle	N	%<LOD^{Table c77 footnote b}	GM (95% CI)	10^th (95% CI)	50^th (95% CI)	75^th (95% CI)	95^th (95% CI)
Table c77 footnotes Table c77 footnote 1 Breakdown by sex for the 3-5 year old age group is not recommended. Return to table c77 footnote a referrer Table c77 footnote 2 If >40% of samples were below the LOD, the percentile distribution is reported but means were not calculated. Return to table c77 footnote b referrer Table c77 footnote 3 Data not available as participants under the age of 6 years were not included in cycle 1 (2007-2009). Return to table c77 footnote c referrer
Males, Total 3-79 years
1^{Table c77 footnote c}	.	.	.	.	.	.	.
2	1257	22.91	0.50 (0.44 - 0.57)	<LOD	0.44 (0.33 - 0.55)	1.0 (0.83 - 1.2)	3.3 (2.2 - 4.5)
Males, 6-11 years
1	523	54.11	--	<LOD	<LOD	1.3^E (0.60 - 2.0)	6.7^E (3.8 - 9.7)
2	259	22.78	0.86 (0.70 - 1.1)	<LOD	0.90 (0.58 - 1.2)	1.9 (1.4 - 2.4)	3.8 (3.3 - 4.3)
Males, 12-19 years
1	501	54.49	--	<LOD	<LOD	0.67 (0.49 - 0.85)	3.0^E (0.91 - 5.1)
2	249	23.29	0.45 (0.37 - 0.55)	<LOD	0.48 (0.36 - 0.61)	0.81 (0.56 - 1.1)	F
Males, 20-39 years
1	510	64.31	--	<LOD	<LOD	0.55^E (0.34 - 0.77)	2.0 (1.5 - 2.6)
2	163	27.61	0.34 (0.26 - 0.45)	<LOD	0.32 (<LOD - 0.42)	0.65^E (0.34 - 0.96)	X
Males, 40-59 years
1	574	66.38	--	<LOD	<LOD	0.64^E (0.39 - 0.89)	3.7 (2.5 - 4.9)
2	192	27.60	0.50 (0.37 - 0.67)	<LOD	0.44^E (0.22 - 0.66)	0.98 (0.65 - 1.3)	X
Males, 60-79 years
1	541	53.60	--	<LOD	<LOD	1.1 (0.82 - 1.3)	3.8^E (1.3 - 6.3)
2	140	26.43	0.64 (0.47 - 0.86)	<LOD	0.55 (0.37 - 0.74)	1.3^E (<LOD - 1.8)	X
Females, Total 3-79 years
1^{Table c77 footnote c}	.	.	.	.	.	.	.
2	1244	23.79	0.73 (0.61 - 0.88)	<LOD	0.69 (0.56 - 0.82)	1.5 (1.1 - 1.9)	5.2^E (2.9 - 7.6)
Females, 6-11 years
1	503	55.67	--	<LOD	<LOD	1.3^E (0.55 - 2.0)	6.0^E (3.5 - 8.5)
2	247	21.46	1.0 (0.76 - 1.4)	<LOD	0.86 (0.69 - 1.0)	1.8^E (0.93 - 2.6)	F
Females, 12-19 years
1	476	54.83	--	<LOD	<LOD	0.88 (0.59 - 1.2)	3.3 (2.3 - 4.2)
2	253	22.53	0.50 (0.40 - 0.62)	<LOD	0.48 (0.34 - 0.62)	0.98 (0.80 - 1.2)	3.0^E (1.5 - 4.5)
Females, 20-39 years
1	649	64.41	--	<LOD	<LOD	0.92^E (0.51 - 1.3)	4.2 (2.8 - 5.6)
2	184	30.98	0.61 (0.47 - 0.80)	<LOD	0.60^E (0.33 - 0.87)	1.3^E (0.69 - 2.0)	X
Females, 40-59 years
1	644	65.68	--	<LOD	<LOD	1.0^E (0.50 - 1.5)	7.1^E (4.0 - 10)
2	158	29.75	0.78^E (0.52 - 1.2)	<LOD	0.69^E (0.43 - 0.94)	1.5^E (0.62 - 2.5)	X
Females, 60-79 years
1	539	62.15	--	<LOD	<LOD	1.2 (0.91 - 1.5)	4.5 (3.2 - 5.8)
2	145	29.66	0.80 (0.56 - 1.1)	<LOD	0.75^E (<LOD - 1.0)	1.4^E (0.67 - 2.0)	X

Table 14.4.6.1: Diethyldithiophosphate (DEDTP) -- Geometric means and selected percentiles of urine concentrations ( μg/L) for the Canadian population aged 6-79 years ^{Table c78 footnote a}, Canadian Health Measures Survey cycle 1 (2007-2009) and cycle 2 (2009-2011).
Cycle	N	%<LOD^{Table c78 footnote b}	GM (95% CI)	10^th (95% CI)	50^th (95% CI)	75^th (95% CI)	95^th (95% CI)
Table c78 footnotes Table c78 footnote 1 For the purpose of total population comparisons, only values from participants aged 6-79 years were included as participants under the age of 6 years were not included in cycle 1 (2007-2009). Return to table c78 footnote a referrer Table c78 footnote 2 If >40% of samples were below the LOD, the percentile distribution is reported but means were not calculated. Return to table c78 footnote b referrer
Total, 6-79 years
1	5475	96.84	--	<LOD	<LOD	<LOD	<LOD
2	2033	97.15	--	<LOD	<LOD	<LOD	<LOD
Males, 6-79 years
1	2659	96.35	--	<LOD	<LOD	<LOD	<LOD
2	1019	96.37	--	<LOD	<LOD	<LOD	F
Females, 6-79 years
1	2816	97.30	--	<LOD	<LOD	<LOD	<LOD
2	1014	97.93	--	<LOD	<LOD	<LOD	<LOD

Table 14.4.6.2: Diethyldithiophosphate (DEDTP) -- Geometric means and selected percentiles of urine concentrations ( μg/L) for the Canadian population aged 3-79 years by age group, Canadian Health Measures Survey cycle 1 (2007-2009) and cycle 2 (2009-2011).
Cycle	N	%<LOD^{Table c79 footnote a}	GM (95% CI)	10^th (95% CI)	50^th (95% CI)	75^th (95% CI)	95^th (95% CI)
Table c79 footnotes Table c79 footnote 1 If >40% of samples were below the LOD, the percentile distribution is reported but means were not calculated. Return to table c79 footnote a referrer Table c79 footnote 2 Data not available as participants under the age of 6 years were not included in cycle 1 (2007-2009). Return to table c79 footnote b referrer
Total, 3-79 years
1^{Table c79 footnote b}	.	.	.	.	.	.	.
2	2557	97.38	--	<LOD	<LOD	<LOD	<LOD
3-5 years
1^{Table c79 footnote b}	.	.	.	.	.	.	.
2	524	98.28	--	<LOD	<LOD	<LOD	<LOD
6-11 years
1	1029	96.21	--	<LOD	<LOD	<LOD	<LOD
2	516	97.48	--	<LOD	<LOD	<LOD	F
12-19 years
1	980	96.12	--	<LOD	<LOD	<LOD	<LOD
2	511	97.06	--	<LOD	<LOD	<LOD	<LOD
20-39 years
1	1163	97.08	--	<LOD	<LOD	<LOD	<LOD
2	356	96.35	--	<LOD	<LOD	<LOD	<LOD
40-59 years
1	1223	97.30	--	<LOD	<LOD	<LOD	<LOD
2	360	97.22	--	<LOD	<LOD	<LOD	<LOD
60-79 years
1	1080	97.31	--	<LOD	<LOD	<LOD	<LOD
2	290	97.59	--	<LOD	<LOD	<LOD	<LOD

Table 14.4.6.3: Diethyldithiophosphate (DEDTP) -- Geometric means and selected percentiles of urine concentrations ( μg/L) for the Canadian population aged 3-79 years by sex and age group ^{Table c80 footnote a}, Canadian Health Measures Survey cycle 1 (2007-2009) and cycle 2 (2009-2011).
Cycle	N	%<LOD^{Table c80 footnote b}	GM (95% CI)	10^th (95% CI)	50^th (95% CI)	75^th (95% CI)	95^th (95% CI)
Table c80 footnotes Table c80 footnote 1 Breakdown by sex for the 3-5 year old age group is not recommended. Return to table c80 footnote a referrer Table c80 footnote 2 If >40% of samples were below the LOD, the percentile distribution is reported but means were not calculated. Return to table c80 footnote b referrer Table c80 footnote 3 Data not available as participants under the age of 6 years were not included in cycle 1 (2007-2009). Return to table c80 footnote c referrer
Males, Total 3-79 years
1^{Table c80 footnote c}	.	.	.	.	.	.	.
2	1279	96.79	--	<LOD	<LOD	<LOD	<LOD
Males, 6-11 years
1	525	96.19	--	<LOD	<LOD	<LOD	<LOD
2	262	97.33	--	<LOD	<LOD	<LOD	F
Males, 12-19 years
1	503	95.83	--	<LOD	<LOD	<LOD	<LOD
2	255	97.25	--	<LOD	<LOD	<LOD	<LOD
Males, 20-39 years
1	512	97.07	--	<LOD	<LOD	<LOD	<LOD
2	167	94.61	--	<LOD	<LOD	<LOD	X
Males, 40-59 years
1	578	96.89	--	<LOD	<LOD	<LOD	<LOD
2	194	95.36	--	<LOD	<LOD	<LOD	X
Males, 60-79 years
1	541	95.75	--	<LOD	<LOD	<LOD	<LOD
2	141	96.45	--	<LOD	<LOD	<LOD	X
Females, Total 3-79 years
1^{Table c80 footnote c}	.	.	.	.	.	.	.
2	1278	97.97	--	<LOD	<LOD	<LOD	<LOD
Females, 6-11 years
1	504	96.23	--	<LOD	<LOD	<LOD	<LOD
2	254	97.64	--	<LOD	<LOD	<LOD	<LOD
Females, 12-19 years
1	477	96.44	--	<LOD	<LOD	<LOD	<LOD
2	256	96.88	--	<LOD	<LOD	<LOD	<LOD
Females, 20-39 years
1	651	97.08	--	<LOD	<LOD	<LOD	<LOD
2	189	97.88	--	<LOD	<LOD	<LOD	X
Females, 40-59 years
1	645	97.67	--	<LOD	<LOD	<LOD	<LOD
2	166	99.40	--	<LOD	<LOD	<LOD	X
Females, 60-79 years
1	539	98.89	--	<LOD	<LOD	<LOD	<LOD
2	149	98.66	--	<LOD	<LOD	<LOD	X

Table 14.4.6.4: Diethyldithiophosphate (DEDTP) (creatinine adjusted) -- Geometric means and selected percentiles of urine concentrations ( μg/g creatinine) for the Canadian population aged 6-79 years ^{Table c81 footnote a}, Canadian Health Measures Survey cycle 1 (2007-2009) and cycle 2 (2009-2011).
Cycle	N	%<LOD^{Table c81 footnote b}	GM (95% CI)	10^th (95% CI)	50^th (95% CI)	75^th (95% CI)	95^th (95% CI)
Table c81 footnotes Table c81 footnote 1 For the purpose of total population comparisons, only values from participants aged 6-79 years were included as participants under the age of 6 years were not included in cycle 1 (2007-2009). Return to table c81 footnote a referrer Table c81 footnote 2 If >40% of samples were below the LOD, the percentile distribution is reported but means were not calculated. Return to table c81 footnote b referrer
Total, 6-79 years
1	5461	97.09	--	<LOD	<LOD	<LOD	<LOD
2	2024	97.58	--	<LOD	<LOD	<LOD	<LOD
Males, 6-79 years
1	2650	96.68	--	<LOD	<LOD	<LOD	<LOD
2	1016	96.65	--	<LOD	<LOD	<LOD	0.55 (<LOD - 0.73)
Females, 6-79 years
1	2811	97.47	--	<LOD	<LOD	<LOD	<LOD
2	1008	98.51	--	<LOD	<LOD	<LOD	<LOD

Table 14.4.6.5: Diethyldithiophosphate (DEDTP) (creatinine adjusted) -- Geometric means and selected percentiles of urine concentrations ( μg/g creatinine) for the Canadian population aged 3-79 years by age group, Canadian Health Measures Survey cycle 1 (2007-2009) and cycle 2 (2009-2011).
Cycle	N	%<LOD^{Table c82 footnote a}	GM (95% CI)	10^th (95% CI)	50^th (95% CI)	75^th (95% CI)	95^th (95% CI)
Table c82 footnotes Table c82 footnote 1 If >40% of samples were below the LOD, the percentile distribution is reported but means were not calculated. Return to table c82 footnote a referrer Table c82 footnote 2 Data not available as participants under the age of 6 years were not included in cycle 1 (2007-2009). Return to table c82 footnote b referrer
Total, 3-79 years
1^{Table c82 footnote b}	.	.	.	.	.	.	.
2	2547	97.76	--	<LOD	<LOD	<LOD	<LOD
3-5 years
1^{Table c82 footnote b}	.	.	.	.	.	.	.
2	523	98.47	--	<LOD	<LOD	<LOD	<LOD
6-11 years
1	1026	96.49	--	<LOD	<LOD	<LOD	<LOD
2	514	97.86	--	<LOD	<LOD	<LOD	0.73^E (<LOD - 1.2)
12-19 years
1	978	96.32	--	<LOD	<LOD	<LOD	<LOD
2	509	97.45	--	<LOD	<LOD	<LOD	<LOD
20-39 years
1	1159	97.41	--	<LOD	<LOD	<LOD	<LOD
2	354	96.89	--	<LOD	<LOD	<LOD	<LOD
40-59 years
1	1218	97.70	--	<LOD	<LOD	<LOD	<LOD
2	358	97.77	--	<LOD	<LOD	<LOD	<LOD
60-79 years
1	1080	97.31	--	<LOD	<LOD	<LOD	<LOD
2	289	97.92	--	<LOD	<LOD	<LOD	<LOD

Table 14.4.6.6: Diethyldithiophosphate (DEDTP) (creatinine adjusted) -- Geometric means and selected percentiles of urine concentrations ( μg/g creatinine) for the Canadian population aged 3-79 years by sex and age group ^{Table c83 footnote a}, Canadian Health Measures Survey cycle 1 (2007-2009) and cycle 2 (2009-2011).
Cycle	N	%<LOD^{Table c83 footnote b}	GM (95% CI)	10^th (95% CI)	50^th (95% CI)	75^th (95% CI)	95^th (95% CI)
Table c83 footnotes Table c83 footnote 1 Breakdown by sex for the 3-5 year old age group is not recommended. Return to table c83 footnote a referrer Table c83 footnote 2 If >40% of samples were below the LOD, the percentile distribution is reported but means were not calculated. Return to table c83 footnote b referrer Table c83 footnote 3 Data not available as participants under the age of 6 years were not included in cycle 1 (2007-2009). Return to table c83 footnote c referrer
Males, Total 3-79 years
1^{Table c83 footnote c}	.	.	.	.	.	.	.
2	1275	97.10	--	<LOD	<LOD	<LOD	<LOD
Males, 6-11 years
1	523	96.56	--	<LOD	<LOD	<LOD	<LOD
2	261	97.70	--	<LOD	<LOD	<LOD	0.71^E (<LOD - 1.1)
Males, 12-19 years
1	502	96.02	--	<LOD	<LOD	<LOD	<LOD
2	254	97.64	--	<LOD	<LOD	<LOD	<LOD
Males, 20-39 years
1	510	97.45	--	<LOD	<LOD	<LOD	<LOD
2	166	95.18	--	<LOD	<LOD	<LOD	X
Males, 40-59 years
1	574	97.56	--	<LOD	<LOD	<LOD	<LOD
2	194	95.36	--	<LOD	<LOD	<LOD	X
Males, 60-79 years
1	541	95.75	--	<LOD	<LOD	<LOD	<LOD
2	141	96.45	--	<LOD	<LOD	<LOD	X
Females, Total 3-79 years
1^{Table c83 footnote c}	.	.	.	.	.	.	.
2	1272	98.43	--	<LOD	<LOD	<LOD	<LOD
Females, 6-11 years
1	503	96.42	--	<LOD	<LOD	<LOD	<LOD
2	253	98.02	--	<LOD	<LOD	<LOD	<LOD
Females, 12-19 years
1	476	96.64	--	<LOD	<LOD	<LOD	<LOD
2	255	97.25	--	<LOD	<LOD	<LOD	<LOD
Females, 20-39 years
1	649	97.38	--	<LOD	<LOD	<LOD	<LOD
2	188	98.40	--	<LOD	<LOD	<LOD	X
Females, 40-59 years
1	644	97.83	--	<LOD	<LOD	<LOD	<LOD
2	164	100	--	<LOD	<LOD	<LOD	X
Females, 60-79 years
1	539	98.89	--	<LOD	<LOD	<LOD	<LOD
2	148	99.32	--	<LOD	<LOD	<LOD	X

Table 14.5.1.1: 4-Fluoro-3-phenoxybenzoic acid (4-F-3-PBA) -- Geometric means and selected percentiles of urine concentrations ( μg/L) for the Canadian population aged 6-79 years ^{Table c84 footnote a}, Canadian Health Measures Survey cycle 1 (2007-2009) and cycle 2 (2009-2011).
Cycle	N	%<LOD^{Table c84 footnote b}	GM (95% CI)	10^th (95% CI)	50^th (95% CI)	75^th (95% CI)	95^th (95% CI)
Table c84 footnotes Table c84 footnote 1 For the purpose of total population comparisons, only values from participants aged 6-79 years were included as participants under the age of 6 years were not included in cycle 1 (2007-2009). Return to table c84 footnote a referrer Table c84 footnote 2 If >40% of samples were below the LOD, the percentile distribution is reported but means were not calculated. Return to table c84 footnote b referrer
Total, 6-79 years
1	5224	56.45	--	<LOD	<LOD	0.0099 (<LOD - 0.013)	0.076 (0.054 - 0.098)
2	2022	43.37	--	<LOD	0.0091 (0.0080 - 0.010)	0.018 (0.012 - 0.023)	0.11^E (0.035 - 0.18)
Males, 6-79 years
1	2529	54.49	--	<LOD	<LOD	0.011 (<LOD - 0.015)	0.091^E (0.049 - 0.13)
2	1012	44.07	--	<LOD	0.0090 (<LOD - 0.011)	0.018 (0.012 - 0.024)	0.10^E (0.039 - 0.17)
Females, 6-79 years
1	2695	58.29	--	<LOD	<LOD	0.0098 (0.0084 - 0.011)	0.058 (0.045 - 0.071)
2	1010	42.67	--	<LOD	0.0092 (0.0083 - 0.010)	0.018^E (0.010 - 0.026)	F

Table 14.5.1.2: 4-Fluoro-3-phenoxybenzoic acid (4-F-3-PBA) -- Geometric means and selected percentiles of urine concentrations ( μg/L) for the Canadian population aged 3-79 years by age group, Canadian Health Measures Survey cycle 1 (2007-2009) and cycle 2 (2009-2011).
Cycle	N	%<LOD^{Table c85 footnote a}	GM (95% CI)	10^th (95% CI)	50^th (95% CI)	75^th (95% CI)	95^th (95% CI)
Table c85 footnotes Table c85 footnote 1 If >40% of samples were below the LOD, the percentile distribution is reported but means were not calculated. Return to table c85 footnote a referrer Table c85 footnote 2 Data not available as participants under the age of 6 years were not included in cycle 1 (2007-2009). Return to table c85 footnote b referrer
Total, 3-79 years
1^{Table c85 footnote b}	.	.	.	.	.	.	.
2	2539	44.70	--	<LOD	0.0091 (<LOD - 0.010)	0.018 (0.013 - 0.023)	0.11^E (0.040 - 0.17)
3-5 years
1^{Table c85 footnote b}	.	.	.	.	.	.	.
2	517	49.90	--	<LOD	<LOD	0.015^E (<LOD - 0.023)	0.050 (0.032 - 0.067)
6-11 years
1	998	57.52	--	<LOD	<LOD	0.0096 (0.0093 - 0.0098)	F
2	514	43.77	--	<LOD	0.0087 (<LOD - 0.011)	0.015^E (0.0091 - 0.020)	0.056^E (0.028 - 0.085)
12-19 years
1	947	49.10	--	<LOD	F	0.011 (<LOD - 0.015)	0.060^E (0.017 - 0.10)
2	510	41.76	--	<LOD	0.0090 (<LOD - 0.011)	0.015 (0.011 - 0.019)	F
20-39 years
1	1100	54.82	--	<LOD	<LOD	0.011^E (<LOD - 0.015)	0.089^E (0.030 - 0.15)
2	352	43.18	--	<LOD	0.0093 (<LOD - 0.012)	0.019^E (<LOD - 0.030)	0.11^E (0.033 - 0.19)
40-59 years
1	1161	59.09	--	<LOD	<LOD	0.010^E (<LOD - 0.014)	0.079^E (0.048 - 0.11)
2	357	41.46	--	<LOD	0.0094 (0.0083 - 0.010)	0.026^E (0.011 - 0.040)	F
60-79 years
1	1018	61.00	--	<LOD	<LOD	0.0095 (<LOD - 0.011)	0.069^E (0.021 - 0.12)
2	289	48.10	--	<LOD	<LOD	F	F

Table 14.5.1.3: 4-Fluoro-3-phenoxybenzoic acid (4-F-3-PBA) -- Geometric means and selected percentiles of urine concentrations ( μg/L) for the Canadian population aged 3-79 years by sex and age group ^{Table c86 footnote a}, Canadian Health Measures Survey cycle 1 (2007-2009) and cycle 2 (2009-2011).
Cycle	N	%<LOD^{Table c86 footnote b}	GM (95% CI)	10^th (95% CI)	50^th (95% CI)	75^th (95% CI)	95^th (95% CI)
Table c86 footnotes Table c86 footnote 1 Breakdown by sex for the 3-5 year old age group is not recommended. Return to table c86 footnote a referrer Table c86 footnote 2 If >40% of samples were below the LOD, the percentile distribution is reported but means were not calculated. Return to table c86 footnote b referrer Table c86 footnote 3 Data not available as participants under the age of 6 years were not included in cycle 1 (2007-2009). Return to table c86 footnote c referrer
Males, Total 3-79 years
1^{Table c86 footnote c}	.	.	.	.	.	.	.
2	1268	44.16	--	<LOD	0.0090 (<LOD - 0.012)	0.018 (0.012 - 0.023)	0.10^E (0.044 - 0.16)
Males, 6-11 years
1	515	56.31	--	<LOD	<LOD	0.0098 (0.0089 - 0.011)	0.053^E (0.022 - 0.084)
2	261	44.44	--	<LOD	0.0092 (<LOD - 0.011)	0.017^E (<LOD - 0.026)	F
Males, 12-19 years
1	485	47.22	--	<LOD	0.0083^E (<LOD - 0.011)	0.013 (0.0083 - 0.017)	0.061^E (0.032 - 0.091)
2	255	45.49	--	<LOD	F	0.011^E (<LOD - 0.015)	0.040^E (0.023 - 0.056)
Males, 20-39 years
1	484	52.89	--	<LOD	<LOD	0.014^E (<LOD - 0.021)	F
2	162	43.83	--	<LOD	0.0091^E (<LOD - 0.013)	0.017^E (0.0091 - 0.024)	X
Males, 40-59 years
1	541	57.30	--	<LOD	<LOD	0.011^E (<LOD - 0.017)	0.10^E (0.047 - 0.16)
2	192	39.58	0.014 (0.0098 - 0.020)	<LOD	0.0094 (<LOD - 0.011)	0.030^E (0.012 - 0.049)	X
Males, 60-79 years
1	504	58.13	--	<LOD	<LOD	0.0096 (<LOD - 0.011)	0.068^E (0.030 - 0.11)
2	142	47.18	--	<LOD	<LOD	0.012^E (<LOD - 0.019)	X
Females, Total 3-79 years
1^{Table c86 footnote c}	.	.	.	.	.	.	.
2	1271	45.24	--	<LOD	0.0092 (0.0083 - 0.010)	0.018^E (0.011 - 0.025)	F
Females, 6-11 years
1	483	58.80	--	<LOD	<LOD	0.0094 (0.0090 - 0.0098)	F
2	253	43.08	--	<LOD	F	0.011^E (<LOD - 0.015)	0.046^E (0.029 - 0.063)
Females, 12-19 years
1	462	51.08	--	<LOD	<LOD	0.0099 (<LOD - 0.013)	F
2	255	38.04	0.012 (0.0088 - 0.017)	<LOD	0.0094 (0.0085 - 0.010)	0.018^E (<LOD - 0.028)	F
Females, 20-39 years
1	616	56.33	--	<LOD	<LOD	0.0098 (<LOD - 0.012)	0.066^E (0.035 - 0.098)
2	190	42.63	--	<LOD	0.0095 (<LOD - 0.011)	0.025^E (0.011 - 0.040)	X
Females, 40-59 years
1	620	60.65	--	<LOD	<LOD	0.0099 (<LOD - 0.013)	0.057^E (0.034 - 0.079)
2	165	43.64	--	<LOD	0.0094 (<LOD - 0.011)	F	X
Females, 60-79 years
1	514	63.81	--	<LOD	<LOD	0.0094 (<LOD - 0.012)	F
2	147	48.98	--	<LOD	<LOD	F	X

Table 14.5.1.4: 4-Fluoro-3-phenoxybenzoic acid (4-F-3-PBA) (creatinine adjusted) -- Geometric means and selected percentiles of urine concentrations ( μg/g creatinine) for the Canadian population aged 6-79 years ^{Table c87 footnote a}, Canadian Health Measures Survey cycle 1 (2007-2009) and cycle 2 (2009-2011).
Cycle	N	%<LOD^{Table c87 footnote b}	GM (95% CI)	10^th (95% CI)	50^th (95% CI)	75^th (95% CI)	95^th (95% CI)
Table c87 footnotes Table c87 footnote 1 For the purpose of total population comparisons, only values from participants aged 6-79 years were included as participants under the age of 6 years were not included in cycle 1 (2007-2009). Return to table c87 footnote a referrer Table c87 footnote 2 If >40% of samples were below the LOD, the percentile distribution is reported but means were not calculated. Return to table c87 footnote b referrer
Total, 6-79 years
1	5210	56.60	--	<LOD	<LOD	0.017 (<LOD - 0.020)	0.072^E (0.038 - 0.10)
2	2013	43.57	--	<LOD	0.0094 (0.0078 - 0.011)	0.019 (0.015 - 0.022)	F
Males, 6-79 years
1	2520	54.68	--	<LOD	<LOD	0.014 (<LOD - 0.017)	F
2	1009	44.20	--	<LOD	0.0074 (<LOD - 0.0089)	0.016 (0.012 - 0.020)	F
Females, 6-79 years
1	2690	58.40	--	<LOD	<LOD	0.020 (0.017 - 0.023)	0.072^E (0.043 - 0.10)
2	1004	42.93	--	<LOD	0.012 (0.0096 - 0.014)	0.021 (0.016 - 0.025)	F

Table 14.5.1.5: 4-Fluoro-3-phenoxybenzoic acid (4-F-3-PBA) (creatinine adjusted) -- Geometric means and selected percentiles of urine concentrations ( μg/g creatinine) for the Canadian population aged 3-79 years by age group, Canadian Health Measures Survey cycle 1 (2007-2009) and cycle 2 (2009-2011).
Cycle	N	%<LOD^{Table c88 footnote a}	GM (95% CI)	10^th (95% CI)	50^th (95% CI)	75^th (95% CI)	95^th (95% CI)
Table c88 footnotes Table c88 footnote 1 If >40% of samples were below the LOD, the percentile distribution is reported but means were not calculated. Return to table c88 footnote a referrer Table c88 footnote 2 Data not available as participants under the age of 6 years were not included in cycle 1 (2007-2009). Return to table c88 footnote b referrer
Total, 3-79 years
1^{Table c88 footnote b}	.	.	.	.	.	.	.
2	2529	44.88	--	<LOD	0.0096 (<LOD - 0.011)	0.019 (0.016 - 0.022)	F
3-5 years
1^{Table c88 footnote b}	.	.	.	.	.	.	.
2	516	50.00	--	<LOD	<LOD	0.028^E (<LOD - 0.040)	0.090^E (0.057 - 0.12)
6-11 years
1	995	57.69	--	<LOD	<LOD	0.018 (0.015 - 0.020)	0.070^E (0.042 - 0.099)
2	512	43.95	--	<LOD	0.010 (<LOD - 0.012)	0.017 (0.011 - 0.022)	0.066^E (0.024 - 0.11)
12-19 years
1	945	49.21	--	<LOD	<LOD (<LOD - 0.0087)	0.013 (<LOD - 0.016)	0.045^E (0.016 - 0.074)
2	508	41.93	--	<LOD	0.0067 (<LOD - 0.0080)	0.012 (0.0096 - 0.015)	F
20-39 years
1	1096	55.02	--	<LOD	<LOD	0.017 (<LOD - 0.021)	F
2	350	43.43	--	<LOD	0.0087^E (<LOD - 0.012)	0.018^E (<LOD - 0.027)	F
40-59 years
1	1156	59.34	--	<LOD	<LOD	0.018 (<LOD - 0.022)	0.079^E (0.039 - 0.12)
2	355	41.69	--	<LOD	0.012 (0.0096 - 0.015)	0.022 (0.017 - 0.027)	F
60-79 years
1	1018	61.00	--	<LOD	<LOD	0.018 (<LOD - 0.023)	0.095^E (0.026 - 0.16)
2	288	48.26	--	<LOD	<LOD	0.018^E (<LOD - 0.029)	F

Table 14.5.1.6: 4-Fluoro-3-phenoxybenzoic acid (4-F-3-PBA) (creatinine adjusted) -- Geometric means and selected percentiles of urine concentrations ( μg/g creatinine) for the Canadian population aged 3-79 years by sex and age group ^{Table c89 footnote a}, Canadian Health Measures Survey cycle 1 (2007-2009) and cycle 2 (2009-2011).
Cycle	N	%<LOD^{Table c89 footnote b}	GM (95% CI)	10^th (95% CI)	50^th (95% CI)	75^th (95% CI)	95^th (95% CI)
Table c89 footnotes Table c89 footnote 1 Breakdown by sex for the 3-5 year old age group is not recommended. Return to table c89 footnote a referrer Table c89 footnote 2 If >40% of samples were below the LOD, the percentile distribution is reported but means were not calculated. Return to table c89 footnote b referrer Table c89 footnote 3 Data not available as participants under the age of 6 years were not included in cycle 1 (2007-2009). Return to table c89 footnote c referrer
Males, Total 3-79 years
1^{Table c89 footnote c}	.	.	.	.	.	.	.
2	1264	44.30	--	<LOD	0.0077 (<LOD - 0.0093)	0.017 (0.013 - 0.020)	F
Males, 6-11 years
1	513	56.53	--	<LOD	<LOD	0.018 (0.014 - 0.022)	0.072^E (0.036 - 0.11)
2	260	44.62	--	<LOD	0.011 (<LOD - 0.014)	0.018^E (<LOD - 0.027)	F
Males, 12-19 years
1	484	47.31	--	<LOD	0.0080 (<LOD - 0.0096)	0.014 (0.011 - 0.018)	0.041 (0.031 - 0.051)
2	254	45.67	--	<LOD	<LOD (<LOD - 0.0068)	0.011 (<LOD - 0.014)	0.024^E (0.015 - 0.034)
Males, 20-39 years
1	482	53.11	--	<LOD	<LOD	0.015^E (<LOD - 0.021)	F
2	161	44.10	--	<LOD	0.0055 (<LOD - 0.0067)	F	X
Males, 40-59 years
1	537	57.73	--	<LOD	<LOD	0.014 (<LOD - 0.016)	F
2	192	39.58	0.012 (0.0095 - 0.015)	<LOD	0.011 (<LOD - 0.014)	0.020 (0.015 - 0.026)	X
Males, 60-79 years
1	504	58.13	--	<LOD	<LOD	0.013 (<LOD - 0.017)	0.058^E (0.034 - 0.082)
2	142	47.18	--	<LOD	<LOD	0.016 (<LOD - 0.019)	X
Females, Total 3-79 years
1^{Table c89 footnote c}	.	.	.	.	.	.	.
2	1265	45.45	--	<LOD	0.012 (0.0097 - 0.014)	0.021 (0.017 - 0.025)	F
Females, 6-11 years
1	482	58.92	--	<LOD	<LOD	0.017 (0.014 - 0.020)	0.063^E (<LOD - 0.10)
2	252	43.25	--	<LOD	<LOD (<LOD - 0.012)	0.015 (<LOD - 0.020)	0.056^E (0.034 - 0.077)
Females, 12-19 years
1	461	51.19	--	<LOD	<LOD	0.012 (<LOD - 0.015)	F
2	254	38.19	0.010 (0.0079 - 0.013)	<LOD	0.0086 (0.0068 - 0.010)	0.017^E (<LOD - 0.024)	0.099^E (<LOD - 0.17)
Females, 20-39 years
1	614	56.51	--	<LOD	<LOD	0.019 (<LOD - 0.024)	0.072^E (0.037 - 0.11)
2	189	42.86	--	<LOD	0.013 (<LOD - 0.017)	0.021^E (0.0060 - 0.036)	X
Females, 40-59 years
1	619	60.74	--	<LOD	<LOD	0.022 (<LOD - 0.026)	0.070 (0.048 - 0.091)
2	163	44.17	--	<LOD	0.013 (<LOD - 0.016)	0.022^E (<LOD - 0.030)	X
Females, 60-79 years
1	514	63.81	--	<LOD	<LOD	0.022 (<LOD - 0.030)	F
2	146	49.32	--	<LOD	<LOD	0.021^E (<LOD - 0.030)	X

Table 14.5.2.1: cis-3-(2,2-Dibromovinyl)-2,2-dimethylcyclopropane carboxylic acid (cis-DBCA) -- Geometric means and selected percentiles of urine concentrations ( μg/L) for the Canadian population aged 6-79 years ^{Table c90 footnote a}, Canadian Health Measures Survey cycle 1 (2007-2009) and cycle 2 (2009-2011).
Cycle	N	%<LOD^{Table c90 footnote b}	GM (95% CI)	10^th (95% CI)	50^th (95% CI)	75^th (95% CI)	95^th (95% CI)
Table c90 footnotes Table c90 footnote 1 For the purpose of total population comparisons, only values from participants aged 6-79 years were included as participants under the age of 6 years were not included in cycle 1 (2007-2009). Return to table c90 footnote a referrer Table c90 footnote 2 If >40% of samples were below the LOD, the percentile distribution is reported but means were not calculated. Return to table c90 footnote b referrer
Total, 6-79 years
1	5022	50.36	--	<LOD	<LOD	0.019 (0.014 - 0.025)	0.073 (0.060 - 0.087)
2	2013	37.75	0.012 (0.010 - 0.014)	<LOD	0.0094 (0.0082 - 0.011)	0.030 (0.025 - 0.036)	0.15^E (0.073 - 0.23)
Males, 6-79 years
1	2433	49.65	--	<LOD	<LOD	0.020 (0.019 - 0.020)	0.074 (0.060 - 0.089)
2	1013	36.72	0.012 (0.010 - 0.015)	<LOD	0.0096 (0.0070 - 0.012)	0.034^E (0.021 - 0.046)	0.14^E (0.046 - 0.24)
Females, 6-79 years
1	2589	51.02	--	<LOD	<LOD	0.019^E (0.0068 - 0.031)	0.072 (0.052 - 0.092)
2	1000	38.80	0.011 (0.0090 - 0.014)	<LOD	0.0092 (0.0068 - 0.012)	0.028 (0.020 - 0.035)	F

Table 14.5.2.2: cis-3-(2,2-Dibromovinyl)-2,2-dimethylcyclopropane carboxylic acid (cis-DBCA) -- Geometric means and selected percentiles of urine concentrations ( μg/L) for the Canadian population aged 3-79 years by age group, Canadian Health Measures Survey cycle 1 (2007-2009) and cycle 2 (2009-2011).
Cycle	N	%<LOD^{Table c91 footnote a}	GM (95% CI)	10^th (95% CI)	50^th (95% CI)	75^th (95% CI)	95^th (95% CI)
Table c91 footnotes Table c91 footnote 1 If >40% of samples were below the LOD, the percentile distribution is reported but means were not calculated. Return to table c91 footnote a referrer Table c91 footnote 2 Data not available as participants under the age of 6 years were not included in cycle 1 (2007-2009). Return to table c91 footnote b referrer
Total, 3-79 years
1^{Table c91 footnote b}	.	.	.	.	.	.	.
2	2535	37.24	0.012 (0.010 - 0.014)	<LOD	0.0094 (0.0084 - 0.010)	0.030 (0.025 - 0.036)	0.15^E (0.076 - 0.23)
3-5 years
1^{Table c91 footnote b}	.	.	.	.	.	.	.
2	522	35.25	0.014 (0.010 - 0.018)	<LOD	F	0.031^E (0.017 - 0.044)	F
6-11 years
1	974	48.67	--	<LOD	<LOD	0.019^E (0.011 - 0.028)	0.097 (0.064 - 0.13)
2	513	33.33	0.015 (0.012 - 0.021)	<LOD	F	0.035 (0.024 - 0.045)	F
12-19 years
1	927	43.26	--	<LOD	0.0072^E (<LOD - 0.011)	0.020 (0.015 - 0.025)	0.085 (0.069 - 0.10)
2	507	34.12	0.014 (0.012 - 0.017)	<LOD	F	0.034 (0.027 - 0.042)	0.19 (0.14 - 0.24)
20-39 years
1	1055	52.13	--	<LOD	<LOD	0.017^E (<LOD - 0.028)	0.085^E (0.051 - 0.12)
2	355	39.44	0.012 (0.0086 - 0.016)	<LOD	F	0.033 (0.025 - 0.042)	F
40-59 years
1	1109	54.19	--	<LOD	<LOD	0.019 (0.013 - 0.025)	0.067 (0.056 - 0.077)
2	352	40.91	--	<LOD	0.0093 (0.0060 - 0.013)	0.027^E (0.012 - 0.042)	F
60-79 years
1	957	52.56	--	<LOD	<LOD	0.019 (0.015 - 0.024)	0.071 (0.052 - 0.091)
2	286	46.15	--	<LOD	0.0089^E (<LOD - 0.013)	0.025 (0.022 - 0.028)	F

Table 14.5.2.3: cis-3-(2,2-Dibromovinyl)-2,2-dimethylcyclopropane carboxylic acid (cis-DBCA) -- Geometric means and selected percentiles of urine concentrations ( μg/L) for the Canadian population aged 3-79 years by sex and age group ^{Table c92 footnote a}, Canadian Health Measures Survey cycle 1 (2007-2009) and cycle 2 (2009-2011).
Cycle	N	%<LOD^{Table c92 footnote b}	GM (95% CI)	10^th (95% CI)	50^th (95% CI)	75^th (95% CI)	95^th (95% CI)
Table c92 footnotes Table c92 footnote 1 Breakdown by sex for the 3-5 year old age group is not recommended. Return to table c92 footnote a referrer Table c92 footnote 2 If >40% of samples were below the LOD, the percentile distribution is reported but means were not calculated. Return to table c92 footnote b referrer Table c92 footnote 3 Data not available as participants under the age of 6 years were not included in cycle 1 (2007-2009). Return to table c92 footnote c referrer
Males, Total 3-79 years
1^{Table c92 footnote c}	.	.	.	.	.	.	.
2	1272	35.77	0.012 (0.010 - 0.015)	<LOD	0.0096 (0.0068 - 0.012)	0.033^E (0.021 - 0.045)	0.14^E (0.048 - 0.23)
Males, 6-11 years
1	501	50.70	--	<LOD	<LOD	0.019^E (0.011 - 0.028)	0.074 (0.055 - 0.094)
2	261	34.10	0.016 (0.012 - 0.023)	<LOD	F	0.036^E (0.015 - 0.057)	F
Males, 12-19 years
1	476	42.44	--	<LOD	0.0082 (<LOD - 0.011)	0.022 (0.018 - 0.026)	0.083 (0.067 - 0.098)
2	254	35.83	0.013 (0.0096 - 0.017)	<LOD	F	0.031^E (0.017 - 0.045)	0.14^E (0.070 - 0.20)
Males, 20-39 years
1	463	50.97	--	<LOD	<LOD	F	0.056^E (0.023 - 0.090)
2	167	39.52	0.0093^E (0.0061 - 0.014)	<LOD	F	F	X
Males, 40-59 years
1	513	52.05	--	<LOD	<LOD	0.020 (0.015 - 0.025)	0.071 (0.052 - 0.089)
2	192	35.42	0.016^E (0.011 - 0.023)	<LOD	0.019^E (0.0087 - 0.030)	0.048^E (0.029 - 0.068)	X
Males, 60-79 years
1	480	51.88	--	<LOD	<LOD	0.020 (0.018 - 0.022)	0.073 (0.049 - 0.097)
2	139	41.73	--	<LOD	0.0093^E (<LOD - 0.015)	0.027 (0.017 - 0.036)	X
Females, Total 3-79 years
1^{Table c92 footnote c}	.	.	.	.	.	.	.
2	1263	38.72	0.011 (0.0092 - 0.013)	<LOD	0.0092 (0.0069 - 0.011)	0.028 (0.021 - 0.036)	F
Females, 6-11 years
1	473	46.51	--	<LOD	<LOD	0.019^E (0.0080 - 0.031)	0.11^E (0.065 - 0.16)
2	252	32.54	0.014^E (0.0098 - 0.021)	<LOD	F	0.033^E (0.021 - 0.045)	F
Females, 12-19 years
1	451	44.12	--	<LOD	0.0061^E (<LOD - 0.011)	0.020^E (0.011 - 0.028)	0.086^E (0.052 - 0.12)
2	253	32.41	0.016 (0.011 - 0.021)	<LOD	0.019^E (0.0072 - 0.031)	0.037 (0.027 - 0.046)	0.23^E (0.13 - 0.33)
Females, 20-39 years
1	592	53.04	--	<LOD	<LOD	F	0.093^E (0.056 - 0.13)
2	188	39.36	0.014 (0.010 - 0.020)	<LOD	0.019^E (<LOD - 0.033)	0.034 (0.024 - 0.045)	X
Females, 40-59 years
1	596	56.04	--	<LOD	<LOD	F	0.062 (0.046 - 0.079)
2	160	47.50	--	<LOD	<LOD	0.014^E (<LOD - 0.022)	X
Females, 60-79 years
1	477	53.25	--	<LOD	<LOD	0.019^E (0.0095 - 0.029)	0.067 (0.046 - 0.087)
2	147	50.34	--	<LOD	F	0.024 (0.019 - 0.028)	X

Table 14.5.2.4: cis-3-(2,2-Dibromovinyl)-2,2-dimethylcyclopropane carboxylic acid (cis-DBCA) (creatinine adjusted) -- Geometric means and selected percentiles of urine concentrations ( μg/g creatinine) for the Canadian population aged 6-79 years ^{Table c93 footnote a}, Canadian Health Measures Survey cycle 1 (2007-2009) and cycle 2 (2009-2011).
Cycle	N	%<LOD^{Table c93 footnote b}	GM (95% CI)	10^th (95% CI)	50^th (95% CI)	75^th (95% CI)	95^th (95% CI)
Table c93 footnotes Table c93 footnote 1 For the purpose of total population comparisons, only values from participants aged 6-79 years were included as participants under the age of 6 years were not included in cycle 1 (2007-2009). Return to table c93 footnote a referrer Table c93 footnote 2 If >40% of samples were below the LOD, the percentile distribution is reported but means were not calculated. Return to table c93 footnote b referrer
Total, 6-79 years
1	5008	50.50	--	<LOD	<LOD	0.019 (0.016 - 0.022)	0.087 (0.066 - 0.11)
2	2004	37.92	0.011 (0.0096 - 0.013)	<LOD	0.011 (0.0086 - 0.013)	0.025 (0.020 - 0.029)	0.12^E (0.071 - 0.17)
Males, 6-79 years
1	2424	49.83	--	<LOD	<LOD	0.016 (0.013 - 0.019)	0.070 (0.051 - 0.090)
2	1010	36.83	0.010 (0.0083 - 0.012)	<LOD	0.0095 (0.0073 - 0.012)	0.024 (0.017 - 0.030)	0.12^E (0.055 - 0.18)
Females, 6-79 years
1	2584	51.12	--	<LOD	<LOD	0.024 (0.019 - 0.029)	0.096 (0.073 - 0.12)
2	994	39.03	0.013 (0.010 - 0.015)	<LOD	0.013 (0.0098 - 0.015)	0.026 (0.021 - 0.030)	0.14^E (0.059 - 0.22)

Table 14.5.2.5: cis-3-(2,2-Dibromovinyl)-2,2-dimethylcyclopropane carboxylic acid (cis-DBCA) (creatinine adjusted) -- Geometric means and selected percentiles of urine concentrations ( μg/g creatinine) for the Canadian population aged 3-79 years by age group, Canadian Health Measures Survey cycle 1 (2007-2009) and cycle 2 (2009-2011).
Cycle	N	%<LOD^{Table c94 footnote a}	GM (95% CI)	10^th (95% CI)	50^th (95% CI)	75^th (95% CI)	95^th (95% CI)
Table c94 footnotes Table c94 footnote 1 If >40% of samples were below the LOD, the percentile distribution is reported but means were not calculated. Return to table c94 footnote a referrer Table c94 footnote 2 Data not available as participants under the age of 6 years were not included in cycle 1 (2007-2009). Return to table c94 footnote b referrer
Total, 3-79 years
1^{Table c94 footnote b}	.	.	.	.	.	.	.
2	2525	37.39	0.012 (0.0099 - 0.014)	<LOD	0.011 (0.0088 - 0.013)	0.025 (0.021 - 0.030)	0.12^E (0.074 - 0.18)
3-5 years
1^{Table c94 footnote b}	.	.	.	.	.	.	.
2	521	35.32	0.024 (0.018 - 0.032)	<LOD	0.020^E (<LOD - 0.027)	0.052^E (0.026 - 0.078)	F
6-11 years
1	971	48.82	--	<LOD	<LOD	0.025 (0.020 - 0.029)	0.13^E (0.073 - 0.19)
2	511	33.46	0.018 (0.013 - 0.024)	<LOD	0.016^E (<LOD - 0.022)	0.038^E (0.023 - 0.052)	F
12-19 years
1	925	43.35	--	<LOD	0.0077 (<LOD - 0.0088)	0.016 (0.014 - 0.018)	0.071 (0.050 - 0.092)
2	505	34.26	0.011 (0.0092 - 0.012)	<LOD	0.010 (<LOD - 0.012)	0.025 (0.020 - 0.029)	0.13 (0.092 - 0.16)
20-39 years
1	1051	52.33	--	<LOD	<LOD	0.017 (<LOD - 0.021)	0.083^E (0.046 - 0.12)
2	353	39.66	0.0098 (0.0072 - 0.013)	<LOD	0.0093^E (<LOD - 0.013)	0.024 (0.016 - 0.032)	F
40-59 years
1	1104	54.44	--	<LOD	<LOD	0.019 (0.016 - 0.023)	0.087 (0.058 - 0.12)
2	350	41.14	--	<LOD	0.011 (0.0079 - 0.014)	0.024 (0.016 - 0.031)	0.12^E (0.047 - 0.19)
60-79 years
1	957	52.56	--	<LOD	<LOD	0.024 (0.017 - 0.031)	0.081 (0.061 - 0.10)
2	285	46.32	--	<LOD	0.013 (<LOD - 0.016)	0.025 (0.019 - 0.030)	0.18^E (0.079 - 0.28)

Table 14.5.2.6: cis-3-(2,2-Dibromovinyl)-2,2-dimethylcyclopropane carboxylic acid (cis-DBCA) (creatinine adjusted) - Geometric means and selected percentiles of urine concentrations (μg/g creatinine) for the Canadian population aged 3-79 years by sex and age group ^{Table c95 footnote a}, Canadian Health Measures Survey cycle 1 (2007-2009) and cycle 2 (2009-2011).
Cycle	N	%<LOD^{Table c95 footnote b}	GM (95% CI)	10^th (95% CI)	50^th (95% CI)	75^th (95% CI)	95^th (95% CI)
Table c95 footnotes Table c95 footnote 1 Breakdown by sex for the 3-5 year old age group is not recommended. Return to table c95 footnote a referrer Table c95 footnote 2 If >40% of samples were below the LOD, the percentile distribution is reported but means were not calculated. Return to table c95 footnote b referrer Table c95 footnote 3 Data not available as participants under the age of 6 years were not included in cycle 1 (2007-2009). Return to table c95 footnote c referrer
Males, Total 3-79 years
1^{Table c95 footnote c}	.	.	.	.	.	.	.
2	1268	35.88	0.010 (0.0086 - 0.013)	<LOD	0.0098 (0.0076 - 0.012)	0.025 (0.018 - 0.031)	0.12^E (0.050 - 0.19)
Males, 6-11 years
1	499	50.90	--	<LOD	<LOD	0.024 (0.017 - 0.031)	F
2	260	34.23	0.019 (0.013 - 0.027)	<LOD	0.014^E (<LOD - 0.021)	0.045^E (0.024 - 0.065)	F
Males, 12-19 years
1	475	42.53	--	<LOD	0.0073 (<LOD - 0.0083)	0.016 (0.013 - 0.019)	0.087 (0.058 - 0.12)
2	253	35.97	0.0091 (0.0068 - 0.012)	<LOD	0.0086^E (<LOD - 0.012)	0.026^E (0.017 - 0.036)	0.090 (0.063 - 0.12)
Males, 20-39 years
1	461	51.19	--	<LOD	<LOD	0.013 (<LOD - 0.016)	0.055^E (0.024 - 0.087)
2	166	39.76	0.0065^E (0.0043 - 0.0097)	<LOD	<LOD (<LOD - 0.0088)	F	X
Males, 40-59 years
1	509	52.46	--	<LOD	<LOD	0.016 (0.012 - 0.021)	0.067^E (0.032 - 0.10)
2	192	35.42	0.013 (0.0095 - 0.019)	<LOD	0.014^E (0.0084 - 0.020)	0.027^E (0.010 - 0.044)	X
Males, 60-79 years
1	480	51.88	--	<LOD	<LOD	0.018 (0.013 - 0.023)	0.067 (0.050 - 0.084)
2	139	41.73	--	<LOD	0.0091^E (<LOD - 0.014)	0.022^E (0.013 - 0.032)	X
Females, Total 3-79 years
1^{Table c95 footnote c}	.	.	.	.	.	.	.
2	1257	38.90	0.013 (0.011 - 0.015)	<LOD	0.013 (0.010 - 0.015)	0.026 (0.021 - 0.030)	0.15^E (0.072 - 0.22)
Females, 6-11 years
1	472	46.61	--	<LOD	<LOD	0.025 (0.019 - 0.031)	0.14^E (0.055 - 0.23)
2	251	32.67	0.017^E (0.011 - 0.025)	<LOD	0.017 (<LOD - 0.022)	0.031^E (0.018 - 0.045)	F
Females, 12-19 years
1	450	44.22	--	<LOD	0.0080 (<LOD - 0.0095)	0.016 (0.014 - 0.019)	0.058 (0.043 - 0.074)
2	252	32.54	0.013 (0.010 - 0.016)	<LOD	0.012 (0.0076 - 0.016)	0.024 (0.019 - 0.029)	0.15^E (0.082 - 0.22)
Females, 20-39 years
1	590	53.22	--	<LOD	<LOD	0.024^E (<LOD - 0.034)	0.099^E (0.060 - 0.14)
2	187	39.57	0.014 (0.011 - 0.020)	<LOD	0.015^E (<LOD - 0.022)	0.028^E (0.014 - 0.042)	X
Females, 40-59 years
1	595	56.13	--	<LOD	<LOD	0.025 (<LOD - 0.031)	0.092 (0.066 - 0.12)
2	158	48.10	--	<LOD	<LOD	0.019^E (<LOD - 0.027)	X
Females, 60-79 years
1	477	53.25	--	<LOD	<LOD	0.031 (0.021 - 0.041)	0.094 (0.068 - 0.12)
2	146	50.68	--	<LOD	<LOD (<LOD - 0.018)	0.026 (0.017 - 0.035)	X

Table 14.5.3.1: cis-3-(2,2-Dichlorovinyl)-2,2-dimethylcyclopropane carboxylic acid (cis-DCCA) - Geometric means and selected percentiles of urine concentrations (μg/L) for the Canadian population aged 6-79 years ^{Table c96 footnote a}, Canadian Health Measures Survey cycle 1 (2007-2009) and cycle 2 (2009-2011).
Cycle	N	%<LOD^{Table c96 footnote b}	GM (95% CI)	10^th (95% CI)	50^th (95% CI)	75^th (95% CI)	95^th (95% CI)
Table c96 footnotes Table c96 footnote 1 For the purpose of total population comparisons, only values from participants aged 6-79 years were included as participants under the age of 6 years were not included in cycle 1 (2007-2009). Return to table c96 footnote a referrer Table c96 footnote 2 If >40% of samples were below the LOD, the percentile distribution is reported but means were not calculated. Return to table c96 footnote b referrer
Total, 6-79 years
1	5431	1.57	0.085 (0.070 - 0.10)	0.018 (0.014 - 0.023)	0.071 (0.057 - 0.086)	0.17 (0.13 - 0.21)	0.94 (0.72 - 1.2)
2	2033	0.74	0.13 (0.10 - 0.16)	0.025 (0.021 - 0.028)	0.096 (0.078 - 0.11)	0.29^E (0.18 - 0.39)	2.2^E (0.68 - 3.8)
Males, 6-79 years
1	2636	1.37	0.090 (0.073 - 0.11)	0.020 (0.015 - 0.025)	0.072 (0.057 - 0.088)	0.18 (0.13 - 0.22)	1.1 (0.78 - 1.4)
2	1019	0.88	0.11 (0.088 - 0.13)	0.024 (0.019 - 0.030)	0.089 (0.068 - 0.11)	0.23^E (0.15 - 0.31)	1.3^E (0.39 - 2.1)
Females, 6-79 years
1	2795	1.75	0.080 (0.066 - 0.098)	0.017 (0.012 - 0.021)	0.071 (0.055 - 0.086)	0.17 (0.13 - 0.21)	0.79 (0.63 - 0.95)
2	1014	0.59	0.15 (0.11 - 0.20)	0.026 (0.020 - 0.031)	0.10 (0.074 - 0.13)	0.36^E (0.19 - 0.53)	F

Table 14.5.3.2: cis-3-(2,2-Dichlorovinyl)-2,2-dimethylcyclopropane carboxylic acid (cis-DCCA) -- Geometric means and selected percentiles of urine concentrations ( μg/L) for the Canadian population aged 3-79 years by age group, Canadian Health Measures Survey cycle 1 (2007-2009) and cycle 2 (2009-2011).
Cycle	N	%<LOD^{Table c97 footnote a}	GM (95% CI)	10^th (95% CI)	50^th (95% CI)	75^th (95% CI)	95^th (95% CI)
Table c97 footnotes Table c97 footnote 1 If >40% of samples were below the LOD, the percentile distribution is reported but means were not calculated. Return to table c97 footnote a referrer Table c97 footnote 2 Data not available as participants under the age of 6 years were not included in cycle 1 (2007-2009). Return to table c97 footnote b referrer
Total, 3-79 years
1^{Table c97 footnote b}	.	.	.	.	.	.	.
2	2553	0.86	0.12 (0.10 - 0.15)	0.024 (0.021 - 0.028)	0.093 (0.076 - 0.11)	0.27^E (0.17 - 0.37)	2.2^E (0.78 - 3.6)
3-5 years
1^{Table c97 footnote b}	.	.	.	.	.	.	.
2	520	1.35	0.067 (0.049 - 0.091)	0.016 (0.011 - 0.022)	0.065 (0.047 - 0.082)	0.12 (0.078 - 0.15)	F
6-11 years
1	1026	2.73	0.054 (0.043 - 0.067)	0.014 (0.0099 - 0.018)	0.049 (0.038 - 0.060)	0.099 (0.087 - 0.11)	0.38^E (0.18 - 0.57)
2	514	1.17	0.069 (0.059 - 0.082)	0.018 (0.014 - 0.022)	0.056 (0.046 - 0.065)	0.11 (0.082 - 0.14)	F
12-19 years
1	970	0.82	0.090 (0.067 - 0.12)	0.019 (0.013 - 0.025)	0.077 (0.055 - 0.099)	0.18 (0.13 - 0.24)	1.0^E (0.44 - 1.6)
2	510	0.39	0.10 (0.082 - 0.13)	0.026 (0.022 - 0.030)	0.080 (0.065 - 0.095)	0.18^E (0.10 - 0.27)	1.7^E (0.90 - 2.4)
20-39 years
1	1151	1.13	0.086 (0.070 - 0.11)	0.020 (0.015 - 0.024)	0.076 (0.057 - 0.094)	0.15 (0.12 - 0.19)	0.75^E (0.35 - 1.1)
2	359	0.28	0.18^E (0.12 - 0.29)	0.027 (0.019 - 0.035)	0.13 (0.092 - 0.17)	0.37^E (0.13 - 0.61)	F
40-59 years
1	1208	2.15	0.092 (0.073 - 0.12)	0.018 (0.012 - 0.024)	0.077 (0.054 - 0.099)	0.21 (0.16 - 0.26)	1.2 (0.91 - 1.5)
2	359	1.11	0.12 (0.089 - 0.17)	0.024 (0.016 - 0.031)	0.10^E (0.054 - 0.15)	0.32 (0.20 - 0.43)	1.6^E (0.46 - 2.7)
60-79 years
1	1076	0.93	0.083 (0.066 - 0.10)	0.019 (0.015 - 0.024)	0.067 (0.050 - 0.083)	0.16^E (0.094 - 0.23)	0.75 (0.47 - 1.0)
2	291	0.69	0.11^E (0.072 - 0.16)	0.021 (0.014 - 0.029)	0.086 (0.064 - 0.11)	F	F

Table 14.5.3.3: cis-3-(2,2-Dichlorovinyl)-2,2-dimethylcyclopropane carboxylic acid (cis-DCCA) -- Geometric means and selected percentiles of urine concentrations ( μg/L) for the Canadian population aged 3-79 years by sex and age group ^{Table c98 footnote a}, Canadian Health Measures Survey cycle 1 (2007-2009) and cycle 2 (2009-2011).
Cycle	N	%<LOD^{Table c98 footnote b}	GM (95% CI)	10^th (95% CI)	50^th (95% CI)	75^th (95% CI)	95^th (95% CI)
Table c98 footnotes Table c98 footnote 1 Breakdown by sex for the 3-5 year old age group is not recommended. Return to table c98 footnote a referrer Table c98 footnote 2 If >40% of samples were below the LOD, the percentile distribution is reported but means were not calculated. Return to table c98 footnote b referrer Table c98 footnote 3 Data not available as participants under the age of 6 years were not included in cycle 1 (2007-2009). Return to table c98 footnote c referrer
Males, Total 3-79 years
1^{Table c98 footnote c}	.	.	.	.	.	.	.
2	1277	1.10	0.10 (0.086 - 0.13)	0.024 (0.018 - 0.029)	0.088 (0.068 - 0.11)	0.22^E (0.14 - 0.31)	1.2^E (0.39 - 2.1)
Males, 6-11 years
1	524	2.48	0.052 (0.039 - 0.070)	0.013^E (<LOD - 0.021)	0.046 (0.035 - 0.056)	0.092 (0.078 - 0.11)	F
2	260	0.77	0.071 (0.054 - 0.093)	0.019 (0.014 - 0.024)	0.055 (0.045 - 0.065)	0.11^E (0.034 - 0.19)	F
Males, 12-19 years
1	498	0.20	0.082 (0.062 - 0.11)	0.020 (0.017 - 0.024)	0.069 (0.051 - 0.087)	0.14^E (0.076 - 0.20)	0.97^E (0.40 - 1.5)
2	255	0.39	0.089 (0.071 - 0.11)	0.026 (0.022 - 0.030)	0.073 (0.059 - 0.088)	0.14^E (0.074 - 0.20)	0.95^E (0.27 - 1.6)
Males, 20-39 years
1	506	1.78	0.089 (0.069 - 0.11)	0.020 (0.014 - 0.026)	0.075 (0.054 - 0.096)	0.16^E (0.10 - 0.22)	F
2	168	0.60	0.11^E (0.073 - 0.16)	0.027^E (0.017 - 0.036)	0.11 (0.085 - 0.14)	F	X
Males, 40-59 years
1	569	1.76	0.10 (0.080 - 0.14)	0.021 (0.014 - 0.027)	0.081 (0.056 - 0.11)	0.23^E (0.14 - 0.33)	1.3^E (0.42 - 2.2)
2	194	2.06	0.12^E (0.084 - 0.18)	0.021^E (0.010 - 0.032)	0.10^E (0.035 - 0.17)	0.31^E (0.19 - 0.43)	X
Males, 60-79 years
1	539	0.56	0.091 (0.071 - 0.12)	0.026 (0.019 - 0.032)	0.076 (0.051 - 0.10)	0.18^E (0.11 - 0.24)	0.71 (0.50 - 0.93)
2	142	0.70	0.10^E (0.067 - 0.16)	0.025^E (0.016 - 0.033)	0.081^E (0.051 - 0.11)	0.19^E (0.069 - 0.31)	X
Females, Total 3-79 years
1^{Table c98 footnote c}	.	.	.	.	.	.	.
2	1276	0.63	0.15 (0.11 - 0.20)	0.025 (0.020 - 0.030)	0.099 (0.077 - 0.12)	0.36^E (0.20 - 0.52)	F
Females, 6-11 years
1	502	2.99	0.055 (0.045 - 0.068)	0.015 (0.012 - 0.017)	0.054 (0.039 - 0.069)	0.11 (0.088 - 0.14)	0.41^E (0.22 - 0.59)
2	254	1.57	0.068 (0.054 - 0.084)	0.016 (0.010 - 0.022)	0.057 (0.039 - 0.076)	0.11 (0.076 - 0.15)	F
Females, 12-19 years
1	472	1.48	0.10^E (0.070 - 0.15)	0.017^E (<LOD - 0.028)	0.086 (0.054 - 0.12)	0.22^E (0.13 - 0.30)	F
2	255	0.39	0.12 (0.086 - 0.18)	0.026 (0.017 - 0.035)	0.093 (0.073 - 0.11)	F	1.8^E (0.82 - 2.8)
Females, 20-39 years
1	645	0.62	0.084 (0.068 - 0.10)	0.020 (0.015 - 0.025)	0.078 (0.059 - 0.097)	0.15 (0.11 - 0.18)	0.68 (0.46 - 0.90)
2	191	0	0.30^E (0.15 - 0.61)	0.027^E (0.0088 - 0.045)	F	F	X
Females, 40-59 years
1	639	2.50	0.080 (0.063 - 0.10)	0.014^E (0.0070 - 0.021)	0.072^E (0.045 - 0.099)	0.19 (0.14 - 0.24)	0.79 (0.55 - 1.0)
2	165	0	0.12^E (0.078 - 0.19)	0.027^E (0.015 - 0.039)	0.099^E (0.042 - 0.16)	0.33^E (0.15 - 0.52)	X
Females, 60-79 years
1	537	1.30	0.076 (0.059 - 0.098)	0.017 (0.014 - 0.021)	0.061 (0.044 - 0.077)	0.14^E (0.064 - 0.22)	0.86^E (0.44 - 1.3)
2	149	0.67	0.11^E (0.068 - 0.18)	0.019^E (0.010 - 0.027)	F	F	X

Table 14.5.3.4: cis-3-(2,2-Dichlorovinyl)-2,2-dimethylcyclopropane carboxylic acid (cis-DCCA) (creatinine adjusted) -- Geometric means and selected percentiles of urine concentrations ( μg/g creatinine) for the Canadian population aged 6-79 years ^{Table c99 footnote a}, Canadian Health Measures Survey cycle 1 (2007-2009) and cycle 2 (2009-2011).
Cycle	N	%<LOD^{Table c99 footnote b}	GM (95% CI)	10^th (95% CI)	50^th (95% CI)	75^th (95% CI)	95^th (95% CI)
Table c99 footnotes Table c99 footnote 1 For the purpose of total population comparisons, only values from participants aged 6-79 years were included as participants under the age of 6 years were not included in cycle 1 (2007-2009). Return to table c99 footnote a referrer Table c99 footnote 2 If >40% of samples were below the LOD, the percentile distribution is reported but means were not calculated. Return to table c99 footnote b referrer
Total, 6-79 years
1	5417	1.57	0.10 (0.087 - 0.12)	0.027 (0.024 - 0.031)	0.086 (0.072 - 0.099)	0.18 (0.13 - 0.22)	1.1 (0.84 - 1.3)
2	2024	0.74	0.12 (0.10 - 0.15)	0.029 (0.026 - 0.032)	0.088 (0.071 - 0.10)	0.23 (0.17 - 0.28)	F
Males, 6-79 years
1	2627	1.37	0.089 (0.074 - 0.11)	0.024 (0.021 - 0.026)	0.071 (0.059 - 0.083)	0.15 (0.11 - 0.20)	0.99 (0.66 - 1.3)
2	1016	0.89	0.087 (0.075 - 0.10)	0.026 (0.023 - 0.029)	0.069 (0.054 - 0.084)	0.15 (0.12 - 0.18)	0.96^E (0.42 - 1.5)
Females, 6-79 years
1	2790	1.76	0.12 (0.10 - 0.14)	0.033 (0.028 - 0.038)	0.099 (0.085 - 0.11)	0.20 (0.13 - 0.26)	1.2 (0.96 - 1.4)
2	1008	0.60	0.17 (0.13 - 0.22)	0.034 (0.029 - 0.040)	0.11 (0.079 - 0.14)	0.33^E (0.19 - 0.48)	F

Table 14.5.3.5: cis-3-(2,2-Dichlorovinyl)-2,2-dimethylcyclopropane carboxylic acid (cis-DCCA) (creatinine adjusted) -- Geometric means and selected percentiles of urine concentrations ( μg/g creatinine) for the Canadian population aged 3-79 years by age group, Canadian Health Measures Survey cycle 1 (2007-2009) and cycle 2 (2009-2011).
Cycle	N	%<LOD^{Table c100 footnote a}	GM (95% CI)	10^th (95% CI)	50^th (95% CI)	75^th (95% CI)	95^th (95% CI)
Table c100 footnotes Table c100 footnote 1 If >40% of samples were below the LOD, the percentile distribution is reported but means were not calculated. Return to table c100 footnote a referrer Table c100 footnote 2 Data not available as participants under the age of 6 years were not included in cycle 1 (2007-2009). Return to table c100 footnote b referrer
Total, 3-79 years
1^{Table c100 footnote b}	.	.	.	.	.	.	.
2	2543	0.87	0.12 (0.10 - 0.15)	0.029 (0.026 - 0.032)	0.088 (0.071 - 0.10)	0.23 (0.17 - 0.28)	F
3-5 years
1^{Table c100 footnote b}	.	.	.	.	.	.	.
2	519	1.35	0.11 (0.084 - 0.16)	0.031 (0.022 - 0.039)	0.091 (0.064 - 0.12)	0.18^E (0.10 - 0.26)	F
6-11 years
1	1023	2.74	0.083 (0.070 - 0.098)	0.028 (0.022 - 0.033)	0.071 (0.063 - 0.079)	0.13 (0.094 - 0.17)	0.58^E (0.21 - 0.95)
2	512	1.17	0.080 (0.068 - 0.094)	0.027 (0.023 - 0.031)	0.059 (0.052 - 0.066)	0.13 (0.098 - 0.16)	0.71^E (<LOD - 1.2)
12-19 years
1	968	0.83	0.079 (0.062 - 0.10)	0.022 (0.020 - 0.024)	0.061 (0.043 - 0.080)	0.14 (0.10 - 0.18)	0.98^E (0.55 - 1.4)
2	508	0.39	0.079 (0.063 - 0.10)	0.024 (0.020 - 0.027)	0.061 (0.047 - 0.074)	0.12^E (0.055 - 0.19)	0.88^E (0.53 - 1.2)
20-39 years
1	1147	1.13	0.096 (0.080 - 0.12)	0.026 (0.021 - 0.031)	0.084 (0.069 - 0.099)	0.16 (0.13 - 0.20)	0.82^E (0.40 - 1.2)
2	357	0.28	0.16^E (0.10 - 0.23)	0.029 (0.025 - 0.034)	0.10 (0.072 - 0.13)	0.26^E (0.084 - 0.44)	F
40-59 years
1	1203	2.16	0.12 (0.097 - 0.14)	0.029 (0.023 - 0.035)	0.097 (0.079 - 0.11)	0.23 (0.15 - 0.31)	1.2 (0.97 - 1.5)
2	357	1.12	0.12 (0.10 - 0.15)	0.032 (0.023 - 0.041)	0.084^E (0.046 - 0.12)	0.23 (0.18 - 0.29)	1.3^E (0.50 - 2.1)
60-79 years
1	1076	0.93	0.12 (0.093 - 0.14)	0.034 (0.031 - 0.037)	0.093 (0.073 - 0.11)	0.20^E (0.12 - 0.28)	1.2^E (0.61 - 1.7)
2	290	0.69	0.13^E (0.083 - 0.19)	0.030 (0.020 - 0.041)	0.096 (0.067 - 0.12)	0.23^E (<LOD - 0.37)	F

Table 14.5.3.6: cis-3-(2,2-Dichlorovinyl)-2,2-dimethylcyclopropane carboxylic acid (cis-DCCA) (creatinine adjusted) -- Geometric means and selected percentiles of urine concentrations ( μg/g creatinine) for the Canadian population aged 3-79 years by sex and age group ^{Table c101 footnote a}, Canadian Health Measures Survey cycle 1 (2007-2009) and cycle 2 (2009-2011).
Cycle	N	%<LOD^{Table c101 footnote b}	GM (95% CI)	10^th (95% CI)	50^th (95% CI)	75^th (95% CI)	95^th (95% CI)
Table c101 footnotes Table c101 footnote 1 Breakdown by sex for the 3-5 year old age group is not recommended. Return to table c101 footnote a referrer Table c101 footnote 2 If >40% of samples were below the LOD, the percentile distribution is reported but means were not calculated. Return to table c101 footnote b referrer Table c101 footnote 3 Data not available as participants under the age of 6 years were not included in cycle 1 (2007-2009). Return to table c101 footnote c referrer
Males, Total 3-79 years
1^{Table c101 footnote c}	.	.	.	.	.	.	.
2	1273	1.10	0.088 (0.075 - 0.10)	0.026 (0.023 - 0.029)	0.069 (0.054 - 0.084)	0.15 (0.12 - 0.18)	0.96^E (0.44 - 1.5)
Males, 6-11 years
1	522	2.49	0.079 (0.065 - 0.095)	0.027 (<LOD - 0.032)	0.068 (0.062 - 0.074)	0.11 (0.078 - 0.15)	F
2	259	0.77	0.081 (0.064 - 0.10)	0.027 (0.020 - 0.034)	0.059 (0.052 - 0.066)	0.12^E (0.057 - 0.19)	F
Males, 12-19 years
1	497	0.20	0.070 (0.053 - 0.092)	0.022 (0.019 - 0.024)	0.052 (0.036 - 0.069)	0.12^E (0.075 - 0.17)	0.71^E (0.25 - 1.2)
2	254	0.39	0.063 (0.050 - 0.079)	0.020 (0.017 - 0.023)	0.051 (0.041 - 0.061)	0.092^E (0.054 - 0.13)	0.76^E (0.25 - 1.3)
Males, 20-39 years
1	504	1.79	0.082 (0.065 - 0.10)	0.022 (0.019 - 0.026)	0.067 (0.054 - 0.081)	0.14 (0.090 - 0.18)	F
2	167	0.60	0.077 (0.055 - 0.11)	0.027 (0.021 - 0.033)	0.068 (0.045 - 0.090)	0.13 (0.098 - 0.17)	X
Males, 40-59 years
1	565	1.77	0.10 (0.082 - 0.13)	0.024 (0.019 - 0.029)	0.081 (0.061 - 0.10)	0.21^E (0.12 - 0.29)	1.3^E (0.60 - 2.0)
2	194	2.06	0.11 (0.083 - 0.13)	0.027 (0.018 - 0.035)	0.076^E (0.040 - 0.11)	0.20 (0.15 - 0.25)	X
Males, 60-79 years
1	539	0.56	0.096 (0.080 - 0.11)	0.029 (0.023 - 0.035)	0.074 (0.054 - 0.094)	0.16 (0.11 - 0.22)	0.67^E (0.31 - 1.0)
2	142	0.70	0.098^E (0.067 - 0.14)	0.024^E (0.0092 - 0.039)	0.082^E (0.052 - 0.11)	0.16^E (0.086 - 0.24)	X
Females, Total 3-79 years
1^{Table c101 footnote c}	.	.	.	.	.	.	.
2	1270	0.63	0.17 (0.13 - 0.22)	0.035 (0.029 - 0.040)	0.11 (0.080 - 0.14)	0.33^E (0.19 - 0.46)	F
Females, 6-11 years
1	501	2.99	0.087 (0.071 - 0.11)	0.028 (0.021 - 0.035)	0.077 (0.058 - 0.096)	0.15 (0.11 - 0.19)	0.54 (0.34 - 0.73)
2	253	1.58	0.080 (0.064 - 0.10)	0.025 (0.019 - 0.031)	0.064 (0.050 - 0.078)	0.13^E (0.083 - 0.18)	F
Females, 12-19 years
1	471	1.49	0.091 (0.071 - 0.12)	0.023 (<LOD - 0.028)	0.073 (0.052 - 0.095)	0.17 (0.12 - 0.21)	1.6^E (0.47 - 2.8)
2	254	0.39	0.10 (0.076 - 0.13)	0.030 (0.023 - 0.037)	0.073 (0.059 - 0.087)	F	1.1^E (0.41 - 1.8)
Females, 20-39 years
1	643	0.62	0.11 (0.093 - 0.14)	0.032 (0.025 - 0.039)	0.099 (0.080 - 0.12)	0.18 (0.13 - 0.23)	0.78^E (0.41 - 1.2)
2	190	0	0.31^E (0.16 - 0.59)	0.040^E (0.020 - 0.061)	F	F	X
Females, 40-59 years
1	638	2.51	0.13 (0.11 - 0.16)	0.040 (0.034 - 0.045)	0.10 (0.087 - 0.12)	0.24^E (0.13 - 0.36)	1.2 (0.98 - 1.4)
2	163	0	0.14 (0.11 - 0.20)	0.042 (0.027 - 0.057)	0.11^E (0.050 - 0.17)	0.26^E (0.12 - 0.40)	X
Females, 60-79 years
1	537	1.30	0.14 (0.10 - 0.18)	0.036 (0.027 - 0.045)	0.11 (0.079 - 0.14)	0.24^E (0.11 - 0.38)	1.5^E (0.81 - 2.2)
2	148	0.68	0.16^E (0.087 - 0.28)	0.034^E (0.021 - 0.046)	0.11^E (0.059 - 0.17)	0.30^E (<LOD - 0.48)	X

Table 14.5.4.1: trans-3-(2,2-Dichlorovinyl)-2,2-dimethylcyclopropane carboxylic acid (trans-DCCA) -- Geometric means and selected percentiles of urine concentrations ( μg/L) for the Canadian population aged 6-79 years ^{Table c102 footnote a}, Canadian Health Measures Survey cycle 1 (2007-2009) and cycle 2 (2009-2011).
Cycle	N	%<LOD^{Table c102 footnote b}	GM (95% CI)	10^th (95% CI)	50^th (95% CI)	75^th (95% CI)	95^th (95% CI)
Table c102 footnotes Table c102 footnote 1 For the purpose of total population comparisons, only values from participants aged 6-79 years were included as participants under the age of 6 years were not included in cycle 1 (2007-2009). Return to table c102 footnote a referrer Table c102 footnote 2 If >40% of samples were below the LOD, the percentile distribution is reported but means were not calculated. Return to table c102 footnote b referrer
Total, 6-79 years
1	5457	0.40	0.20 (0.17 - 0.24)	0.040 (0.032 - 0.049)	0.17 (0.14 - 0.20)	0.43 (0.33 - 0.53)	2.5 (1.9 - 3.1)
2	2037	0.39	0.29 (0.23 - 0.37)	0.051 (0.043 - 0.059)	0.22 (0.17 - 0.26)	0.68 (0.45 - 0.91)	6.8^E (1.9 - 12)
Males, 6-79 years
1	2650	0.30	0.22 (0.18 - 0.26)	0.046 (0.036 - 0.055)	0.18 (0.15 - 0.20)	0.44 (0.31 - 0.57)	2.8^E (1.4 - 4.2)
2	1021	0.39	0.25 (0.20 - 0.31)	0.048 (0.035 - 0.061)	0.21 (0.17 - 0.25)	0.55^E (0.30 - 0.81)	F
Females, 6-79 years
1	2807	0.50	0.19 (0.16 - 0.22)	0.036 (0.028 - 0.043)	0.16 (0.13 - 0.20)	0.41 (0.32 - 0.51)	2.1 (1.5 - 2.7)
2	1016	0.39	0.34 (0.25 - 0.47)	0.052 (0.039 - 0.065)	0.22 (0.16 - 0.29)	0.77^E (0.33 - 1.2)	F

Table 14.5.4.2: trans-3-(2,2-Dichlorovinyl)-2,2-dimethylcyclopropane carboxylic acid (trans-DCCA) -- Geometric means and selected percentiles of urine concentrations ( μg/L) for the Canadian population aged 3-79 years by age group, Canadian Health Measures Survey cycle 1 (2007-2009) and cycle 2 (2009-2011).
Cycle	N	%<LOD^{Table c103 footnote a}	GM (95% CI)	10^th (95% CI)	50^th (95% CI)	75^th (95% CI)	95^th (95% CI)
Table c103 footnotes Table c103 footnote 1 If >40% of samples were below the LOD, the percentile distribution is reported but means were not calculated. Return to table c103 footnote a referrer Table c103 footnote 2 Data not available as participants under the age of 6 years were not included in cycle 1 (2007-2009). Return to table c103 footnote b referrer
Total, 3-79 years
1^{Table c103 footnote b}	.	.	.	.	.	.	.
2	2558	0.35	0.29 (0.23 - 0.37)	0.051 (0.043 - 0.059)	0.22 (0.17 - 0.26)	0.67 (0.45 - 0.90)	6.8^E (2.1 - 11)
3-5 years
1^{Table c103 footnote b}	.	.	.	.	.	.	.
2	521	0.19	0.22 (0.16 - 0.31)	0.055 (0.038 - 0.071)	0.19 (0.13 - 0.25)	0.40^E (0.22 - 0.59)	F
6-11 years
1	1027	0.29	0.17 (0.15 - 0.21)	0.041^E (0.025 - 0.057)	0.15 (0.12 - 0.18)	0.34 (0.27 - 0.41)	1.4 (1.1 - 1.8)
2	516	0.78	0.21 (0.18 - 0.25)	0.048 (0.037 - 0.059)	0.17 (0.15 - 0.19)	0.37 (0.24 - 0.50)	F
12-19 years
1	978	0.10	0.24 (0.18 - 0.33)	0.048^E (0.030 - 0.066)	0.20 (0.16 - 0.24)	0.49^E (0.27 - 0.70)	3.8^E (2.0 - 5.6)
2	511	0	0.27 (0.21 - 0.34)	0.057 (0.048 - 0.067)	0.20 (0.16 - 0.25)	0.50^E (0.23 - 0.77)	4.8^E (2.1 - 7.5)
20-39 years
1	1158	0.60	0.20 (0.16 - 0.24)	0.042 (0.031 - 0.053)	0.17 (0.14 - 0.21)	0.40 (0.30 - 0.49)	2.0^E (1.1 - 2.8)
2	359	0	0.41^E (0.25 - 0.66)	0.061 (0.040 - 0.082)	0.28^E (0.12 - 0.43)	0.79^E (0.35 - 1.2)	F
40-59 years
1	1216	0.58	0.21 (0.17 - 0.26)	0.037 (0.029 - 0.044)	0.18 (0.13 - 0.22)	0.51 (0.33 - 0.69)	3.2^E (1.9 - 4.5)
2	360	0.56	0.27 (0.20 - 0.35)	0.041^E (0.022 - 0.060)	0.22 (0.15 - 0.30)	0.69^E (0.41 - 0.96)	F
60-79 years
1	1078	0.37	0.18 (0.15 - 0.22)	0.040 (0.032 - 0.047)	0.15 (0.12 - 0.18)	0.35^E (0.21 - 0.49)	1.9^E (1.1 - 2.6)
2	291	0.69	0.23^E (0.14 - 0.39)	0.041^E (0.026 - 0.056)	0.17^E (0.082 - 0.25)	F	F

Table 14.5.4.3: trans-3-(2,2-Dichlorovinyl)-2,2-dimethylcyclopropane carboxylic acid (trans-DCCA) -- Geometric means and selected percentiles of urine concentrations ( μg/L) for the Canadian population aged 3-79 years by sex and age group ^{Table c104 footnote a}, Canadian Health Measures Survey cycle 1 (2007-2009) and cycle 2 (2009-2011).
Cycle	N	%<LOD^{Table c104 footnote b}	GM (95% CI)	10^th (95% CI)	50^th (95% CI)	75^th (95% CI)	95^th (95% CI)
Table c104 footnotes Table c104 footnote 1 Breakdown by sex for the 3-5 year old age group is not recommended. Return to table c104 footnote a referrer Table c104 footnote 2 If >40% of samples were below the LOD, the percentile distribution is reported but means were not calculated. Return to table c104 footnote b referrer Table c104 footnote 3 Data not available as participants under the age of 6 years were not included in cycle 1 (2007-2009). Return to table c104 footnote c referrer
Males, Total 3-79 years
1^{Table c104 footnote c}	.	.	.	.	.	.	.
2	1279	0.31	0.25 (0.20 - 0.31)	0.048 (0.036 - 0.060)	0.21 (0.17 - 0.25)	0.55^E (0.31 - 0.80)	F
Males, 6-11 years
1	524	0.19	0.17 (0.13 - 0.22)	0.040^E (0.017 - 0.064)	0.14 (0.11 - 0.17)	0.30 (0.24 - 0.36)	1.5^E (0.81 - 2.1)
2	262	0.76	0.21 (0.16 - 0.28)	0.047^E (0.028 - 0.066)	0.18 (0.15 - 0.22)	0.39^E (0.13 - 0.65)	F
Males, 12-19 years
1	501	0	0.22 (0.17 - 0.30)	0.049 (0.033 - 0.064)	0.19 (0.15 - 0.22)	0.43^E (0.24 - 0.62)	2.4^E (0.75 - 4.0)
2	255	0	0.24 (0.18 - 0.30)	0.058 (0.048 - 0.067)	0.18 (0.13 - 0.23)	0.42^E (0.26 - 0.59)	F
Males, 20-39 years
1	510	0.78	0.21 (0.16 - 0.26)	0.045 (0.033 - 0.057)	0.17 (0.13 - 0.21)	0.41^E (0.25 - 0.57)	F
2	168	0	0.27^E (0.18 - 0.39)	0.060^E (0.029 - 0.091)	0.25^E (0.15 - 0.36)	0.53^E (0.18 - 0.88)	X
Males, 40-59 years
1	576	0.35	0.25 (0.19 - 0.33)	0.043 (0.031 - 0.056)	0.20 (0.15 - 0.25)	0.60^E (0.35 - 0.84)	F
2	194	1.03	0.27^E (0.18 - 0.40)	0.038^E (0.016 - 0.060)	0.21^E (0.085 - 0.34)	0.76^E (0.37 - 1.1)	X
Males, 60-79 years
1	539	0.19	0.20 (0.16 - 0.25)	0.052 (0.044 - 0.060)	0.17 (0.13 - 0.21)	0.39 (0.26 - 0.52)	1.7^E (1.1 - 2.3)
2	142	0	0.22^E (0.13 - 0.38)	0.041^E (0.024 - 0.059)	0.17^E (0.074 - 0.26)	F	X
Females, Total 3-79 years
1^{Table c104 footnote c}	.	.	.	.	.	.	.
2	1279	0.39	0.34 (0.24 - 0.46)	0.052 (0.040 - 0.064)	0.22 (0.16 - 0.28)	0.74^E (0.33 - 1.1)	F
Females, 6-11 years
1	503	0.40	0.18 (0.15 - 0.22)	0.042 (0.029 - 0.056)	0.16 (0.12 - 0.21)	0.38 (0.28 - 0.49)	1.4 (0.98 - 1.9)
2	254	0.79	0.21 (0.16 - 0.26)	0.048 (0.036 - 0.060)	0.16 (0.12 - 0.20)	0.37^E (0.21 - 0.53)	F
Females, 12-19 years
1	477	0.21	0.27 (0.19 - 0.37)	0.045^E (0.023 - 0.067)	0.21 (0.16 - 0.26)	0.66^E (0.36 - 0.96)	F
2	256	0	0.31 (0.22 - 0.44)	0.057^E (0.032 - 0.083)	0.25 (0.17 - 0.32)	F	5.9^E (2.9 - 9.0)
Females, 20-39 years
1	648	0.46	0.19 (0.16 - 0.23)	0.037 (0.025 - 0.050)	0.17 (0.13 - 0.22)	0.37 (0.29 - 0.46)	1.7^E (1.1 - 2.4)
2	191	0	F	0.065^E (0.035 - 0.095)	F	F	X
Females, 40-59 years
1	640	0.78	0.18 (0.15 - 0.23)	0.033 (0.025 - 0.041)	0.16^E (0.099 - 0.22)	0.45^E (0.27 - 0.63)	2.2 (1.4 - 2.9)
2	166	0	0.27^E (0.17 - 0.42)	0.047^E (0.018 - 0.077)	0.22^E (0.13 - 0.32)	0.60^E (0.19 - 1.0)	X
Females, 60-79 years
1	539	0.56	0.16 (0.13 - 0.21)	0.034 (0.026 - 0.042)	0.12 (0.090 - 0.16)	0.30^E (0.11 - 0.50)	2.0^E (0.92 - 3.1)
2	149	1.34	0.24^E (0.13 - 0.45)	0.039^E (0.023 - 0.056)	F	F	X

Table 14.5.4.4: trans-3-(2,2-Dichlorovinyl)-2,2-dimethylcyclopropane carboxylic acid (trans-DCCA) (creatinine adjusted) -- Geometric means and selected percentiles of urine concentrations ( μg/g creatinine) for the Canadian population aged 6-79 years ^{Table c105 footnote a}, Canadian Health Measures Survey cycle 1 (2007-2009) and cycle 2 (2009-2011).
Cycle	N	%<LOD^{Table c105 footnote b}	GM (95% CI)	10^th (95% CI)	50^th (95% CI)	75^th (95% CI)	95^th (95% CI)
Table c105 footnotes Table c105 footnote 1 For the purpose of total population comparisons, only values from participants aged 6-79 years were included as participants under the age of 6 years were not included in cycle 1 (2007-2009). Return to table c105 footnote a referrer Table c105 footnote 2 If >40% of samples were below the LOD, the percentile distribution is reported but means were not calculated. Return to table c105 footnote b referrer
Total, 6-79 years
1	5443	0.40	0.25 (0.21 - 0.29)	0.062 (0.057 - 0.067)	0.19 (0.16 - 0.22)	0.46 (0.35 - 0.56)	3.0 (2.3 - 3.7)
2	2028	0.39	0.28 (0.23 - 0.35)	0.062 (0.054 - 0.069)	0.20 (0.15 - 0.24)	0.56 (0.42 - 0.70)	F
Males, 6-79 years
1	2641	0.30	0.22 (0.18 - 0.26)	0.056 (0.049 - 0.063)	0.17 (0.14 - 0.19)	0.39 (0.28 - 0.50)	2.6^E (1.7 - 3.6)
2	1018	0.39	0.21 (0.17 - 0.25)	0.054 (0.044 - 0.064)	0.17 (0.13 - 0.21)	0.36 (0.25 - 0.47)	F
Females, 6-79 years
1	2802	0.50	0.28 (0.24 - 0.32)	0.068 (0.060 - 0.076)	0.22 (0.17 - 0.26)	0.51 (0.37 - 0.65)	3.3 (2.8 - 3.9)
2	1010	0.40	0.38 (0.28 - 0.52)	0.070 (0.058 - 0.083)	0.24 (0.18 - 0.31)	0.93^E (0.52 - 1.3)	F

Table 14.5.4.5: trans-3-(2,2-Dichlorovinyl)-2,2-dimethylcyclopropane carboxylic acid (trans-DCCA) (creatinine adjusted) -- Geometric means and selected percentiles of urine concentrations ( μg/g creatinine) for the Canadian population aged 3-79 years by age group, Canadian Health Measures Survey cycle 1 (2007-2009) and cycle 2 (2009-2011).
Cycle	N	%<LOD^{Table c106 footnote a}	GM (95% CI)	10^th (95% CI)	50^th (95% CI)	75^th (95% CI)	95^th (95% CI)
Table c106 footnotes Table c106 footnote 1 If >40% of samples were below the LOD, the percentile distribution is reported but means were not calculated. Return to table c106 footnote a referrer Table c106 footnote 2 Data not available as participants under the age of 6 years were not included in cycle 1 (2007-2009). Return to table c106 footnote b referrer
Total, 3-79 years
1^{Table c106 footnote b}	.	.	.	.	.	.	.
2	2548	0.35	0.28 (0.23 - 0.35)	0.063 (0.055 - 0.070)	0.20 (0.15 - 0.24)	0.57 (0.43 - 0.71)	F
3-5 years
1^{Table c106 footnote b}	.	.	.	.	.	.	.
2	520	0.19	0.39 (0.27 - 0.55)	0.097 (0.063 - 0.13)	0.32 (0.22 - 0.42)	0.78^E (0.48 - 1.1)	F
6-11 years
1	1024	0.29	0.27 (0.24 - 0.31)	0.086 (0.078 - 0.095)	0.21 (0.18 - 0.24)	0.46 (0.37 - 0.54)	2.4^E (1.3 - 3.6)
2	514	0.78	0.24 (0.21 - 0.29)	0.077 (0.068 - 0.087)	0.18 (0.16 - 0.21)	0.43 (0.30 - 0.55)	F
12-19 years
1	976	0.10	0.21 (0.17 - 0.27)	0.056 (0.047 - 0.065)	0.15 (0.11 - 0.20)	0.42^E (0.25 - 0.60)	2.4^E (1.2 - 3.5)
2	509	0	0.21 (0.16 - 0.26)	0.057 (0.049 - 0.065)	0.16 (0.12 - 0.19)	0.32^E (0.092 - 0.54)	2.4^E (1.3 - 3.5)
20-39 years
1	1154	0.61	0.22 (0.19 - 0.26)	0.058 (0.050 - 0.067)	0.17 (0.14 - 0.21)	0.40 (0.31 - 0.49)	2.3^E (1.4 - 3.3)
2	357	0	0.35^E (0.23 - 0.54)	0.059 (0.039 - 0.079)	0.22^E (0.13 - 0.30)	0.58^E (0.28 - 0.89)	F
40-59 years
1	1211	0.58	0.27 (0.23 - 0.33)	0.063 (0.057 - 0.069)	0.20 (0.17 - 0.23)	0.50^E (0.30 - 0.70)	3.6 (2.9 - 4.4)
2	358	0.56	0.27 (0.23 - 0.32)	0.065 (0.051 - 0.079)	0.20^E (0.12 - 0.27)	0.60 (0.43 - 0.76)	F
60-79 years
1	1078	0.37	0.25 (0.21 - 0.31)	0.066 (0.060 - 0.072)	0.20 (0.16 - 0.25)	0.48^E (0.29 - 0.66)	2.9^E (1.7 - 4.2)
2	290	0.69	0.27^E (0.16 - 0.45)	0.052 (0.036 - 0.069)	0.19^E (0.10 - 0.27)	F	F

Table 14.5.4.6: trans-3-(2,2-Dichlorovinyl)-2,2-dimethylcyclopropane carboxylic acid (trans-DCCA) (creatinine adjusted) - Geometric means and selected percentiles of urine concentrations (μg/g creatinine) for the Canadian population aged 3-79 years by sex and age group ^{Table c107 footnote a}, Canadian Health Measures Survey cycle 1 (2007-2009) and cycle 2 (2009-2011).
Cycle	N	%<LOD^{Table c107 footnote b}	GM (95% CI)	10^th (95% CI)	50^th (95% CI)	75^th (95% CI)	95^th (95% CI)
Table c107 footnotes Table c107 footnote 1 Breakdown by sex for the 3-5 year old age group is not recommended. Return to table c107 footnote a referrer Table c107 footnote 2 If >40% of samples were below the LOD, the percentile distribution is reported but means were not calculated. Return to table c107 footnote b referrer Table c107 footnote 3 Data not available as participants under the age of 6 years were not included in cycle 1 (2007-2009). Return to table c107 footnote c referrer
Males, Total 3-79 years
1^{Table c107 footnote c}	.	.	.	.	.	.	.
2	1275	0.31	0.21 (0.18 - 0.25)	0.055 (0.045 - 0.065)	0.17 (0.13 - 0.21)	0.38 (0.27 - 0.49)	F
Males, 6-11 years
1	522	0.19	0.26 (0.22 - 0.30)	0.083 (0.073 - 0.092)	0.20 (0.17 - 0.23)	0.39 (0.30 - 0.49)	2.5^E (0.76 - 4.3)
2	261	0.77	0.24 (0.20 - 0.30)	0.082 (0.065 - 0.098)	0.19 (0.16 - 0.21)	0.46^E (0.25 - 0.66)	F
Males, 12-19 years
1	500	0	0.19 (0.14 - 0.25)	0.054 (0.045 - 0.063)	0.15 (0.11 - 0.19)	0.38^E (0.19 - 0.58)	1.8^E (0.90 - 2.7)
2	254	0	0.17 (0.13 - 0.21)	0.054 (0.046 - 0.063)	0.13 (0.097 - 0.16)	0.24^E (0.13 - 0.34)	1.8^E (<LOD - 3.0)
Males, 20-39 years
1	508	0.79	0.19 (0.16 - 0.24)	0.053 (0.039 - 0.067)	0.14 (0.11 - 0.17)	0.32 (0.22 - 0.43)	2.5^E (<LOD - 4.3)
2	167	0	0.19 (0.14 - 0.25)	0.059 (0.042 - 0.076)	0.17 (0.12 - 0.22)	0.32 (0.23 - 0.42)	X
Males, 40-59 years
1	572	0.35	0.25 (0.19 - 0.31)	0.056 (0.044 - 0.069)	0.19 (0.16 - 0.22)	0.49^E (0.29 - 0.69)	3.9^E (2.0 - 5.8)
2	194	1.03	0.23 (0.18 - 0.29)	0.050^E (0.031 - 0.069)	0.15^E (0.050 - 0.24)	0.51^E (0.28 - 0.73)	X
Males, 60-79 years
1	539	0.19	0.21 (0.18 - 0.25)	0.059 (0.053 - 0.065)	0.16 (0.13 - 0.19)	0.37 (0.24 - 0.51)	1.6^E (0.95 - 2.3)
2	142	0	0.21^E (0.14 - 0.33)	0.039^E (0.017 - 0.060)	0.19^E (0.11 - 0.27)	0.38^E (0.15 - 0.61)	X
Females, Total 3-79 years
1^{Table c107 footnote c}	.	.	.	.	.	.	.
2	1273	0.39	0.38 (0.29 - 0.51)	0.071 (0.058 - 0.083)	0.24 (0.18 - 0.31)	0.93^E (0.53 - 1.3)	F
Females, 6-11 years
1	502	0.40	0.29 (0.24 - 0.34)	0.087 (0.075 - 0.098)	0.22 (0.17 - 0.28)	0.51 (0.36 - 0.67)	2.1^E (0.66 - 3.4)
2	253	0.79	0.24 (0.19 - 0.31)	0.077 (0.067 - 0.086)	0.18 (0.13 - 0.22)

Language selection

Search

Second Report on Human Biomonitoring of Environmental Chemicals in Canada - Tables 13.1.1 to 15.12.6